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RESUMEN 
La brucelosis causada por Brucella abortus es una zoonosis de importancia 
mundial que afecta a animales domésticos, silvestres.  La evolución histórica del 
problema en Costa Rica, desde su primer reporte en los inicios del siglo XX se 
describe en el Capítulo 1.  Igualmente, se discuten las diversas estrategias de 
control aplicadas y las razones por la que esta infección no ha sido controlada ni 
erradicada en el país. Los datos más recientes (2014-2016) sobre la prevalencia por 
hato de la brucelosis bovina en Costa Rica (CR) muestran un rango de entre el 4.1% 
y el 10.5% dependiendo de la prueba diagnóstica usada. En el capítulo 2, se 
describe los muestreos realizados para conocer la seroprevalencia de esta 
enfermedad en cabras, ovejas, cerdos, búfalos y caballos, así como en 16 especies 
de cetáceos. En cabras, ovejas y cerdos se obtuvo una prevalencia nula y B. 
melitensis o B. suis no fueron detectadas en el territorio nacional en animales ni 
humanos. En el caso de caballos y búfalos se reportó una seroprevalencia colectiva 
de 6.5% y 21.7% e individual de 1.4% y 0.65% respectivamente. Se aislaron varias 
cepas de B. abortus en búfalos, pero no en caballos. En los cetáceos se tuvo una 
seroprevalencia individual de 46.9% y se confirmó la infección por B. ceti en el 70 
% de los delfines rayados (S. coeruleoalba) a nivel de sistema nervioso central. En 
el capítulo 3 se describe los análisis del genoma completo (WGS) de éstas B. ceti 
que resultaron ser únicas a nivel mundial (P1-ST26) y su adaptación a estos 
hospederos marinos se debe a procesos de pseudogenización siendo esta una 
fuente de variación genética dentro del género. Adicionalmente, durante este 
período de estudio se logró aislar una Brucella marina (ST27) no clasificable, 
causado placentitis en un cachalote enano (Kogia sima). Esta cepa muestra un 
genoma semejante a las Brucella spp marinas aisladas de humanos. Por su parte, 
los análisis filogenéticos de las B. abortus aisladas, demostraron cinco grupos 
circulando en CR, el más antiguo introducido a mediados del siglo XIX mientras que 
los otros grupos se introdujeron más recientemente durante los siglos XX y XXI.   
Finalmente, en el capítulo 4 se propone una estrategia adaptada para el control la 
brucelosis bovina en Costa Rica. A pesar de que en América Latina existe 
tecnología suficiente para controlar y estudiar la enfermedad, incluidas las técnicas 
de aislamiento e identificación de nueva generación, pocos países han logrado 
describir sistemáticamente la realidad epidemiológica de la brucelosis para bovinos 
y otras especies de mamíferos que sirven de reservorio natural de la brucelosis. Lo 
anterior aunado con el desuso de herramientas diagnósticas y de profilaxis clásicas, 
baratas y comprobadas como efectivas en países que han logrado controlar la 
brucelosis bovina en el pasado, han limitado el avance y la sostenibilidad económica 
y de intervención en nuestros países donde los recursos son limitados. Por lo tanto, 
la información de este trabajo puede servir de ejemplo para los actores involucrados 
en la toma de decisiones para lograr un avance hacia el control y erradicación de la 
enfermedad en Latinoamérica.  
viii 
 
ABSTRACT 
 Brucellosis caused by Brucella abortus is a worldwide zoonosis infecting 
domestic and wildlife animals. The history of the disease in Costa Rica, the 
strategies for its control and the reasons why this infection has not been eradicated 
in the country are discussed in Chapter 1. From 2014-2016, the herd seroprevalence 
of brucellosis in cattle in Costa Rica (CR) ranged between 4.1% and 10.5%, 
depending on the diagnostic tests used. Likewise, the seroprevalence of brucellosis 
in other mammals such as goats, sheep, pigs, water buffaloes, horses, and 16 
species of cetaceans, are described in Chapter 2. B. melitensis or B. suis were not 
found in animals or humans of Costa Rica nor serology in goat, sheep, and pigs. 
However, horses and buffaloes showed a herd seroprevalence of 6.5%, 21.7%, and 
individual seroprevalence of 1.4% and 0.65%, respectively. Several strains of B. 
abortus were isolated in buffaloes, but not in horses. In stranded cetaceans, there 
was an individual seroprevalence of 46.9%, and central nervous system infections 
due to B. ceti were confirmed in 70% of striped dolphins (S. coeruleoalba). In chapter 
3 the whole-genome sequence analyses (WGS) of these B. ceti showed that these 
strains are unique worldwide (P1-ST26) and did suffer host adaptation by 
pseudogenization, which result in a source of genetic variation within the 
genus Brucella. A new strain of marine Brucella named ST27 causing placentitis and 
abortion in a dwarf sperm whale (Kogia sima) was also isolated. This strain displayed 
similar genetic characteristics to those marine Brucellae causing zoonosis in 
humans. The genomic characterization and phylodynamic analysis of the B. 
abortus isolates, showed five clusters circulating in CR, been the oldest introduced 
during the mid of 19th century. The other four clusters were introduced more recently 
during the 20th and 21th century. Finally, in chapter 4, we propose a strategy to control 
brucellosis in Costa Rica.  
 Although there is sufficient technology in Latin America to control and study 
this disease, including identification and new generation techniques, few countries 
have been able to systematically describe the epidemiological reality of brucellosis 
for cattle and other species of mammals that serve as natural reservoir of brucellosis. 
All the above mentioned and combined with the abandonment of classic diagnostic 
and prophylaxis tools, cheap and proven effective in countries that achieve the 
control bovine brucellosis in the past, have limited the progress and sustainability of 
the interventions in our countries where resources are limited. Therefore, the 
information in this work can serve as an example for the actors involved in the 
decision-making process in order to achieve progress towards the control and 
eradication of the disease in Latin America. 
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INTRODUCTION 
 
Our goal has been the description of the epidemiology of brucellosis in Costa 
Rica and to report the presence of the vario species and strains Brucella organisms 
in domestic animals and marine mammals. In order to have a regional perspective, 
we also revise the historical and current situation of Brucella abortus and B. 
melitensis in the Americas and the different strategies used for the control of the 
disease for each country are included (Annex 1 and 2). 
From 2012 to 2014, the Bacteriology Laboratory of the National Animal Health 
Service (SENASA), using commercial culture media, isolated the first three B. 
abortus strains by the Veterinary Services in Costa Rica.   However, in 2015 a new 
culture media for Brucella genus previously developed by Agri-Food Research and 
Technology Center of the Government of Aragon, Spain (CITA), and currently 
recommended by the World Organization for Animal Health (OIE) was introduced 
into the laboratories. After that, greater efficacy was achieved in the isolation 
of Brucellae from clinical samples, secretions, and products of infected animals such 
as abortions, vaginal fluids, organs, milk, and even from tissues of dead animals in 
a moderate state of decomposition. From July 2015 to July 2019, 122 isolates of B. 
abortus from cattle (Bos taurus) and 36 from buffaloes (Bubalus bubalis), 30 B. 
ceti from striped dolphins (Stenella coeruleoalba), a strain from a common dolphin 
(Delphinus delphis), as well as a strain of Brucella spp. ST27, not classifiable with 
standard isolated techniques from a dwarf sperm whale (Kogia sima), was achieved. 
These last two isolates correspond to new hosts in the Eastern Tropical Pacific 
Ocean and not reported so far in the literature. Sera from bovine, goat, sheep, swine, 
equine, cetacean, and humans were collected to make the serological diagnosis and 
estimate the prevalence of brucellosis in the different species in Costa Rica. 
These biological materials were the input for the epidemiological studies and 
the characterization and phylogenetic relationships of the Brucellae present in the 
country. 
In Chapter 1, the history of bovine brucellosis in Costa Rica is described, as 
well as the control and eradication strategies used and the reasons why these 
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strategies have not been effective, and therefore the disease remains endemic in 
the country despite the efforts made. This information is included in the article                
“Epidemiology of bovine brucellosis in Costa Rica: lessons learned from failures in 
the control of the disease” PLoS ONE 12(8): e0182380. 
https://doi.org/10.1371/journal.pone.0182380. 
Chapter 2 includes studies of brucellosis performed in Costa Rica in humans 
and other animal hosts other than cattle. The resulted data was published during 
2017 in the article “Brucellosis in mammals of Costa Rica: an epidemiological 
survey” PLoS ONE, 12(8), e0182644. http://doi.org/10.1371/journal.pone.0182644  
Chapter 3 presents the results of the phylogenetic analyses of marine and 
terrestrial strains obtained in Costa Rica. These analysis are presented in one 
published article and two articles submitted during 2020. The three articles are 
“Brucella genetic variability in wildlife marine mammals’ populations relates to host 
preference and ocean distribution. Genome Biol Evol 2017 
evx137.  https://doi.org/10.1093/gbe/evx137. The second article is “Dwarf sperm 
whale is a reservoir of Brucella sp. ST27, linked to human infections” Emerg Infect 
Dis (submitted), and the third article is “Persistence of Brucella abortus Lineages 
Revealed by Genomic Characterization and Phylo-temporal Analysis”. PLOS 
Neglected Tropical Diseases (submitted). 
Finally, in Chapter 4, based on the results obtained in the previous chapters 
and the current prevalence of bovine brucellosis in the country, we propose a 
strategy for its control in the medium and long term. 
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METHODOLOGIAL STRATEGIES 
The details of the materials methods that were used in this work are 
extensively described in chapters 1 to 3 and the corresponding attached 
publications. In this sense, here, we describe the methodological strategies and the 
experimental route that was followed for the realization of this thesis. 
For Chapter 1, corresponding to “Bovine brucellosis in Costa Rica: lessons 
learned from failure in the control of the disease”, the total number of bovines in CR 
was close to 1.55 million, distributed in about 15000 farms and 50000 herds. For 
sampling purposes, the country was divided into six regions: Northern, Central, 
Brunca, Chorotega, Caribbean Huetar, and Central Pacific. Three different 
management systems are commonly carried out in the country: beef, dairy, and 
double purpose cattle. The seroprevalence of brucellosis in beef, dairy and double 
purpose animals was estimated in a non-random sample and, random sample, 
systematically taken in the different regions of CR. To assess both herd and animal 
prevalence by the management system in the later population, a random sample of 
250 farms per strata, proportionally allocated by region, were sampled. This sample 
size was calculated using public access WinEpiscope 2.0 software (Thursfield et al., 
2001). A farm was declared positive when at least one serum sample resulted 
positive. For sample size, the Cannon & Roe formula to demonstrate freedom 
from/absence of infection (Cannon & Roe, 1982). A total of 765 farms accounting for 
close to 13078 cows were sampled during 2012-2013: 250 dairy herds (3902 cows), 
254 beef herds (4485 cows), and 261 dual- purpose herds (4691 cows). In addition, 
a non-random serum sample of 532199 cows comprising 7907 herds (~16% of CR 
herds), arriving during 2014-2016 to the laboratories of the Veterinary Services for 
routine diagnoses, were analyzed. For all purposes, repeated herds were 
considered. Relevant data concerning the geographical localization, area of the farm 
and management characteristics of the herd or individual animals were collected in 
addition to other relevant information. In both studies, the diagnostic strategy was 
first, screening all bovines by RBT, and then testing of the RBT positives (RBT+) by 
iELISA (OIE, 2018). Necropsies or sample collection were carried out as described 
elsewhere (OIE, 2018). Animal samples included blood, tissues, secretions, and 
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aborted fetuses Cultures were done using non-selective and selective media (OIE, 
2018). The selected bacterial colonies were subjected to identification following 
regular bacteriological procedures (Alton et al., 1988). References from different 
Brucella species were used for comparative purposes during all the procedures (Le 
Flèche et al., 2006).  Brucella DNA from control and field isolates were extracted as 
described previously (Le Flèche et al., 2006) with and the identification of Brucella 
species was performed by multiple-ocus variable-number tandem repeat analysis-
16 (MLVA16) following standard procedures (Le Flèche et al., 2006, CNRS, 2017). 
Control Brucella species were used for validation. In all procedures, we followed the 
ethical considerations established by the different organisms and ethical committees 
of Costa Rica (Procuraduría General de la República, 1994, 2006, 2012). 
For Chapter 2, “Brucellosis in mammals of Costa Rica”, the national territory 
was divided into the same six regions, mentioned above. The estimated population 
of sheep and goats in CR was close to 12358 and 4626, distributed in about 164 and 
271 herds, respectively. In the case of water buffaloes, the estimated population was 
13000 animals within 100 herds, for pigs close to 435500 animals, for horses 67000 
and 30 species of cetaceans.  For sampling purposes, the herds of sheep and goat 
were divided into three sections. For sheep, the first section “A” included 6200 
animals in 22 herds of broodstock farms with ≤150 individuals; section “B” were 3577 
animals in 37 herds from farms with eventual broodstock activities, with populations 
ranging from 149-60 animals; and section “C” were 2691 in 105 herds for productive 
farms with population of ≤ 59 animals. For goats, we used the same criteria used for 
sheep. Section “A” included 1406 goats in 13 herds; section “B” were 1603 
distributed in 14 herds; and section “C” were 1617 from 137 farms. Seventy-eight 
caprine and 139 ovine herds, corresponding to 2013 and 1668 animals, respectively, 
were selected. In the case of water buffaloes, a total of 2586 animals from 46 herds 
were sampled. A total of 2256 blood samples from pigs coming from eight herds, 
160 blood from slaughterhouses, and 58 feral pigs from East side of Cocos Island 
National Park were taken. For horses, 1270 animals from 215 farms were sampled, 
and for stranded cetaceans 54 were analyzed.  The sample sizes for sheep and 
goats were determined according to Cannon and Roe (Cannon & Roe, 1982), using 
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Win Episcope 2.0 software (Thursfield et al., 2001). This estimation included 500 
sheep and 413 goats to be sampled, distributed in 10 and 13 herds respectively, 
selected by region as described above. Sheep and goat herds were chosen 
randomly from sections A and B, which are the broodstock herds, and largely 
reflected the sanitary conditions of section C.  In the random sampling, a biased 
priority was given to females with a history of reproductive problems and low body 
condition, in order to increase the probability of positive results. Breeding rams in 
each farm were also examined for the detection of orchitis, epididymitis and 
reproductive problems. For feral pigs, the size of the sample was selected for an 
expected maximum population of 500 pigs distributed in the entire island. The rest 
of the animal species sampled corresponded to the surveillance performed as part 
of the National Brucellosis Control Program of the CR-NAHS and according to the 
OIE serological assays, as mentioned above (OIE,2018). The bacteriological and 
molecular analyses were performed, as mentioned for Chapter 1. 
Protocols for the use of animal serum samples were revised and approved by 
the “Comite Institucional para el Cuido y Uso de los Animales de la Universidad de 
CR (CICUA 057-16366), and “Comite Institucional para el Cuido y Uso de los 
Animales of the National University, Heredia, CR (SIA 0545-15), and in agreement 
with the corresponding law “Ley de Bienestar de los Animales, CR” (Ley 7451 on 
Animal Welfare), and according to the “International Convention for the Protection of 
Animals” endorsed by Costa Rican Veterinary General Law on the CR-NAHS (Ley 
8495). 
For Chapter 3, corresponding to “Phylogenetic characterization of marine and 
terrestrial Brucellae isolated in Costa Rica”, 23 isolations of Brucella ceti from 
stranded striped dolphins with neurobrucellosis from the Eastern Tropical Pacific, as 
well as four from the Mediterranean Sea, nine from the North Atlantic Ocean, one 
from France, four Brucella pinnipedialis from the North Atlantic Ocean, and one 
Brucella sp. from California were used. Genotyping techniques such as multiplex 
PCR Bruceladder, MLST, PCR detection of ST27 or bcsp31, HRMRT-PCR and PCR 
targeting specific IS711 elements were performed either as previously described or 
in silico. The terrestrial strain included a total of 95 B abortus strains isolated from 
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bovines, water buffaloes, and humans in Costa Rica. Both marine and terrestrial 
strains were sequenced at the Wellcome Trust Sanger Institute on Illumina platforms 
according to in house protocols for wholegenome sequencing (WGS) (Quail et al., 
2008, 2012).  
To construct a multiple sequence alignment for phylogenetic reconstruction, 
whole-genome sequence data from two Ochrobactrum species and the Brucella 
isolates from different hosts were aligned by bwa and mapped with SMALT v.0.5.8 
against B. abortus 9-941, with an average coverage of 98.81%. Single Nucleotide 
Polymorphisms (SNPs) were called using samtools (Li et al., 2009), and 311,780 
variable sites were extracted using snp sites (Page et al., 2016). The resulting 
alignment was used for maximum likelihood phylogenetic reconstruction with RAxML 
v7.0.4 (Stamatakis., 2006). 
To detect pseudogenes in B. ceti, we selected five phylogenetically 
representative draft genomes from marine mammal Brucellae and automatically 
transferred the annotation of the manually curated draft genome working strain B. 
abortus 2308 Wisconsin (Suárez-Esquivel et al. 2016). Pseudogenes were defined, 
as any gene containing deletions or insertions that removed start or stop codons, or 
at least one in-frame stop codons and/or frame shifts compared with orthologs in B. 
abortus 2308 Wisconsin or reference genomes.To examine relevant phenotypic 
genes (virulence-related, outer membrane, lipopolysaccharide [LPS] and flagellar 
genes), regions of interest were examined, as mention before, through bwa 
alignment and SMALT mapping. The number of SNPs, insertions and deletions in 
each one of the genes was recorded. 
For the study of B. abortus strains, a total of 167 isolates of B. abortus from 
bovines, 16 from humans, and 5 from water buffaloes were included in the study.  
From these isolates, 95 were analyzed by WGS, as previously described. The origin 
and dates of the introduction of circulating B. abortus strains in CR were explored by 
calibrating the B. abortus phylotemporal events and comparing the nodes and dates, 
according to the incursions of bovine species and breeds into the territory. A SNPs 
matrix, including 322266 sites from 228 Brucella spp. genomes and two 
Ochrobactrum spp. genomes as outgroup was aligned to the reference strain B. 
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abortus 9-941 to produce a maximum likelihood phylogenetic tree.   To characterize 
each one of the CR lineages, we looked at known genomic traits associated with 
variability in Brucella (Ocampo-Sosa and García-Lobo, 2008b; Wattam et al., 2009; 
Mancilla et al., 2011; that could provide information to explain phenotypic or infective 
behavioral differences among the isolates. For that, we identified the SNPs position 
on specific coding sequences (CDS), checked for changes in genomics islands (GI) 
or anomalous regions, and assessed the number and positions of the insertion 
element IS711 within the lineages. Bayesian Evolutionary Analysis Sampling Trees 
(BEAST) were used, to determine the time of the introduction events of the different 
CR B. abortus lineages. All procedures involving live Brucella were carried out 
according to the “Reglamento de Bioseguridad de la CCSS 39975- 0”, year 2012, 
after the “Decreto Ejecutivo #30965-S”, year 2002 and research protocol NFEG06 
approved by the National University, Costa Rica. 
For Chapter 4, “Proposal for a suitable strategy to control brucellosis in Costa 
Rica” the information of brucellosis at national level mentioned in chapters 1 and 2 
was used as well as, the information summarized in Annex 1 of the experience of all 
the countries in the Americas for the control of the disease and strategies used in 
the last ninety years, by each one of them. At national level, this information included 
the current epidemiological status of the disease, animals, and bacterial species 
involved in the natural cycle of brucellosis within the country, scarce or null economic 
support, or resources for control of the disease  
1 
 
Chapter 1: Bovine brucellosis in Costa Rica: lessons learned from failure in 
the control of the disease.  
Brucellosis, caused by Brucella abortus, is a major disease of cattle and a 
zoonosis. Several studies for estimating the seroprevalence of bovine brucellosis in 
CR have been carried out. The last trial before this work was in 1982 (Vicente et al., 
1983). Therefore, after more than three decades, we undertook a new investigation 
covering all regions of the country to estimate the prevalence and distribution of 
brucellosis in Costa Rica (CR) and describe the species and circulating strains of the 
genus Brucella in the country.  The prevalence estimated by Rose Bengal test (RBT) 
ranged from 10.5%-11.4%; alternatively, the prevalence estimated by testing the 
RBT positives in iELISA ranged from 4.1%-6.0%, respectively. 
However, cattle in CR are not vaccinated with B. abortus S19, but with RB51 
(vaccination coverage close to 11%), and under these conditions, the RBT displays 
99% specificity and 99% sensitivity. Therefore, the RBT herd depicted in the random 
analysis stands as a feasible assessment. Studies of three decades revealed that 
bovine brucellosis prevalence has increased in CR.  
Biochemical and molecular studies identified B. abortus as the etiological 
agent of bovine brucellosis. Multiple locus variable-number tandem repeat analysis-
16 revealed four B. abortus clusters. Cluster one and three are intertwined with 
isolates from other countries, while clusters two and four have only representatives 
from CR 
Cluster one is widely distributed in all regions of the country and maybe the 
primary B. abortus source. The other clusters seem to be restricted to specific areas 
in CR. The implications of our findings, in relation to the control of the disease in CR, 
are critically discussed.  
Chapter 1 includes the following paper: Hernández-Mora, G., Ruiz-Villalobos, 
N., Bonilla-Montoya, R., Romero- Zúñiga., J.J, Jiménez-Arias, J., González-
Barrientos, R., Barquero Calvo, E., Chacón- Díaz, C., Rojas, N., Chaves-Olarte, E., 
Guzmán-Verri C., Moreno, E. Epidemiology of bovine brucellosis in Costa Rica: 
lessons learned from failures in the control of the disease. PLoS ONE 12(8): 
e0182380. https://doi.org/10.1371/journal.pone.0182380 
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Abstract
Brucellosis, caused by Brucella abortus is a major disease of cattle and a zoonosis. In order
to estimate the bovine brucellosis prevalence in Costa Rica (CR), a total 765 herds (13078
bovines) from six regions of CR were randomly sampled during 2012–2013. A non-random
sample of 7907 herds (532199 bovines) of the six regions, arriving for diagnoses during
2014–2016 to the Costa Rican Animal Health Service was also studied. The prevalence
estimated by Rose Bengal test (RBT) ranged from 10.5%-11.4%; alternatively, the preva-
lence estimated by testing the RBT positives in iELISA, ranged from 4.1%-6.0%, respec-
tively. However, cattle in CR are not vaccinated with B. abortus S19 but with RB51
(vaccination coverage close to 11%), and under these conditions the RBT displays 99%
specificity and 99% sensitivity. Therefore, the RBT herd depicted in the random analysis
stands as a feasible assessment and then, the recommended value in case of planning an
eradication program in CR. Studies of three decades reveled that bovine brucellosis preva-
lence has increased in CR. B. abortus was identified by biochemical and molecular studies
as the etiological agent of bovine brucellosis. Multiple locus variable-number tandem repeat
analysis-16 revealed four B. abortus clusters. Cluster one and three are intertwined with iso-
lates from other countries, while clusters two and four have only representatives from CR.
Cluster one is widely distributed in all regions of the country and may be the primary B. abor-
tus source. The other clusters seem to be restricted to specific areas in CR. The implications
of our findings, in relation to the control of the disease in CR, are critically discussed.
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Introduction
As any other Latin American country, bovine brucellosis is a significant animal health problem
and a relevant zoonosis in Costa Rica (CR). Consequently, the disease is of veterinary and of
public health relevance. Bovine brucellosis (then recognized as “Bang´s disease”) was clinically
described in the Central Valley and in the volcanic highlands at the end of the XIX century,
when different breeds of cattle were imported from United States and Europe. The introduc-
tion of zebu breeds to CR, mainly from Brazil, initiated at the start of XX century; thereafter,
brucellosis was officially recognized as an endemic disease [1–7]. However, cattle exist in CR
since 1560, after the introduction of European breeds by the Spanish conquerors from neigh-
boring Nicaragua and Honduras countries. After this, recurrent abortions and reproductive
problems of cattle due to brucellosis have been reported until the present time [6].
Although in 1900 the bovine population in CR was close to 350000 [6], brucellosis became
just a notifiable disease in 1915, after the first Brucella sp. isolation from the blood of a human
patient [7,8]. Intervention measures by the Costa Rican National Animal Health Service
(CR-NAHS) aimed to the control of the disease in cattle started in 1950 [9]. At that time,
reports of “epidemic” abortions, smooth B. abortus S19 vaccination and agglutination diagnos-
tic tests were the only strategies followed. In 1958, the serological diagnosis of brucellosis in
bovine herds was declared obligatory and a national campaign for the control and eradicated
of the disease started under voluntary basis with B. abortus S19 calf vaccination and elimina-
tion of the positive reactor animals [10]. At that time the importation of S19 vaccine was under
the supervision of the CR-NAHS.
From 1963 to 1965, CR suffered constant ash eruptions of the Irazu´ volcano, affecting areas
of the Central Valley and the surrounding highlands. This natural disaster forced the authori-
ties to abandon the brucellosis program and to allocate the economic resources and personnel
in solving the emergency. This natural disaster favored the unrestricted traffic of animals from
the affected areas to other regions. Nowadays, and despite the current legislation for traceabil-
ity of bovine movements nationwide [11], the brucellosis status of the animals is seldom
requested and, therefore, infected animals may still be mobilized from one region to another.
However, this undisciplined movement of bovines was diminished during the recent ash erup-
tions of the Turrialba volcano in 2015–2016, when nearly 300 (90%) of the surrounding volca-
nic herds were tested for brucellosis and the positive animals slaughter before their transfer to
safer areas [12,13].
In spite of the efforts, the first attempts for controlling brucellosis failed and in the seventies
bovine brucellosis was already widespread in CR [9,10,14]. With a loan from the Inter-Ameri-
can Development Bank, additional actions to implement a brucellosis control program on an
obligatory basis were undertaken [14]. Still, those were difficult times for Central America.
Although CR did not have internal military conflicts, the critical growing political upheaval
against authoritarian regimes in several neighboring Central American nations negatively
impacted the country. In addition, during the early eighties CR suffered a severe economic
recession. As consequence, the field activities devoted to the control of brucellosis, such as S19
vaccination, test and slaughter considerably diminished [10,15].
Although not implemented, the obligatory basis of the control program remained until
1999, period at which the legislation for the National Bovine Brucellosis Program was finally
modified to a voluntary basis by the CR-NAHS in coordination with the livestock producers,
the milk industry, other private enterprises and non-governmental organizations [16].
Following, the eradication of brucellosis in United States and Canada with B. abortus S19
and the corresponding banning of vaccination policies in these countries, rough B. abortus
RB51 vaccine was implemented in CR in 1999 [17]. Although S19 vaccination is still allowed
Bovine brucellosis in Costa Rica
PLOS ONE | https://doi.org/10.1371/journal.pone.0182380 August 10, 2017 2 / 17
partially sponsored by scholarships project of
Ministerio de Ciencia, Tecnologı´a y
Telecomunicaciones (MICITT-PINN) PND-033-15-
2 and NR-V by University of Costa Rica
scholarships project 803B4.5010, 17-12-15. The
funders had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
[18], the importation of this smooth vaccine strain was interrupted in 2000 by the CR-NAHS.
For all practical purposes the vaccination with S19 was abandoned in the country and in the
Central American region [17]. Since 1999, private enterprises, mainly the dairy companies, are
devoted to immunize a low number of herds with RB51 vaccine [10,19].
Currently, vaccination and most of the serological testing of the bovines is on voluntary
basis. However, CR-NAHS may request testing of the animals for epidemiological surveillance
or upon suspicion of brucellosis. By law, all animals depicted as positive must be marked and
thereafter slaughter with no further indemnity [19].
Several studies for estimating the prevalence of bovine brucellosis in CR have been carried
out (Fig 1). The last trial before this work was made in 1982 [14]. Therefore, after more than
three decades we undertook a new investigation covering all different regions of the country.
In this work we describe the distribution of bovine brucellosis, the updated prevalence of the
infection and the B. abortus strains circulating in CR during the lapse of 2012–2016. We also
critically discuss the epidemiological implication of our findings in relation to the control pro-
grams and the vaccination strategies carried out in CR during the last decades. Distribution
and prevalence of brucellosis in other susceptible hosts in CR such as sheep, goats, water buffa-
loes, pigs, horses, dolphins and humans are described in an accompanying paper [20].
Materials and methods
Geography of Costa Rica
CR is a country located in the middle of the Central American isthmus with a surface area of
51100 Km2 with Pacific Ocean and Caribbean Sea coastlines of 1016 km and 212 km, respec-
tively. To the North, CR borders with Nicaragua and to the Southwest with Panama. It has
been estimated that CR has sixty volcanos, most of them extinct or dormant, but six of them
are active. All the volcanos are aligned in a volcanic range were large part of the National parks
Fig 1. Prevalence of bovine brucellosis in CR during five decades estimated by agglutination tests.
The prevalence from 1965–1969 was assessed by tube agglutination; the prevalence from 1970–1986 was
assessed by card test in combination with 2- mercaptoethanol agglutination assay; the prevalence from
1987–1994 were estimated by RBT [10,14]. Prevalence values from 2012–2016 assessed by RBT are from
this work.
https://doi.org/10.1371/journal.pone.0182380.g001
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are located. The country is divided in seven provinces, with a human population close to five
million, most of them living in the Central Valley, between the volcanic chain and the moun-
tain range. Socioeconomically the country is divided in six regions: Northern, Central, Brunca,
Chorotega, Caribbean Huetar and Central Pacific [21]. The total number of bovines in CR is
close to 1.55 million, distributed in about 15000 farms and 50000 herds (S1 Table) [22]. Three
different management systems are commonly carried out in the country: beef, dairy and dou-
ble purpose cattle. Most dairy farms of European breeds (Bos taurus) are located in the high-
lands (from 1000–2500 m); while in the low lands (below 1000 m) are most of the zebu (Bos
indicus) and mixed breeds (e.g. cebu-holstein cross), used for beef or double purpose produc-
tion, respectively [22].
Study population and statistics
The seroprevalence of brucellosis in beef, dairy and double purpose animals were estimated in
two bovine populations: i) a non-random sample from sera arriving to the CR-NAHS labora-
tories for regular diagnosis from herds with history of brucellosis, abortion, reproductive
problems, commercial transactions, attendance to exhibitions, exportations and importation
of cattle and bovines from herds declared “brucellosis free”, and; ii) a random sample system-
atically taken in the different regions of CR. To assess both herd and animal prevalence by
management system in the later population, a random sample of 250 farms per strata, propor-
tionally allocated by region, were sampled. This sample size was calculated using public access
WinEpiscope 2.0 software [23], fitting the following parameters: bovine herd prevalence of
10%, confidence level of 95% and accepted error of 4% for 235 farms; however, it was decided
to sample a total of 250 farms per region. A farm was declared positive when at least one
serum sample resulted positive. For sample size, the Cannon & Roe formula to demonstrate
freedom from/absence of infection, the expected prevalence was adjusted to 15% and a confi-
dence level of 95% [24]. The estimated herd prevalence was founded on the average herd prev-
alence obtained on pilot study performed in dairy herds in the highlands of the Central Valley
of CR. This model does not strictly estimate the within-herd prevalence, but assess the pres-
ence of disease. In both studies, the diagnostic strategy was first, screening all bovines by RBT,
and then testing of the RBT positives (RBT+) by iELISA.
The univariate prevalence analysis at the global level and according to production system,
were calculated by RBT and RBT++iELISA. In addition, bivariate prevalence for production
system by region was also estimated. The prevalence confidence intervals were calculated
using beta distribution in the Program @risk [25]. Due to the 99% sensitivity and 99% specific-
ity of the RBT in the absence of S19 vaccination [26,27], a perfection assay was assumed in the
analyses.
Serum samples
For sampling purposes, the six socioeconomically divided regions of CR were tested (Fig 2). A
total of 765 farms accounting for close to 13078 cows (2–6 years of age) were sampled (X ¼ 18
cows/farm) during 2012-2013-year period: 250 dairy herds (3902 cows), 254 beef herds (4485
cows) and 261 dual purpose herds (4691 cows). In addition, a non-random serum sample of
532199 cows (~35% of the CR bovines) of the six regions (X ¼ 67 cows/farm) comprising
7907 herds (~16% of CR herds), arriving during 2014–2016 to the laboratories of the
CR-NAHS for routine diagnoses, were analyzed. For all purposes, repeated herds were taken
into account. For epidemiological purposes, no distinction between breeds or bovine species
was considered during the survey.
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Blood samples were collected with a syringe or a sterile vacutainer with Z serum clot activator
(Vacutainer System, Greiner Bio-one), transported in refrigeration conditions and sera obtained
by centrifugation. Each sampled received an individual consecutive number upon arrival to the
laboratory. Analyses of the sera were performed within 24–72 hours after collection or arrival at
the National Veterinary Laboratories of the CR-NAHS in Heredia, CR, or the Immunology Lab-
oratory of Medicine Veterinary School of the National University, Heredia, CR.
Information collected for bovine sample
Relevant data concerning the geographical localization, area of the farm and management
characteristics of the herd or individual animals, were collected. The information also included
the presence of other domestic and wildlife species, veterinary services, reproductive parame-
ters and history of abortion/stillbirth, replacement animals, and history of vaccination against
brucellosis. Breed and individual identification was registered.
Serological tests
Rose Bengal test (RBT) (ID-VET, France) was used as general screening test [28]. Indirect pro-
tein A/G ELISA (iELISA) (ID-VET, France) and competitive ELISA (cELISA) (Svanovir,
Fig 2. Sampling of cattle farms in the six regions of Costa Rica. (A) A total of 750 farms accounting for
close to 18000 cows (2–6 year-old) were sampled during 2012–2013 year period: 250 dairy herds (3902
cows), 254 beef herds (4485 cows) and 261 dual purpose herds (4691cows). (B) Map of CR indicating the
different sapling regions (depicted by numbers). Areas of low density of sampling correspond to national parks
or protected areas devoid of cattle.
https://doi.org/10.1371/journal.pone.0182380.g002
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SVANOVA, Sweden) were used as confirmatory tools as described elsewhere [28]. Standardi-
zations of RBT, iELISA and cELISA were performed as described previously [27]. The cut-off
values and the specificities and sensitivities of the iELISA and cELISA have been previously
established [27,29]. All bovine sera samples were initially screened by RBT and the positives
then tested by iELISA and cELISA.
Culture conditions and Brucella identification
The following strains obtained from PIET/CIET strain collections were used as controls for
biochemical and molecular studies: Brucella ceti Atlantic dolphin type (B14/94), B. ceti Atlantic
porpoise type (B1/94), Brucella pinnipedialis seal type (B2/94), Brucella abortus 2308W (biovar
1 virulent reference strain), B. abortus S19 (biovar 1 reference vaccine strain), Brucella meliten-
sis Rev1 (biovar 1 reference vaccine strain), Brucella suis (S2 biovar 1), Brucella canis (CR206-
10; CR isolate), Brucella neotomae 5K33 (reference strain), Brucella ovis PA (virulent reference
strain) and Brucella microti (CCM4915, reference strain).
According to the National Brucellosis Control Program of the CR-NAHS of the Ministry of
Agriculture and Livestock Management, all diagnosed seropositive cattle were selected for
obligatory culling [19]. Necropsies or sample collection were carried out at the Pathology
Department in the Veterinary School of Universidad Nacional, CR and official slaughter-
houses. Animal samples included milk and other secretions such as vaginal swabs and semen,
reproductive organs, lymph nodes, spleen, kidney and liver. In some cases, aborted fetuses
were also collected and sampled. Cultures were done at the Bacteriology Laboratory of the Vet-
erinary School and at the laboratories of SENASA, using non-selective and selective media
including blood agar and Columbia agar, supplemented with 5% of dextrose and sheep blood
as well as Modified Brucella Selective Supplement (Oxoid1 (SR0209) and CITA medium [30].
Cultures were incubated in 10% CO2 atmosphere at 37˚C for at least two weeks. The selected
bacterial colonies were subjected to Gram staining, agglutination with acriflavine and acridine
orange dyes and tested for urease and oxidase activity, citrate utilization, nitrate reduction,
H2S production, growth in the presence of thionin (20 μg/mL) and basic fuchsin (20 μg/mL)
and uptake of crystal violet according to described procedures [31].
Brucella DNA samples from each isolate and control strains were extracted with DNeasy
Blood & Tissue kit from QIAGEN 1, and stored at -80˚C until used. Identification of Bru-
cella species was performed by multiple locus variable-number tandem repeat analysis-16
(MLVA16) following standard procedures [32]. Brucella control strains were used for valida-
tion. The profiles were entered in the database MLVA-NET for the corresponding analysis
[33].
Ethical considerations
The sampling of bovines is part of the National Brucellosis Control Program of the CR-NAHS
of the Ministry of Agriculture and Livestock Management [19] and the Law of Reportable
Infectious Diseases of the Ministry of Health of CR [34]. Protocols for the use of bovine serum
and tissue samples were revised and approved by the ‘‘Comite´ Institucional para el Cuido y
Uso de los Animales de la Universidad de CR”(CICUA 057–16366), and ‘‘Comite´ Institucional
para el Cuido y Uso de los Animales” of the Universidad Nacional, CR (SIA 0434–14 and SIA
0545–15), and in agreement with the corresponding law ‘‘Ley de Bienestar de los Animales”,
CR [35], and according to the “International Convention for the Protection of Animals”
endorsed by Costa Rican Veterinary General Law on the CR-NAHS [36].
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Results
In CR the CR-NAHS uses RBT as screening tests and iELISA and cELISA as confirmatory
assays [37]. Following this, the results obtained in the analysis of non-random and random
samples are presented in Table 1. The RBT herd prevalence levels obtained between the non-
random and the random samples were 11.4 and 10.5, respectively. When positive RBT sera
was tested by iELISA, the estimated herd prevalence values lowered to 6 and 4.1 respectively
Comparable prevalence values observed by RBT++iELISA were obtained when RBT positives
were tested by cELISA. The confidence limit 95% of the random sample was 3–6, in rounded
numbers. Statistical significance comparisons were made among the different management
systems, the random and non-random samples and among the various serological assays used.
The only result that showed significant difference in RBT was the double purpose herds in the
non-random sampling. When positive RBT samples were tested by iELISA, the results of dairy
herds from the non-random sampling were significantly different from the other two manage-
ment systems. Finally, when comparing both samplings procedures, there were significant dif-
ferences in the results between beef and double purpose cattle (Table 1).
The higher brucellosis RBT prevalence levels in the non-random (Table 2) and random
sampling (Table 3) were obtained with double purpose cattle from the Northern Huetar
(17.2% and 17%, respectively) and the Caribbean Huetar (20.2% and 13%, respectively) been
the latter one the poorer and less developed of CR. In the case of beef cattle, the regions with
Table 1. Herd and bovine brucellosis reactors according to management system and sampling procedures*.
Management System Number RBT (%) RBT++IELISA
Non-random sample from 2014-2016 Herds Beef 806 90 (11.2) aα 56 (6.9) cδ
Dairy 4479 431 (9.6) aβ 186 (4.2) dε
Double purpose 2622 377 (14.4) bγ 231 (8.8) cζ
Total 7907 898 (11.4) 473 (6.0)
Bovines Beef 48129 414 (0.9) 320 (0.7)
Dairy 346326 481 (0.1) 299 (0.1)
Double purpose 137744 569 (0.4) 463 (0.3)
Total 532199 1464 (0.3) 1082 (0.2)
Random sample from 2012–2013 Herds Beef 254 24 (9.4) aα 8 (3.1) cη
Dairy 250 22 (8.8) aβ 11 (4.4) cε
Double purpose 261 34 (13.0) aγ 12 (4.6) cθ
Total 765 80 (10.5) 31 (4.1)
Bovines Beef 4485 33 (0.7) 9 (0.2)
Dairy 3902 37 (1.0) 15 (0.4)
Double purpose 4691 90 (1.9) 50 (1.1)
Total 13078 160 (1.2) 74 (0.6)
* Numbers in parenthesis indicate the seroprevalence. Latin alphabet letters (a-c) represent statistical differences of p 0.05 values, among productive
systems, within the sampling method. Greek alphabet letters (α-θ) represent statistical differences of p 0.05 values among productive systems, sampling
methods and according to type of serological test. Letters “a” and “c” within the same column indicate no significant statistical differences among the various
management systems and among the non-random and random sampling. On the contrary, letters “b” and “d” indicate that there are significant statistical
differences among the various management systems and among random and non-random sampling. Greek letters “α”, “β” and “γ” indicate that there are not
significant statistical differences among the RBT results between the non-random and the random sampling. Alternatively, Greek letters “δ”, “ζ”, “η”, “θ”
depict significant statistical differences among the results obtained in RBT++iELISA within the sampling method. On the contrary, the Greek letter “ε”
indicates no significant statistical differences among the two sampling methods using RBT++iELISA. In the random sample, the confident limit 95% for beef
cattle ranged from 1.6–6.1, for dairy cattle from 2.5–7.7, for double purpose cattle from 2.7–7.9 and for the total population of animals from 2.8–5.7. Bovine
population in CR shown in S1 Table.
https://doi.org/10.1371/journal.pone.0182380.t001
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the highest number of RBT positive herds in the random and non-random samples were also
the Northern Huetar (15.1% and 9%, respectively) and Caribbean Huetar (23.9% and 23%,
respectively); while the largest numbers of RTB positive dairy herds were detected in the Cen-
tral (9.5% and 11.9%, respectively) and Caribbean Huetar (15.8% and 20%, respectively)
regions. Due to the small number dairy herds in the Central Pacific region, fewer farms were
sampled. In spite of this, positive herds were detected. As expected and regardless of the sam-
ple method, when positive RBT samples were tested by iELISA, the prevalence values were
lower but commensurate to the RBT in the same regions (Tables 1 and 2). The RB51 animal
vaccination coverage for five-year period was estimated in 11%, being more frequent in
bovines from dairy farms. Although it was not possible to assess the actual numbers or RB51
revaccinated bovines, we confirmed that it was a common and a recommended practice in CR.
B. abortus has been isolated from dairy, meat and double purpose cattle in all the six regions
of CR (Fig 3A). Consistent with previous findings [38,39], B. abortus biovar 1, 2 and 3 were
isolated in different latitudes of CR. B. abortus MLVA16 clusters were estimated based on
differences in three or less tandem repetitions. Following this, the MLVA16 analysis of 326
strains demonstrated that the CR B. abortus stains (S2 Table) clustered in four main groups
(MLVA16 meta-data accessible at http://microbesgenotyping.i2bc.paris-saclay.fr/), suggesting
at least four different B. abortus founders (Fig 3B). Bacteria in cluster one corresponds to the
main group, harboring most of the CR isolates; while clusters two, three and four are repre-
sented by just a few isolates. Cluster one also includes clinical isolates from aborted fetuses
which were identified as B. abortus RB51 vaccine by Bruce-ladder and supported by MLVA16
(baboCR58 and baboCR57). Clusters one and two are intertwined with B. abortus from differ-
ent latitudes. For instance, within cluster one there are isolates from central Europe, USA,
Table 2. Herd prevalence in a non-random sample according to region and management system 2014–2016.
Region Beef Milk Double purpose Total
N˚ Herd RBT RBT++ iELISA N˚ Herd RBT RBT+ iELISA N˚ Herd RBT RBT++ iELISA N˚ Herd RBT RBT++ iELISA
1. Northern Huetar 73 15.1 8.2 1441 11.5 4.1 1048 17.2 11.0 2562 13.9 7.0
2. Central Region 74 5.4 2.7 2037 9.5 4.9 262 8.4 6.1 2373 9.3 4.9
3. Brunca Region 510 10.9 7.5 380 5.2 0.2 446 13.2 3.3 1336 10.1 4.0
4. Chorotega
Region
82 6.1 2.4 431 6.0 3.2 365 7.9 5.7 878 6.8 4.2
5. Caribbean Huetar 46 23.9 19.6 114 15.8 11.4 396 20.2 15.4 556 19.6 14.9
6. Central Pacific 21 14.2 9.5 76 10.5 0.0 105 6.6 1.9 202 8.9 1.9
Total 806 11.1 7.3 4479 9.6 4.1 2622 14.4 8.8 7907 11.3 6.0
https://doi.org/10.1371/journal.pone.0182380.t002
Table 3. Herd prevalence in a random sample according to region and management system 2012–2013.
Region Beef Milk Double purpose Total
N˚ Herd RBT RBT++ iELISA N˚ Herd RBT RBT++ iELISA N˚ Herd RBT RBT++ iELISA N˚ Herd RBT RBT++ iELISA
1. Northern Huetar 55 9.0 3.6 67 4.4 3.0 117 17.0 8.5 239 11.7 5.9
2. Central Region 32 12.5 0.0 109 11.9 4.6 30 6.7 0.0 171 11.1 2.9
3. Brunca Region 54 1.9 1.9 40 10.0 0.0 35 1.9 0.0 129 4.7 0.8
4. Chorotega
Region
53 9.4 1.9 15 6.6 0.0 48 12.5 2.1 116 10.3 1.7
5. Caribbean Huetar 43 23.2 9.3 15 20.0 20.0 23 13.0 4.3 81 16.0 9.9
6. Central Pacific 17 11.7 0.0 4 25.0 25.0 8 0.0 0.0 29 10.3 3.4
Total 254 10.6 3.1 250 10.0 4.4 261 12.3 4.6 765 10.5 4.1
https://doi.org/10.1371/journal.pone.0182380.t003
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India and Brazil. Likewise, cluster three is intertwined with isolates from central Europe, India
and Brazil. In contrast, cluster two and four seem to have only representatives from CR. While
cluster one is found in all the six regions of CR, cluster three seems confined to the northern
areas of the Caribbean Huetar and Chorotega regions and cluster four mainly to the Central
and southern areas of the Brunca region. Cluster two is represented just by two isolates con-
fined to the Central region.
Discussion
We have analyzed the brucellosis herd prevalence in CR by random and non-random meth-
ods. The rational of these two schemes is different: while the random sampling is based on a
probability theory in which each herd in the population is identified, and has an equal chance
of being in the sample; the non-random sampling takes advantage of the samples routinely
available for diagnoses. This last non-probability sample is useful for quick and inexpensive
studies and for developing hypotheses. When non-random schemes include a large number of
individuals and herds within a given population -as it is our case- the values rendered by the
analysis may complement the random analysis, and therefore, useful to enforce or deny the
hypothesis.
Depending on the strategy employed, brucellosis prevalence varies. For instance, if the
RBT results are used as sole parameters, then the prevalence ranges from 10.5% to 11.4%.
Fig 3. MLVA16 dendogram of B. abortus isolates from different regions of Costa Rica. (A) Map of CR indicating the different
regions from which B. abortus were isolated (circles). The color of the circles corresponds to the I-IV clusters, respectively. (B)
MLVA16 dendogram constructed from the analysis of 107 B. abortus isolates (depicted in blue lines) are compared with MLVA16 of
219 B. abortus representative isolates from other latitudes (indicted in black lines). Clusters I to IV are indicted in the figure. S2
MLVA16 genetic profiles for the CR B. abortus isolates are presented in S2 Table.
https://doi.org/10.1371/journal.pone.0182380.g003
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Alternatively, if the criterion used is the screening of the RBT positives by iELISA, then the
prevalence span from 4.1% to 6%. The confidence limit 95% for the random analysis was
3–6%. However, these data deserve careful interpretation. First, detection of RBT false posi-
tives due to residual antibodies after vaccination is ruled out in CR. Indeed, the only vaccine
used is rough RB51 devoid of O-chain lipopolysaccharide and the vaccine animal coverage in
CR is rather low (11%). Under these conditions and in our hands, with a collection of sera
from negative and culture positive animals [27], the RBT performs with 99% specificity and
99% sensitivity, values that are commensurate with the findings of other investigators [26]. In
spite of this, the RBT may still detect cross reacting antibodies against other bacteria (e.g.,
Yersinia enterocolitica O:9) sharing antigenic determinants with Brucella, and then render
some false positive reactions [40,41]. Nevertheless, under high brucellosis prevalence, the RBT
false positives may have little impact. Moreover, the iELISA and cELISA may also detect cross
reacting antibodies [40,41]. Second, the specificity (~98%) and sensitivity (~97%) of the so
called “confirmatory assays”, such as iELISA and cELISA [28], depend on the cut off values
established [26,27;41]. The current iELISA and cELISA cut off values used in CR and in other
Latin American countries were adjusted under S19 vaccination [29], and then intended for
detecting antibodies in the infected but not in the S19-vaccinated animals. Finally, the RBT
and the iELISA or cELISA may detect different subsets of positive animals [27,41]. This is rele-
vant, taking into account that not all animals were tested by iELISA or cELISA, but just the
RBT positives.
Regarding the model used here, there are some drawbacks that deserve attention. Accord-
ingly, a herd was declared positive when at least one serum sample was positive in the RBT fol-
lowing the Cannon & Roe strategy [24]. Sticking to this, it seemed that the average number of
18 animals/herd sampled, became somewhat short. Since the test is not perfect (99% specific-
ity) the probability that 18 bovines in a negative herd, all tested negative, was close to 83%.
Then, it follows that the probability that at least one bovine was false-positive –and in conse-
quence the whole herd–, was close to 17%. Likewise, the probability of obtaining a false-posi-
tive in given herd decreased with the increased number of positive-diagnosed animals within
the group. Testing the RBT positives by iELISA (RBT++iELISA) ensured higher specificity,
and the lowest possible prevalence, but not the highest prevalence, which was given by the
RBT. It is worth mentioning that while the RBT does not depend on quantitative measures;
the iELISA and cELISA depend upon cut-off values, which may vary depending on the epide-
miological conditions.
In spite of the limitations of the model and the possibility of cross reactions by the RBT, this
test stands as the most reliable assay in the absence of S19 vaccination and low RB51 vaccina-
tion coverage [41]. Considering this, it is likely that the RBT herd prevalence depicted in the
random analysis is closer to the reality of the country and then, the standing prevalence in case
of planning an eradication program in CR. Although the rational of the non-random scheme
is different from that of the random sampling, the data in the former somewhat supports the
values obtained in the latter.
At least four different B. abortus MLVA16 clusters are circulating in CR, indicating that the
bacterium was introduced more than once in the territory. Cluster one and three are inter-
twined with isolates from other countries, while clusters two and four have only CR represen-
tatives. Since cluster one is widely distributed in all different regions of the country, it seems to
be the dominant and the primary source. The relationship of the local strains with B. abortus
from North America, Brazil and Central Europe is not surprising, taking into account that CR
cattle came from those lands. The other B. abortus clusters may be of more recent introduc-
tion. It seems to be some association between the MLVA16 clusters and the distribution of the
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CR isolates. However, in order to unambiguously determine this association and the origin of
the clusters, more isolates from different regions are required.
Through the years, efforts have been carried out by the CR animal health authorities to con-
trol bovine brucellosis. Unfortunately, these efforts -mainly based in control programs from
other latitudes- have been erratic and constantly interrupted [10,14,42,43]. For instance, it is
evident that the brucellosis prevalence (estimated by agglutination tests) has increased in rela-
tion to that observed in the second half of the eighties and first half of the nineties (Fig 1). Dur-
ing the period of 1978–1985 -after a loan from the Inter-American Development Bank-, a
brucellosis control program, known as National Program of Animal Health (PRONASA), was
undertaken. PRONASA was intended for ten years and it was coordinated by the CR-NAHS
of the Ministry of Agriculture and Livestock Management [10,44,45]. The plan included oblig-
atory B. abortus S19 vaccination of young replacements, monitoring of abortions, compulsory
diagnoses by RBT, 2-mercaptoetanol, rivanol and milk-ring agglutination tests, culling of the
serological positive animals with no compensation, and control of animal displacements at
specific regional checkpoints [10,14]. During the early years of PRONASA the national vaccine
coverage reached close to 43% of bovines and the surveillance was actively taken [14].
Unfortunately, the strong economic recession initiated in 1982 undermined the brucellosis
control program. In addition, new political endeavors endorsed the end of PRONASA which
was then substituted by PROGASA [44]. In time, this caused the dismantled of the majority of
the veterinary field services devoted to the program and, in practical terms, the end of the bru-
cellosis surveillance campaign [10]. By 1984, S19 vaccination reached only one third of the
expected coverage [14]. By 1990 the vaccination coverage was less than 15% and finally by the
end of the decade, S19 vaccination was interrupted with the subsequent advent of rough B.
abortus RB51 vaccine handled by private hands, mainly by the dairy industry [10,14,19,46]. As
stated, the current RB51 vaccination coverage at five year lapse at the animal level is not more
that 11%, as estimated in this study and by the annual importation of RB51 vaccine doses to
CR [47]. However, this value does not take into consideration revaccination protocols, which
are common practices in Costa Rica, and which may interfere with the diagnosis.
Considering the PRONASA 1978–1985 brucellosis control campaign, some errors were
made [14,42]. Regardless of the type of vaccine employed, the vaccination coverage in CR has
never reached the required levels for adequate herd immunity (at least 70% of coverage).
Moreover, the serological testing necessary to detect the brucellosis positive herds reached dur-
ing the campaigns, was always lower than expected. In addition, the removal of the positive
animals was not systematically applied and the economy and political situation of the country
did not allow compensation for culling of the reactors. This favored hiding of the positive ani-
mals, clandestine sales and transfer of infected cattle to other areas. Moreover, the sole vaccina-
tion of young replacements with S19 seemed not enough. Indeed, the logic behind calf S19
vaccination implies extensive survey and constant identification and removal of the positive
bovines. However, since testing was not extensively applied, then a significant number of sus-
ceptible and infected adult bovines were not identified. All these aspects favored the perma-
nence and spreading of the infection in the country.
One key factor that worsened the problem and deserves attention, concerns to the vaccina-
tion policy during the last two decades. In order to “avoid diagnosis confusion" in the detec-
tion of Brucella infected animals, the regular use of B. abortus S19 was banned in countries free
of bovine brucellosis (e.g. United States and Canada). The Animal Health authorities replaced
S19 with RB51 in 2000, before achieving any control of the disease. In addition, the vaccination
platform was transferred into private hands mainly to dairy and pharmaceutical companies
[18]. We were unable to find documents justifying the rational for these “technical” decisions
carried out in CR. This caused the practical obliteration of B. abortus S19 from the program
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and the introduction of RB51 as the canonical vaccine [17]. This is not trivial since S19 is the
only vaccine that has demonstrated to be successful in eradicating bovine brucellosis [48]. All
these events have caused additional problems. Two of them relate to the frequent revaccina-
tion, practice known to induce diagnostic problems and increase costs [17, 49–51]. In addi-
tion, the unrestricted use of RB51 may promote a “false sense of security”, relaxing the
surveillance protocols in the vaccinated herds [52].
Experiences of the various brucellosis eradication programs have demonstrated that the
first campaigns were mostly unsuccessful [48]. In countries such as United States, Canada,
Australia, New Zeeland or those from Western Europe, eradication of brucellosis was achieved
only after the development of joint efforts among the livestock producers, authorities and
industry who finally understood the scientific and epidemiological data. They embraced the
eradication of brucellosis as their own problem and perceived it as an opportunity to reduce
the losses, increase the value of their products and ending with human suffering caused this
zoonotic disease [48]. Among the most successful strategies followed by these countries were
[48]: i) widespread B. abortus S19 vaccination coverage of female bovine at risk; ii) single dose
immunization of female bovine with complete or reduced S19 vaccine; iii) extensive diagnoses
of bovines and herds by sensitive and specific serological assays; iv) obligatory culling of the
serological positive animals with compensation actions, and; v) restriction in the traffic of ani-
mals from infected areas to free areas.
Although these experiences are relevant, it is unlikely that eradication of bovine brucellosis
in CR would be achieved by just applying fixed strategies from other latitudes. Indeed, the
eradication of bovine brucellosis is far more complex than just vaccination, testing and slaugh-
tering of the reactors. It is mandatory to consider the idiosyncrasy of each country at the time
of initiating campaigns towards the elimination of the disease. For instance, due to the high
brucellosis prevalence in CR, immediate slaughtering of all the rectors and confining the herds
seem unpractical and not economically feasible. First, it would be necessary to lower the preva-
lence by limiting the rate of infection and reducing the number of abortions. These may be
achieved by extensive and unrestricted vaccination of all female bovines (young and adults) by
the conjunctival route with reduced dose S19 vaccine; this, without previous diagnoses and
without testing of the animals for two years. Such a strategy—which seems unorthodox−, is
known to practically eliminate the clinical disease and to diminish the degree of cattle infection
at risk [53]. After few years (e.g. two years), this approach would reduce the prevalence and
density of the bacteria in the bovine population to numbers where “a clean” vaccination pro-
gram of young replacements with S19 (e.g. reduce dose by the conjunctiva route) would be fea-
sible. Then, a serological identification and slaughter of the positive animals might be initiated
under more favorable herd infection conditions, allowing some compensation for culling the
reactors.
Since the first surveillances performed eighty years ago [7], it is clear that brucellosis
remains as a relevant disease of cattle in CR. The steady increase in the brucellosis detection
and the consistent isolation of the bacterium in all regions supports the high prevalence and
validate the notion that in CR B. abortus is a source of important economic losses and human
health suffering [17,20]. Within this perspective, it seems that the brucellosis conditions pre-
vailing in CR are not unique, and other regions in Latin America display similar vaccination
strategies and epidemiological profiles [54–56]. Therefore, our findings are relevant within a
broadest context.
Why does after one hundred years of the first isolation of Brucella in CR, this small country
has not been capable to lower the prevalence and eradicate brucellosis? Certainly, countries
about the same size as CR have eradicated brucellosis. Moreover, CR has been able to resolve
very complex problems [57–59]. For instance, since 1949 the army was abolished, and since
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1970 the natural protected areas of the country cover 26% of the territory of CR. Likewise, the
Costa Rican public healthcare system is ranked among the highest in the American Continent.
Literacy is also comparatively high for a middle range income country. Regarding the cattle
industry, a large part of the milk and meat producers are well organized in cooperatives and
associations. Above 97% of the farms are electrified, communicated by roads and the veteri-
nary services attending the farms are well trained [6,36]. It seems, therefore, that in order to
achieve brucellosis eradication in CR, joint efforts are necessary among scientists, producers,
cattle industry and the government. Without cooperation among these parties, even good
intentions and first-class strategies are condemned to failure.
Conclusions
1. Bovine brucellosis due to B. abortus is widespread in CR and the prevalence of the disease
has increased in relation to the last three decades.
2. In the absence of S19 vaccination, the RBT herd prevalence depicted in the random analysis
tends to lay close to the reality and then, the suggested value in case of planning an eradica-
tion program in CR.
3. In the absence of S19 vaccination, the iELISA and cELISA used as “confirmatory tests”
need to be adjusted to the required levels of sensitivity and specificity to fulfill the brucello-
sis epidemiological conditions of CR.
4. The vaccination campaigns in CR have never been adequately adopted to increase the herd
immunity required to decrease the number of susceptible animals below a desired thresh-
old, for control programs.
5. The vaccination coverage in CR is rather low and revaccination with RB51 is a common
practice in CR.
6. At least four different B. abortus MLVA16 clusters are circulating in CR, indicating that the
bacterium has been introduced more than once in the territory. Cluster one -widely distrib-
uted in all different regions of the country- seems to be the dominant and the primary B.
abortus source in CR.
7. The brucellosis campaigns have been interrupted due to economic problems, deficient ani-
mal health services, absence of personnel and weak political support to technical and scien-
tific concerns.
8. The availability of reliable epidemiological data on bovine brucellosis in all regions of CR
establishes a background level to envision strategies for the control of bovine brucellosis in
the country.
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Chapter 2: Brucellosis in mammals of Costa Rica  
Brucellosis has been an endemic disease of cattle and humans in Costa Rica 
since the beginning of the 20th century. However, brucellosis in sheep, goats, pigs, 
water buffaloes, horses,and cetaceans, has not been reported in the country. In this 
work, published during 2017 (Hernández-Mora et al., 2017b), we have performed a 
brucellosis survey in these host mammal species from 1999-2016.  
The individual brucellosis seroprevalence in goat and sheep flocks was 
0.98% and 0.7%, respectively, with no Brucella isolation using commercial Brucella 
medium as well as CITA and Farrell culture media. Antibodies against Brucella .were 
not detected in feral or domestic pigs. This data suggest the absence of B. 
melitensis, B.suis, and B. ovis in these animal species in Costa Rica. This 
information is also supported by the lack of isolations from humans infected with this 
Brucella species.  In horses, the individual seroprevalence of brucellosis and water 
buffaloes were estimated at 6.5% and 21.7%, respectively, with no Brucella isolation.  
Six cetacean species including striped dolphin (S. coeruleoalba), bottlenose 
dolphin (Tursiops truncatus), spotted dolphin (S. attenuata), common dolphin 
(Delphinus delphis), rough-toothed dolphin (Steno bredanensis), and Cuvier beaked 
whale (Ziphius cavirostris), showed positive reactions against Brucella antigens in 
RBT, cELISA, iELISA and inmuchromatographic rapid test (B-Brucella Rapid Test).  
B. ceti was isolated in 70% (n= 29) of striped dolphins (S. coeruleoalba) using culture 
mentioned above. A steady increase in the diagnosis of human brucellosis cases 
was observed. Considering the prevalence of brucellosis in the various host 
mammals of Costa Rica, different measures are recommended.  
Chapter 2 includes the following paper: Hernández-Mora, G., Bonilla-
Montoya, R., Barrantes- Granados, O., Esquivel-Suárez, A., Montero-Caballero, D., 
González-Barrientos, R., Fallas-Monge, Z., Palacios- Alfaro, J.D., Baldi, M., 
Campos, E., Chanto, G., Barquero-Calvo, E., Chacón-Díaz, C., Chaves Olarte, E., 
Guzmán Verri, C., Romero-Zúñiga, J.J., Moreno, E. Brucellosis in mammals of Costa 
Rica: an epidemiological survey. PLoS ONE, 12(8), e0182644. 
http://doi.org/10.1371/journal.pone.0182644 
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Abstract
Brucellosis has been an endemic disease of cattle and humans in Costa Rica since the
beginning of XX century. However, brucellosis in sheep, goats, pigs, water buffaloes, horses
and cetaceans, has not been reported in the country. We have performed a brucellosis sur-
vey in these host mammal species, from 1999–2016. In addition, we have documented the
number of human brucellosis reported cases, from 2003–2016. The brucellosis seropreva-
lence in goat and sheep herds was 0.98% and 0.7% respectively, with no Brucella isolation.
Antibodies against Brucella were not detected in feral or domestic pigs. Likewise, brucellosis
seroprevalence in horse and water buffalo farms was estimated in 6.5% and 21.7%, respec-
tively, with no Brucella isolation. Six cetacean species showed positive reactions against
Brucella antigens, and B. ceti was isolated in 70% (n = 29) of striped dolphins (Stenella coer-
uleoalba). A steady increase in the diagnosis of human brucellosis cases was observed.
Taking into account the prevalence of brucellosis in the various host mammals of Costa
Rica, different measures are recommended.
Introduction
Costa Rica (CR) is a Central American country with a surface area of 51100 Km2 and a human
population close to five million. Most of the inhabitants are located in the Central Valley,
flanked by the volcanic chain and the mountain range. The country is divided in six adminis-
trative areas: Chorotega, Central Pacific, Brunca, Central, Northern Huetar and Caribbean
Huetar. CR has two ocean fronts: the Pacific Ocean and the Caribbean Sea. In addition, there
is the Cocos Island located in the Pacific Ocean [1].
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Bovine brucellosis is a significant problem in CR [2] and human brucellosis has been
endemic since the beginning of last century [3,4]. However, the presence of Brucella organisms
in sheep, goats, pigs, water buffaloes, horses and cetaceans and the impact that brucellosis has
in these animals has been barely explored in CR [5]. Moreover, very little information in the
number of human cases arriving to the CR health centers has been recorded.
Up to now, five species of Brucella have been isolated in CR: Brucella abortus (biotypes 1, 2
and 3) in cattle and humans, Brucella suis (biotype 1) in domestic swine, Brucella canis in dogs,
Brucella neotomae in humans and Brucella ceti (dolphin type) in dolphins [2,5–7]. B. melitensis
and B. ovis have not been reported in CR.
In this work we describe the distribution and the prevalence of brucellosis in different
mammal species and the cumulative number of human brucellosis cases in CR. We discuss
our findings in concordance to the conditions and measures carried out in the country and the
zoonotic potential. Brucellosis in cattle is not reported here, since it has been thoroughly
described in the accompanying manuscript [2].
Materials and methods
Serum samples
Sheep and goats. The total number of sheep and goats in CR is close to 12358 and 4626,
distributed in about 164 and 271 herds, respectively (Table 1). For sampling purposes CR was
divided in six administrative areas by the Costa Rican National Animal Health Service
(CR-NAHS) of the Ministry of Agriculture and Livestock Management: Chorotega, Central
Pacific, Brunca, Central, Northern Huetar and Caribbean Huetar. Herds from each species
were divided in three sections. For sheep the first section “A” included 6200 animals in 22
herds of broodstock farms with150 individuals; section “B” were 3577 animals in 37 herds
from farms with eventual broodstock activities, with populations ranging from 149–60 ani-
mals; and section “C” were 2691 in 105 herds for productive farms with population59 ani-
mals. For goats, we used the same criteria used for sheep. Section “A” included 1406 goats in
13 herds; section “B” were 1603 distributed in 14 herds; and section “C” were 1617 from 137
farms. Seventy-eight caprine and 139 ovine herds, corresponding to 2013 and 1668 animals
respectively, were sampled nationwide as part of the surveillance program, during 2014–2016.
Water buffalos. The estimated water buffalo population in the country corresponds to
13000 animals, distributed in about 100 herds. About 70% of the water buffalo farms are
devoted to mozzarella cheese production. The rest, are dedicated to meat production, leather
industry or as wild fauna in zoological parks [8,9]. A total of 2586 animal blood samples, corre-
sponding to 46 herds located in the six administrative areas were taken during 2014–2016.
Pigs. The estimated number of domestic swine in continental CR is close to 435500, most
of them under intensive management farms, located in the Northern Huetar and Central
Pacific regions [10]. A total of 2256 pigs from eight herds were sampled from 2014–2016. In
addition, 160 blood samples collected at the slaughter house in the Central region were also
studied. As part of the control of Wildlife Service of National Parks of CR, 58 feral pigs were
sampled in the East side of Cocos Island National Park (23.85 km2) located in the West Pacific
Ocean (5˚31008@N 87˚04018@O), during 1998–2000. This region included close to half of the
area. The sampling spots were chosen randomly and their location estimated on the basis of
recognized pathways and reference points already established in maps used by the National
Park rangers. Ages were estimated on the basis of size, weight, secondary sexual organ develop-
ment, hair distribution, hoof size and dentition. Samples were analyzed at the CR-NAHS Lab-
oratory or at the Veterinary Medicine School, National University, Heredia, CR.
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Horses. The estimated population of horses in CR is close to 67000 in about 20000 farms
[10]. In CR there is little tradition for eating horse meat. Therefore, most of the equines are
devoted to sports, recreation and work. A total of 1270 horse blood samples from 215 farms
located in the six administrative areas were taken during 2014–2016.
Cetaceans. Thirty cetacean species have been documented in Costa Rican waters, repre-
senting about 36% of the 83 species known worldwide [11]. From 2004–2016, 115 individuals
from sixteen species were reported stranded in the Costa Rican shorelines (Table 2). Cetacean
blood samples were taken at the stranding sites. After death, the animals were transported to
the Veterinary School of the National University of CR, for necropsy and bacteriological
studies.
Humans. Brucellosis in humans has been documented in CR since 1915 [3,4]. A survey
for human brucellosis from 2003–2016 was carried out at the laboratories of Public Health Ser-
vices (CCSS) of CR. In addition, a total of 250 abattoir workers were monitored for antibodies
against Brucella antigens, from 2015–2016. All human case reports and bacteriology were
received at the National Reference Bacteriology Laboratory at the Costa Rican Institute for
Research and Training in Nutrition and Health (INCIENSA), for confirmation.
Table 1. Numbers of ovine and caprine herds and numbers of animals by geographical region in Costa Rica (2015).
Region Ovine Caprine
Herd Animals Herd Animals
1. Northern Huetar 36 2440 39 2077
2. Central 59 4295 117 1973
3. Brunca 21 1246 41 128
4. Chorotega 28 2792 22 312
5. Caribbean Huetar 9 637 28 79
6. Central Pacific 11 948 24 57
Total 164 12358 271 4626
https://doi.org/10.1371/journal.pone.0182644.t001
Table 2. Number of cetaceans stranded in Costa Rica from January 2004 to September 2016.
Common name Specie Number of animals
Striped dolphin Stenella coeruleoalba 51
Bottlenose dolphin Tursiops truncatus 10
Spotted dolphin Stenella attenuata 8
Humpback whale Megaptera novaengliae 8
False killer whale Pseudorca crassidens 6
Spinner dolphin Stenella longirostris 4
Rough tooth dolphin Steno bredanensis 4
Dwarf sperm whale Kogia sima 4
Cuvier beaked whale Ziphius cavirostris 3
Risso’s dolphin Grampus griseus 2
Pilot whale Globicephala macrorhynchus 2
Sperm whale Physeter machrocephalus 2
Common dolphin Delphinus delphis 1
Beaked whale Mesoplodon spp. 1
Beaked whale Mesoplodon spp. 1
Sei Whale Balaenoptera borealis 1
Unknown species* Unknown 7
Total 115
https://doi.org/10.1371/journal.pone.0182644.t002
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Information collected and blood animal samples
Relevant data concerning geographical localization, size of the farm, management and charac-
teristics of the herds or individual animals were collected. The information also included veter-
inary services, reproductive parameters, history of abortion/stillbirth and the presence of other
domestic and wildlife species in the farms. Breeds and identifications were registered.
Blood samples were collected with syringes or a sterile vacutainers with Z serum clot activa-
tor (Vacutainer System, Greiner Bio-one), transported under refrigeration, and sera obtained
by centrifugation. Each sample received a consecutive number. Analyses of the sera were per-
formed within 24–72 hours after collection at the CR-NAHS Brucellosis Serology Laboratory
or at the Immunology Laboratory at the School of Veterinary Medicine, National University,
Heredia, CR. Humans blood samples were sent to the National Reference Bacteriology Labora-
tory (INCIENSA) for confirmation.
Serological tests
Rose Bengal test (RBT) (ID-VET, France), indirect protein A/G ELISA (iELISA) (ID-VET,
France) and competitive ELISA (cELISA) (Svanovir, SVANOVA, Sweden) and fluorescent
polarization assay (FPA) (Sentry 100 instrument, Diachemix, United States) were used as diag-
nostic tools, as described elsewhere [12–14]. For the standardization of small ruminant brucel-
losis diagnostic tests, positive and negative sera from sheep and goats were obtained from
Spain and Mexico respectively. Twenty sera from B. melitensis biotype 1 culture positive sheep,
twenty sera from B. melitensis biotype 1 culture positive goats, twenty- one sera from non-vac-
cinated negative sheep and twenty-one sera from non-vaccinated negative goats were obtained
and used for validation as previously described [14,15]. In Costa Rica sheep and goats are not
vaccinated. Therefore, the specificity of RBT in the absence of vaccination has been estimated
to be ~100%; likewise, under these conditions the sensitivity has also been estimated in ~100%
[14]. The cut off values for iELISA, cELISA and FPA in sheep and goats were 120% S/P, 30%
positivity and 20 milipolarization units, respectively. Since standardized diagnostic tests for
water buffalo brucellosis are not available, RBT, iELISA and cELISA, including the cut-off val-
ues, were used as reported for cattle [16]. Dolphin sera were collected and tested in RBT,
iELISA and cELISA as described before [17]. For swine, modified RBT, iELISA and cELISA
was used as described elsewhere [18]. Likewise, for horses, background levels for the same tests
were estimated with sera from 20 healthy horses with no signs of brucellosis and with no con-
tact with cattle or small ruminants. All animal sera samples were initially screened by RBT and
then by iELISA, cELISA and FPA, following the procedures described elsewhere [13,15,17].
For humans, RBT and microagglutination in 96/well round bottom plates were used for
screening, as described before [19].
Culture conditions and Brucella identification
Bacteriological cultures and identification of Brucella isolates were performed as described in
the accompanying paper [2]. Briefly, various reference Brucella species were used as positive
controls for genetic and bacteriological identification of samples [2]. According to the National
Brucellosis Control Program of the CR-NAHS, seropositive sheep, goats, buffalos or pigs are
selected for obligatory culling and pathological examination [20]. Necropsies were carried out
at the Pathology Department in the Veterinary School of the National University, CR. Animal
samples, included milk and other secretions such as vaginal swabs, semen and cerebrospinal
fluid. Tissues samples included reproductive organs lymph nodes, spleen, kidney, liver and
brain. In some cases aborted fetuses were also collected and sampled. Cultures were performed
at the CR-NAHS or at the Bacteriology Laboratory of the Veterinary School. Non-selective
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and selective media, including blood agar and Columbia agar, supplemented with 5% of dex-
trose and sheep blood as well as Modified Brucella Selective Supplement Oxoid1 (SR0209)
and CITA medium, under 10% CO2 atmosphere, were used [21]. The selected bacterial colo-
nies were subjected to Gram staining, agglutination with acriflavine and acridine orange dyes,
tested for urease and oxidase activity, citrate utilization, nitrate reduction, H2S production,
growth in the presence of CO2, thionin (20 μg/mL) and basic fuchsin (20 μg/mL) and uptake
of crystal violet, according to described procedures [12].
Brucella DNA samples from each isolate and control strains were extracted with DNeasy
Blood & Tissue kit from QIAGEN, and stored at -80˚C until used. Identification of Brucella
species was performed by bruce-ladder, single-nucleotide polymorphisms and MLVA16 analy-
sis following standard procedures [22–25]. Brucella control strains were used for validation.
The profiles were analyzed following standardized procedures (http://mlva.u-psud.fr/brucella/
) and thereafter entered in the database MLVA-NET (http://microbesgenotyping.i2bc.paris-
saclay.fr/).
Ethical considerations
Sampling of domestic and wildlife animals is part of the National Brucellosis Control Program
of the CR-NAHS [20] and the Law of Reportable Infectious Diseases of the Ministry of Health
of CR [26]. Dolphin serum samples were taken from stranded dolphins following the proce-
dures described before [27]. Protocols for the use of animal serum samples were revised and
approved by the ‘‘Comite´ Institucional para el Cuido y Uso de los Animales de la Universidad
de CR” (CICUA 057–16366), and ‘‘Comite´ Institucional para el Cuido y Uso de los Animales”
of the National University, Heredia, CR (SIA 0545–15), and in agreement with the corre-
sponding law ‘‘Ley de Bienestar de los Animales”, CR (Ley 7451 on Animal Welfare), and
according to the “International Convention for the Protection of Animals” endorsed by Costa
Rican Veterinary General Law on the CR-NAHS (Ley 8495).
Human samples were handled by the authorities of the Public Health Service of CR (Social
Security Services CCSS and Ministry of Health) and then submitted to National Reference Bac-
teriology Laboratory at INCIENSA for diagnostic confirmation. In this institution the samples
were handled according to the INCIENSA ethical committee specifications and the agreement
between INCIENSA and SENASA (Oficio 16-06-2013). Upon registration to the Medical
Health Centre, all patients were informed regarding the purpose of the work and provided the
corresponding written consents according to the respective Law (Ley 9234, La Gaceta 79). All
samples were taken following the procedures dictated by the Costa Rican National Health sys-
tem (Ley 9234, La Gaceta 79), and the World Medical Association Declaration of Helsinki (Ethi-
cal Principles for Medical Research Involving Human Subjects, General Assembly, Seoul,
October 2008), regarding blood samples.
Statistics
For sheep and goats, the sample sizes were determined according to Cannon and Roe [28]
using Win Episcope 2.0 software [29], with an expected brucellosis prevalence of 0.6% for
sheep and 0.7% for goats, with a confidence level of 95%. This estimation included 500 sheep
and 413 goats to be sampled, distributed in 10 and 13 herds respectively, sorted by region as
described above. Herd selection was chosen assuming that the management and biosecurity
actions, regarding these two ruminants, are similar in CR. Herds were chosen randomly from
sections “A” and “B”, which are the broodstock herds, and largely reflected the sanitary condi-
tions of section “C”. From each herd selected, a proportional sample population was calculated
based on the clinical signs compatible with brucellosis, with a confident level of 95% and an
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expected prevalence of 5%, according with Cannon and Roe [28]. In addition to the random
sampling, and in order to increase the probability of positive results, a biased priority was
given to females with a history of abortions, weak or stillborn births, placenta retention, or
with conditions that rendered individuals more susceptible to any infection, such as low body
condition and pale mucous membranes. If the total number of animals defined for the herd
was not covered with these specifications, random adult females were selected. Breeding rams
in each farm were also examined for the detection of orchitis, epididymitis and reproductive
problems. For feral pigs, the size of the sample was selected for an expected maximum popula-
tion of 500 pigs distributed in the entire island, with a 95% confidence level and a tentative
prevalence of 5%. The rest of the animal species sampled corresponded to the surveillance per-
formed as part of the National Brucellosis Control Program of the CR-NAHS and according to
the OIE specifications [13].
Results
Sheep and goats
Most of the ovine and caprine herds are located in the lowlands of CR (below 1000 m) and
are mainly devoted to dairy (caprine) and meat (ovine) production (Table 1). The sampling
procedure was carried out at the indicated regions, from 2015–2016 (Fig 1). From a total of
510 sheep sampled, corresponding to 10 herds, eleven animals (five herds) were RBT posi-
tive and five cELISA positive. None of the RBT positive animals were positive in iELISA,
cELISA or FPA. Likewise, from a total of 424 goats, covering close to 10% of the Costa
Rican population, only five animals demonstrated positive reactions in RBT. However,
none of these RBT positive samples resulted positive in iELISA, cELISA or FPA. According
to these results, the estimated brucellosis RBT prevalence values for goat and sheep herds
were 0.98% and 0.7%, respectively. The RBT positive animals were culled and tested for the
presence of Brucella spp. in lymph nodes, spleen, liver, placenta, mammary gland, milk and
fetus organs. All cultured samples tested negative for Brucella spp. Epidemiological and
clinical surveys of the sheep and goat populations and the corresponding farms did not
demonstrate clinical brucellosis.
From the 3681 ovine and caprine routinely sampled at the CR-NAHS laboratories for regu-
lar diagnosis, only one caprine was classified as positive in RBT and iELISA. The animal was
slaughter and their various organs tested for the presence of Brucella, with negative results.
Clinical disease compatible with B. ovis infection was not detected in rams. Likewise, this bac-
terium was not isolated from semen samples. Taken together these data, the “positive” RBT
reactions were estimated as unspecific and the presence of brucellosis in ovine and caprine
herds ruled out.
Water buffalos
Most water buffalos are located in the low lands, since they require fresh water habitats for sub-
sistence. From a total of 2586 samples distributed in 46 herds, collected from 2014–2016 (Fig
1), 17 animals tested positive in RBT, 38 in cELISA and 77 in the iELISA. The total number of
herds positive in these three assays was ten. All RBT positive samples were also positive in
iELISA and cELISA; and all samples positive for cELISA were also positive in iELISA. FPA was
not performed. In spite of the efforts, Brucella organisms were not isolated from vaginal swabs,
dairy products, placental tissues, fetuses, testes, lymph nodes, mammary gland, blood, spleen
or liver of the culled seropositive animals. However, due to the reported clinical characteristics
and the testimonies of persistent abortions and positive serological reactions, Brucella infec-
tions were suspected. Moreover, it is likely that B. abortus constitutes an infection source for
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water buffaloes, since bovine brucellosis caused by this Brucella specie is highly prevalent
in CR [2].
Fig 1. Sampling of animal stocks, in the six regions of CR. The epidemiological regions are as follow: 1,
Northern Huetar; 2, Central; 3, Brunca; 4, Chorotega; 5, Caribbean Huetar; 6, Central Pacific. Each red dot
represents an animal stock facility.
https://doi.org/10.1371/journal.pone.0182644.g001
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Pigs
From the number of herds studied and the samples obtained at the slaughter house (Fig 1),
only two pigs of one herd were RBT positive. From these, only one pig was also positive in
iELISA and cELISA. The FPA assay was not performed. Positive animals were culled and
different tissues were cultured for the presence of Brucella, with negative results. In addi-
tion, tissues of aborted fetuses in some farms were also tested for the presence of Brucella,
all with negative results. Likewise, positive serological reactions were not detected in the
feral pig population in the Cocos Island. Histopathological examination of the liver in the
feral swine sample showed chronic inflammation in 84% of the cases, while 20% had multi-
focal granulomatous inflammation with eosinophilic infiltration, probably related to the
presence of parasite nematode Stephanurus dentatus, but not Brucella. Taken together these
data, the positive serological reactions were estimated as non-specific.
Horses
Most horses are located in North Huetar, Chorotega and the northern part of the Caribbean
Huetar regions of CR. Therefore, most of the samples are from these areas (Fig 1). From the
total number of farms studied 14 (6.5%) had seropositive animals, including 18 horses positive
in RBT; from these, only four were also positive in both iELISA and cELISA. In spite of the
efforts, Brucella was not isolated from horses. However, it is likely that B. abortus is a source of
infection in horses, since many of these animals are in close contact with infected bovines in
CR. In addition, some clinical features such as fistulous withers and nonspecific lameness due
to joint infection, have occasionally been observed in horses.
Cetaceans
Cetacean brucellosis in Costa Rican was investigated from 2004–2016. RBT and iELISA,
designed for cetacean diagnosis, were positive in 54 (46.9%) individuals from six different spe-
cies. They included 38 striped dolphins (Stenella coeruleoalba), one bottlenose dolphins (Tur-
siops truncatus), one spotted dolphins (S. attenuata), one common dolphin (Delphinus
delphis), one rough toothed dolphin (Steno bredanensis), and one Cuvier beaked whale
(Ziphius cavirostris). However, striped dolphin (S. coeruleoalba) remains as the only cetacean
specie from which B. ceti has been isolated from different organs in CR.
Strong positive RBT and iELISA reactions were obtained in sera from 37 out of 38 striped dol-
phins stranded at the Pacific coast of CR (Fig 1). Thirty-seven out of 38 striped dolphins, stranded
alive. At the time of stranding, all live animals presented neurological symptoms such as tremors,
buoyancy difficulties, weakness, seizures and locomotion problems. With exception of two dolphins
(one seropositive and one seronegative), all other S. coeruleoalba dolphins displayed neurobrucello-
sis, following previous diagnosis [27]. All of them died at the stranding site within hours after the
event. Necropsy was performed in all cases and B. ceti was isolated from the cerebrospinal fluid of
29 individuals (70%). In addition, B. ceti was also present in placenta, umbilical cord, amniotic and
allantoic fluids, multiple fetal organs, milk, cardiac valve, atlanto occipital joint fluid, lung and lung
nematodes (Halocercus spp.) [6,27,30,31]. All B. ceti isolates belonged to the MLVA16 type P [32],
corresponding to the Pacific Ocean (data accessible at: http://microbesgenotyping.i2bc.paris-saclay.
fr/ [and the following entries: public databases, Brucella v4_1, bmarCR+number, years 2006–2014]).
Humans
According with the Costa Rican National Reference Bacteriology Laboratory (INCIENSA), the
number of human cases reported by the health centers over 12 year (2003–2015) period
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corresponded to 124 patients (Fig 2A): fifty one were from the Central region 37 from the
Caribbean Huetar region and 36 cases from all other regions. Male and female patients repre-
sented 79 and 41 cases (Fig 2B), respectively, with ages ranging between 8–76 year-old, with a
large proportion of veterinarians, farmers and slaughter plant workers (Fig 2C). From a total
of the 250 abattoir workers only three presented high antibody titers (>1/160) compatible
with an active brucellosis. With the exception of two B. neotomae isolates [7], all other human
brucellosis cases corresponded to B. abortus.
Discussion
For most of the history of CR, sheep and goats have been raised in very low numbers and
the dairy products and meat of these animals barely consumed [33]. Until 1975 the number
of goats and sheep in the country were close to 1000 animals, all together [33]. However, in
the nineties the population of these small ruminants started to increase. Already, in the first
decade of the XXI century, the numbers of goats and sheep were close to 5000 and 3000,
respectively [34]. With the enhanced acceptance of ovine and caprine dairy and meat prod-
ucts, the emergent industries for small ruminants have increased. Indeed, the numbers of
goats and sheep have augmented almost three fold (12852) and twelve fold (35800) [10],
respectively.
Fig 2. Occurrence human brucellosis cases in CR from 2003–2015. (A) Number of human brucellosis cases diagnosed
per year in CR for the period. All cases recorded were due to B. abortus. (B) Distribution per age and proportion of male and
female brucellosis cases in CR, diagnosed for the period. (C) Proportion of 250 seropositive abattoir workers from 2015 to
2016.
https://doi.org/10.1371/journal.pone.0182644.g002
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An epidemiological survey for caprine and ovine brucellosis was performed from 2015–
2016. Although we detected a minor number of RBT positive reactions in small ruminants,
they were regarded as false positives. In spite of the high specificity and sensitivity displayed by
the RBT under controlled conditions with a limited number of known sera, this assay is not
perfect and some non-specific reactions are expected to occur under field conditions. There-
fore, exhaustive clinical, pathological and epidemiological investigations in the serologically
positive sheep and goats were carried out, all rendering negative results for the presence of
Brucella infections. Bacteria displaying similar antigenic determinants as smooth brucellae
may be the source of false positive reactions [35]. In addition, positive serological reactions
due to B. abortus infections cannot be ruled out, since this bacterium is highly prevalent in CR
[2]. However, we did not isolate B, abortus or any other brucellae from the tissues of goats and
sheep. Although B. melitensis may be present in some Central American countries [36], this
bacterium has never been isolated in animals or humans in CR [5, 36]. Following this, it is
important to keep these small ruminants free of brucellosis, restricting the importation of ani-
mals and semen from B. melitensis free countries.
Similar to goats and sheep, the number of water buffalos has steadily increased in CR dur-
ing the last ten years. In 2006 the number of water buffalos in CR was close to 615 animals
[37]; in ten years the population has increased twenty fold, most of them devoted to the pro-
duction of dairy products. Taking into account the persistent positive serological reactions,
their close association of water buffalo with B. abortus infected cattle and the reported cases of
abortions compatible with clinical disease; we believe that some water buffalo populations are
infected with Brucella in CR. Moreover, a significant number of the CR water buffalo popula-
tion originates from Trinidad-Tobago, country endemic for water buffalo brucellosis [8, 38].
The fact that we did not isolate Brucella from water buffalos may be related to the natural resis-
tance of these animals to brucellosis in relation to other bovines [39].
B. suis was isolated from a domestic pig in the Central region of CR in 1984 [5]. Since then,
the bacterium has not been isolated from boars, in spite of the efforts. In CR pigs seldom roam
freely around the houses and most animals are confined to intensive management facilities,
under good health conditions. Moreover, with the exception of Cocos Island, no feral pigs are
present in the CR territory. Since no clinical or epidemiological surveys indicate swine brucel-
losis, it is unlikely that B. suis is currently infecting pigs in the country.
Horses are not primary Brucella hosts and commonly they do not have the ability to trans-
mit the bacterium to other animals or humans. Therefore, horses are not of epidemiological
relevance in keeping the bacterium life cycle; however, these animals are sentinels for the pres-
ence of Brucella in other animals, mainly in cattle. Like humans, they become infected by con-
tact with abortions or with infected cattle, and display a wide range of clinical manifestations
including articular swelling and general weakness [40]. The fact that close to 18 horses dis-
played recurrent positive reactions against Brucella, may be an indication of the high seroprev-
alence of Brucella infections in cattle [2], including water buffalo.
B. ceti infections in dolphins stranded in the CR Pacific coast were detected for the first
time in 2004 [6]. A total of 115 stranding events from at least 16 different species of cetaceans
have been recorded in CR seashores from 2004–2016 (Table 2). From these, six species dis-
played positive serological reactions. However, B. ceti active infections have been only docu-
mented in striped dolphins from the Pacific Ocean of CR. All B. ceti isolates belong to the
same MLVA16 type P. This bacterial group corresponds to a particular cluster distinct from
other B. ceti strains isolated in various oceanic latitudes, and it is a hallmark for S. coeruleoalba
infections in the Eastern Tropical Pacific [32]. Moreover, all the 29 dolphin cases in which B.
ceti organisms were isolated suffered from neurobrucellosis [27]. It seems, therefore, that this
dolphin specie is highly susceptible to B. ceti and that many of the stranding events were due to
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brain infections, as recorded in other latitudes [41]. The surveillance of cetacean brucellosis in
Central American littorals requires attention. This is mandatory to understand the impact that
brucellosis has in the Eastern Tropical Pacific marine mammal populations and to ensure pre-
vention measures for potential human and animal infections [42].
In a previous study in the Central region (Cartago, CR), in which 71% of the human popula-
tion consumed unpasteurized dairy products; an overall seroprevalence of 0.87% was detected
[19]. However, no statistically significant association was found between unpasteurized milk con-
sumption and the presence of antibodies against Brucella organisms. Here, we reported a steady
increase in the number of human brucellosis cases during a lapse of 12 years. Whether the steady
increase of human brucellosis reports corresponded to improved diagnosis or to intensification
in the number of cases, is not known. The number of human brucellosis cases due to B. abortus is
consistent with the high prevalence of bovine brucellosis in CR, and the absence of B. melitensis
in sheep and goats, and B. suis in pigs, two Brucella species that display a higher zoonotic potential
than former bacteria [43]. In CR there are other zoonotic brucellae such as B. neotomae [7] and
B. canis [44], which were not considered in this study. Nevertheless, a careful identification of
strains is required, even with those Brucella species that are considered of low zoonotic risk.
From the epidemiological perspective, it seems that the population of sheep, goats and pigs
in CR are free of B. melitensis infections. This seems to be also the case for B. ovis in rams and
B. suis for pigs. Consequently, humans are also free of these bacterial species. However, with
the increasing number of small ruminant species in the country the risk of Brucella infections
arriving from other latitudes requires permanent surveillance, improved management and
sensitive and specific diagnostic tools.
Conclusions
1. Domestic ovine, caprine and swine herds are free of brucellosis in CR.
2. The presence of Brucella infections in water buffaloes is highly suspected in CR.
3. The presence of B. abortus infections in horses is highly suspected in CR.
4. Striped dolphins from the Pacific Ocean of CR are the main host of B. ceti cluster type P.
5. The main clinical symptom found in striped dolphins corresponded to neurobrucellosis.
6. Detection of human infections, due to B. abortus, has steadily increased since 2005 in CR.
7. Estimating the presence of Brucella infections in different hosts inhabiting CR is relevant for
understanding the impact that brucellosis has in the country and for prevention measures.
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Chapter 3. Phylogenetic characterization of marine and terrestrial Brucellae 
isolated in Costa Rica 
Costa Rica started the investigation of marine brucellosis in 2004 
(Hernández-Mora et al., 2008).  Since then, out of the nineteen species reported as 
stranded in Costa Rica coastal shores, 45% are striped dolphins (Stenella 
coeruleoalba). These animals stranded with tremors, swimming difficulties, 
buoyancy problems, lack of coordination and they died within a few hours after the 
event (Hernández-Mora et al., 2008). B. ceti was isolated from the cerebrospinal 
fluid in 70% of these dolphins, associated with the presence of 
meningoencephalomyelitis (97%),that caused the death of these dolphins (González 
Barrientos et al., 2010; May Collado et al., 2017).  This bacterium was also present 
in the vaginal and uterine fluids, placenta, umbilical cord, allantoidal and amniotic 
fluids, fetal organs, milk, cardiac valve, atlanto-occipital joint fluid, and in lung 
nematodes (Halocerchus spp) (May Collado et al., 2017).    
Using whole-genome sequencing (WGS) on these B. ceti isolations, we 
described in the paper Suárez-Esquivel (2017a), the elements of genetic variation in 
B. ceti isolated from wild dolphins inhabiting the Pacific Ocean, the Atlantic Ocean, 
and the Mediterranean Sea. The B. ceti strains showed distinctive traits according 
to oceanic distribution and preferred host. B. ceti isolates displayed genetic 
variability, represented by an important number of IS711 elements as well as specific 
IS711 and SNPs genomic distribution clustering patterns. Extensive 
pseudogenization was found among isolates from cetaceans as compared with 
terrestrial ones, causing degradation in pathways related to energy, transport of 
metabolites, and regulation/transcription. 
Costa Rican dolphin B. ceti isolates, showed further degradation of metabolite 
transport pathways as well as pathways related to cell wall/membrane/envelope 
biogenesis and motility. Thus, gene loss through pseudogenization is a source of 
genetic variation in Brucella, which in turn, related to adaptation to different hosts. 
This is relevant to the understanding of the natural history of bacterial diseases, their 
zoonotic potential, and the impact of human interventions such as domestication.  
4 
 
Characterization by MLST in silico of the B. ceti isolates has also been 
performed. As a result, sequence type ST26 has been described in all the bacteria 
from the stranded striped dolphins regardless of the origin of the strains, including 
CSF, lung nematodes, placenta, and milk.  In 2018, a Brucella ST27 was identified 
in a stranded dwarf sperm whale (Kogia sima) in Playa Herradura, Puntarenas 
(Figure 1). The Brucella ST27 isolate was also obtained from the fetus, the placenta, 
and other organs of the two dwarf sperm whales, causing reproductive problems.The 
above mentioned confirmed a new Brucella ST27 host in the Eastern Tropical 
Pacific. Previously, Brucella ST27 was isolated in humans with neurobrucellosis and 
spinal osteomyelitis in Peru and New Zealand in 2003 and 2006, respectively. 
However, the source of infection in these patients remains unknown. 
Likewise, as part of the clinical presentation of the dolphin cases with 
neurobrucellosis in Costa Rica, we used computerized axial tomography before 
performing the necropsy (virtopsy), which represents a pioneering advance in 
imaging diagnosis in the country. The information obtained has allowed comparisons 
between human and dolphin neurobrucellosis (Figure 2). 
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Figure 1. WGS phylogenetic reconstruction of B. ceti isolates. The tree is based 
on 27,365 SNPs of different Brucella WGS. The isolates related to marine mammals 
are classified into seven categories, corresponding to clusters revealed by MLVA-16 
analysis and previously described according to geographic origin or host 
association. Cluster H (human-associated isolates– ST27), is highlighted in orange. 
This cluster includes Brucella sp. F5-99, B. ceti strain Cudo, B. ceti strain CR0350 
and the K. sima isolates. WGS from K. sima are shown with red lines. Ochrobactrum 
sp., used as the original root for the tree, was trimmed from the figure to increase 
tree resolution. Each cluster defining branch showed a 100-bootstrap value. Color 
codes for MLVA-16 classification, host, and country of origin are specified next to 
the tree. For increased resolution, visit https://microreact.org/project/xaQYIdp96. 
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Figure 2. Axial tomography Scan on stranded cetacean in Costa Rica.  A) Brain 
of a spinner dolphin (S. longirostris) with no visible lesions. Third and fourth 
ventricles are barely perceptible, negative to brucellosis by serology and culture. The 
young male stranded in Bajamar beach in Puntarenas Costa Rica in November 
2017. B) Brain of a striped dolphin (S. coeruleoalba) with ventriculomegaly and 
secondary hydrocephalus, positive to brucellosis by serology and culture of B. ceti. 
The adult female, stranded in Parque Marino Ballena in Puntarenas Costa Rica in 
January 2018. 
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For B. abortus isolated in Costa Rica from bovines, humans, and water 
buffaloes, we analyzed by whole-genome sequencing (WGS) and performed the 
phylo-temporal analysis of the incursion in Costa. For this purpose, a total number 
of 95 B. abortus isolated in Costa Rica showed five B. abortus lineages, 
phylogenetically related to isolates from the United States (US), United Kingdom 
(UK) and South America (SA). We demonstrated that the predominant CR lineages 
of B. abortus, displaying modest diversity and introduced more than 100 years ago, 
have circulated and spread in the territory in spite of new introductions that seemed 
to be less dispersed. Our findings are relevant from the epidemiological perspective. 
Following the brucellosis prevalence and the idiosyncratic settings of several middle- 
and low- income countries, similar scenarios could be found in other latitudes.  
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Abstract
Intracellular bacterial pathogens probably arose when their ancestor adapted from a free-living environment to an intracellular one,
leading to clonal bacteria with smaller genomes and less sources of genetic plasticity. Still, this plasticity is needed to respond to the
challengesposedbythehost.Membersof theBrucellagenusarefacultative-extracellular intracellularbacteria responsible forcausing
brucellosis in a variety of mammals. The various species keep different host preferences, virulence, and zoonotic potential despite
having 97–99% similarity at genome level. Here, we describe elements of genetic variation in Brucella ceti isolated from wildlife
dolphins inhabiting the Pacific Ocean and the Mediterranean Sea. Comparison with isolates obtained from marine mammals from
the Atlantic Ocean and the broader Brucella genus showed distinctive traits according to oceanic distribution and preferred host.
Marine mammal isolates display genetic variability, represented by an important number of IS711 elements as well as specific IS711
and SNPs genomic distribution clustering patterns. Extensive pseudogenization was found among isolates from marine mammals as
compared with terrestrial ones, causing degradation in pathways related to energy, transport of metabolites, and regulation/tran-
scription. Brucella ceti isolates infecting particularly dolphin hosts, showed further degradation of metabolite transport pathways as
well as pathways related to cell wall/membrane/envelope biogenesis and motility. Thus, gene loss through pseudogenization is a
sourceofgenetic variation inBrucella,which in turn, relates toadaptation todifferenthosts. This is relevant tounderstand thenatural
history of bacterial diseases, their zoonotic potential, and the impact of human interventions such as domestication.
Key words: Brucella, marine mammals, genome degradation.
Introduction
Bacteria living in isolation or stable habitats, such as the in-
tracellular milieu, tend to have clonal populations with
smaller and degraded genomes than free-living ancestors,
which keep larger and more versatile genomes (Moreno
1998; Toft and Andersson 2010). Still, some versatility
must be preserved in order to confront environmental
challenges.
 The Author 2017. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.
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Most of the emergent human pathogens have a zoonotic
origin where transgression of host barriers is critical (Greger
2007; Jones et al. 2008). Understanding how microorganisms
are able to surpass such barriers, particularly host range adap-
tation is relevant to comprehend the emergence of pathogens.
It has been proposed that genetic drift and speciation in
extant clonal bacteria will depend exclusively on mutation
and internal genetic rearrangements (Moreno 1997). Several
mechanisms had been described in mammal bacterial patho-
gens with small genomes to keep genetic variability (Bolotin
and Hershberg 2015). However, it is possible that these mech-
anisms are underrepresented when studying bacterial patho-
gens of domesticated animals. In this sense, domestication
may represent a microbial population bottleneck for diversity:
By selectinganimalsgenetically suited forhumanbenefit, there
is probably selection of their microorganisms. Within this con-
text, to study bacteria infecting wildlife populations, closely
related to bacteria isolated from domesticated animals, may
bring light to pathways followed by these selection processes.
Members of the Brucella genus are facultative extracellular
intracellular a 2-Proteobacteria responsible for causing brucel-
losis in a variety of mammals. This chronic disease results in
abortion and infertility in livestock causing economic losses
mainly in middle and low income countries (Moreno and
Moriyon 2006). Humans are infected through contaminated
animal-derived food products or infected animals. It is consid-
ered by the WHO as a “forgotten neglected zoonosis”, esti-
mating that for every reported human case, there are 25–50
unreported cases (World Health Organization 2014).
Brucella species share 97–99% identity at genome level. In
spite of this close genetic relatedness and genomes with no
lysogenic phages or detected plasmids, there is a strong cor-
relation between genotypes, virulence, and host preference
(Moreno and Moriyon 2006). These traits make Brucella an
appropriate model for understanding bacterial host adapta-
tion. Interestingly, pseudogene accumulation in prokaryotes
has been demonstrated as a hallmark of recent host adapta-
tion. It is also inversely related to host-range, that is, narrow
host-range pathogens tend to have a higher number of pseu-
dogenes, and similar phenomena had been studied in Brucella
(Chain et al. 2005; Tsolis et al. 2009; Wattam et al. 2009;
Goodhead and Darby 2015).
Here we used Brucella isolates from free-living marine
mammals in three of the world’s major oceanic basins to
look for elements of genetic variation and their relation to
host specialization of this zoonotic pathogen. We character-
ized Brucella ceti isolates from dolphins from the Pacific Ocean
and the Mediterranean Sea, and compared them with isolates
obtained from marine mammals (dolphins, porpoises, and
seals) from the Atlantic Ocean. The distinctive traits observed
among the isolates showed signatures of host preference,
speciation, and oceanic distribution. Expanding that compar-
ison to Brucella sp. isolates, revealed genetic variability
elements among isolates from wildlife marine mammals as
compared with those from terrestrial domesticated animals.
This variability is demonstrated through a SNPs and IS711
specific clustering pattern across genomes and a higher num-
ber of IS711 elements. There is also an important number of
pseudogenes affecting specific metabolic pathways and in-
ducing gene loss according to host preference. Therefore,
gene loss should be considered a source of genetic variation
in Brucella, which in turn, relates to adaptation to different
niches and host preference.
Materials and Methods
Bacterial Strains
The list of isolates used in this study is presented in supplemen-
tary data set S1, Supplementary Material online and includes
23 B. ceti isolates from stranded striped dolphins from the
Eastern Tropical Pacific of Costa Rica as well as several previ-
ously described isolates: Four from the Mediterranean Sea,
nine from the North Atlantic Ocean, one from France, four
Brucella pinnipedialis from the North Atlantic Ocean, and
one Brucella sp. from California. These were analyzed along-
side with reference strains from other Brucella species (Brucella
abortus, Brucella canis, Brucella melitensis, Brucella microti,
Brucella neotomae, Brucella ovis and Brucella suis).
Brucella Phenotypic Characterization
All procedures involving live Brucella were carried out accord-
ing to the “Reglamento de Bioseguridad de la CCSS 39975-
0”, year 2012, after the “Decreto Ejecutivo #30965-S”, year
2002 and research protocol NFEG06 approved by the
National University, Costa Rica. Phenotypic analysis of
Brucella isolates was carried out as described (Hernandez-
Mora et al. 2008). Matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry (MALDI-TOF MS) studies of
Brucella protein extracts and gas chromatographic analysis of
fatty acid methyl esters were performed as previously de-
scribed (Isidoro-Ayza et al. 2014). A dendogram derived
from the analysis of concatenated data based on the retention
time of the fatty acid methyl esters, and on the protein masses
detected, was constructed using an Agglomerative
Hierarchical Clustering (AHC) algorithm, using Microsoft
Excel 2000/XLSTAT-Pro (Version 4.07, 2013, Addinsoft, Inc.,
Brooklyn, NY). Proximities were calculated using Squared
Euclidean Distance, and aggregation was calculated using
the unweighted pair-group average method. Raw data are
in supplementary data set S2, Supplementary Material online.
DNA Molecular Studies
DNA was extracted with DNeasy Blood & Tissue kit from
QIAGEN or Promega Wizard Genomic DNA Purification kit,
and stored at 70 C until used.
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Multiple loci variable number of tandem repeats (MLVA-
16) analysis and the corresponding cladograms were gener-
ated according to described protocols (Le Fle`che et al. 2006;
Al Dahouk et al. 2007; Maquart et al. 2009; Isidoro-Ayza et al.
2014) using the MLVA-NET database (http://microbesgenotyp
ing.i2bc.paris-saclay.fr/ (last accessed July 24, 2017); Grissa
et al. 2008). Values obtained for each MLVA marker are in
supplementary data set S2, Supplementary Material online.
DNA polymorphism at the omp2 locus was performed as de-
scribed (Cloeckaert et al. 2001).
Other genotyping techniques such as multiplex PCR Bruce-
ladder, MLST, PCR detection of ST27 or bcsp31, HRM RT-PCR
and PCR targeting specific IS711 elements, were performed
either as previously described (references in data set S1, sup-
plementary Material online) or in silico (supplementary data
set S3, Supplementary Material online).
Whole genome sequencing (WGS) was performed at the
Wellcome Trust Sanger Institute on Illumina platforms accord-
ing to in house protocols (Quail et al. 2009, 2012). For WGS
assembly and alignment sequencing reads were de novo as-
sembled using Velvet Optimiser (Zerbino and Birney 2008)
and contigs were ordered using abacas (Assefa et al. 2009)
against B. abortus 9-941 under accession numbers
NC_006932 and NC_006933 at the National Center for
Biotechnology Information (NCBI). To detect miss-
assemblies, raw data were mapped back against the genome
assemblies using SMALT v.0.5.8 (http://www.sanger.ac.uk/sci
ence/tools/smalt-0; last accessed July 24, 2017). All sequenc-
ing data have been deposited at the European Nucleotide
Archive (ENA) (http://www.ebi.ac.uk/ena/; last accessed July
24, 2017) under the accession codes listed in
Supplementary data set S1, Supplementary Material online.
Other WGS sequences from various Brucella strains used for
comparative purposes were obtained from GenBank (supple-
mentary data set S1, Supplementary Material online).
Incomplete genomes, or low N50 scaffolds from databases
were not included in the analysis.
Phylogenetic Reconstruction
To construct a multiple sequence alignment for phylogenetic
reconstruction, whole-genome sequence data from two
Ochrobactrum species and the Brucella isolates from different
hosts (Supplementary data set S1, Supplementary Material
online) were aligned by bwa and mapped with SMALT
v.0.5.8 against B. abortus 9-941, with an average coverage
of 98.81%. Single Nucleotide Polymorphisms (SNPs) were
called using samtools (Li et al. 2009), and 311,780 variable
sites were extracted using snp sites (Page et al. 2016). The
resulting alignment was used for maximum likelihood phylo-
genetic reconstruction with RAxML v7.0.4 (Stamatakis 2006).
The phylogenetic tree was rooted using Ochrobactrum
anthropi ATCC49188 and Ochrobactrum intermedium strain
type LMG3301. Within this data set the B. ovis lineage shared
the most recent common ancestor withOchrobactrum, there-
fore it was subsequently used to root phylogenies constructed
using only Brucella.
All analyses relevant to reference annotation (e.g., dN/
dScalculation and SNP ascription to coding sequences—
CDS) were relative to B. abortus 9-941 (accession numbers
NC_006932 and NC_006933). The alignment and the tree
files were used to generate a tab file containing coordinates
of SNPs position relative to the root; all three files were used to
produce a visual reconstruction of the SNPs distribution along
the genome per branch (as seen in supplementary fig. S5,
Supplementary Material online).
Comparative Genomics from Whole Genome Sequences
Comparative genomics was facilitated by annotation of B. ceti
draft genome assemblies by Prokka (Seemann 2014) and by
annotation transfer from B. abortus 2308 Wisconsin (Suarez-
Esquivel et al. 2016). The annotation of genes absent in
B. abortus 2308 Wisconsin was completed through manual
comparison against reference genomes (Supplementary data
set S1, Supplementary Material online): B. suis 1330, B. ovis
ATCC 25840, B. melitensis 16M and B. pinnipedialis B2/94.
We identified orthologous protein groups and the number of
new, conserved and total genes added by each genome in-
cluded in the analysis (discovery rate) by using Roary (Page
et al. 2015).Visualizations were done with Artemis and com-
parisons with the Artemis Comparison Tool (ACT; Carver et al.
2005). The presence of recombination events was analyzed
by Genealogies Unbiased By recomBinations In Nucleotide
Sequences (Gubbins) (Croucher et al. 2014).
Pseudogene Analysis
To detect pseudogenes in B. ceti, we selected five phyloge-
netically representative draft genomes from marine mammal
brucellae (B. ceti bmarCR17 -P1 cluster-, B. ceti bmarMR26 -
MR cluster-, B. ceti M644/93/1 -A1 cluster-, B. ceti M187/00/1
-A2/B cluster-, and B. pinnipedialis M2466/93/4 -C2 cluster-)
and automatically transferred the annotation of the manually
curated draft genome working strain B. abortus 2308
Wisconsin (Suarez-Esquivel et al. 2016).
Pseudogenes were defined as any gene containing dele-
tions or insertions that removed start or stop codons, or at
least one in-frame stop codons and/or frame shifts compared
with orthologs in B. abortus 2308 Wisconsin or reference
genomes as described above. Pseudogenes were detected
manually using Artemis and ACT. Pseudogenes from marine
mammal brucellae with no homologs in terrestrial Brucella
were compared against the NCBI nonredundant protein data-
base using BlastX. The putative cellular localization was pre-
dicted by PSORT and the function was classified based on: The
product description in the references annotation; BLAST com-
parison with several Brucella species and other genus;
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metabolic assigned pathway according to KEGG (Kanehisa
et al. 2016). In depth metabolic pathway analysis of pseudo-
genes from particular phylogenetic branching points was car-
ried out using BioCyc (Caspi et al. 2014).
Specific Search for Regions of Interest
In order to examine relevant phenotypic genes (virulence re-
lated, outer membrane, lipopolysaccharide [LPS] and flagellar
genes), regions of interest were examined through bwa align-
ment and SMALT mapping. The number of SNPs, insertions
and deletions in each one of the genes was recorded.
The number and position of the insertion sequence IS711
were searched in the analyzed genomes by mapping the
reads to the 842 bp IS711 of B. ovis (accession number
M94960). Those reads that showed 99% mapping, were
then mapped against the reference WGS B. ovis ATCC
25480 in order to judge where IS711 might be inserted.
The reads that mapped >90% to the WGS were filtered to
50 coverage and used to produce a visual representation
displaying the identified sites per genome and approximate
location according to B. ovis sequence coordinates.
The presence, orientation, and distribution of 24 previously
reported genomic islands (GIs) or anomalous regions (regions
apparently acquired by horizontal gene transfer; Mancilla
2012; Rajashekara et al. 2004; Wattam et al. 2009) were
examined across the four phylogenetically representative B.
ceti genomes (see above). For this, a “genomic-island pseudo-
molecule” was formed by concatenation of 23 genomic
regions obtained from nonmarine Brucella reference sequen-
ces (supplementary data set S1, Supplementary Material on-
line). Islands were concatenated and ordered as follows: GI-4,
GI-3, SAR 1-2, wbk, SAR 1-5, GI-2, GI-1, SAR 1-17, 4 kb,
13 kb, GI-9, GI-8, 26.5 kb, IncP, 12 kb, GI-7, GI-6, GIBs2,
GIBs3, SAR 2-10, GI-5, mtgC, and virB.
A BLAST comparison between the representative B. ceti
genomes and the pseudo-molecule was performed and
visualized using ACT. The described orientation of the islands
was checked in several reference genomes (B. suis 1330,
B. microti CCM 4915, B. abortus 9-941, and B. ovis ATCC
25840) to confirm the presence of inversions. The 24th GI, a
67 kb sequence found mainly in isolates from marine mam-
mals (Audic et al. 2011; Maquart et al. 2008; Bourg et al.
2007) was similarly analyzed independently.
Results and Discussion
Brucella ceti Clusters According to Geographical Region
and Host Type
To study host preference in nondomesticated Brucella hosts,
we performed genotypic analysis of B. ceti isolated from dol-
phins from the Pacific Ocean and the Mediterranean Sea
(table 1), and compared the results with those of isolates
obtained from marine mammals (dolphins, porpoises, and
seals) from the Atlantic Ocean. These findings were then re-
lated to host and geographical origin.
MLVA-16 results were analyzed in the context of a world-
wideBrucelladatabankand indicated that isolates frommarine
mammals showed dispersion and clustering according to the
host from which they were isolated (fig. 1). Five B. ceti clusters
were observed; two correspond to isolates mainly from differ-
ent dolphin species (clusters A1 and A2) inhabiting the North
Atlantic Sea. A third one is represented mostly by isolates from
porpoises (cluster B) from the same sea (Maquart et al. 2009).
Two additional B. ceti clusters affecting dolphins from the
Pacific Ocean and the Mediterranean Sea were evident
(Guzman-Verri et al. 2012; Garofolo et al. 2014; Isidoro-Ayza
et al. 2014). These clusters are herein referred as P1 and MR,
respectively. The new isolates described in this study from the
Eastern Tropical Pacific of Costa Rica belong to the P1 cluster
affecting striped dolphins (Stenella coeruleoalba) (table 1, sup-
plementary fig. S1, Supplementary Material online).
Brucella pinnipedialis isolated from the North Atlantic Sea
was divided in three different MLVA-16 clusters that also re-
lated to host preference: Two were represented by isolates
mainly from harbor seals (Phoca vitulina) (clusters C1 and C2)
and one was represented by isolates from hooded seals
(Cystophora cristata, cluster C3; Maquart et al. 2009). In ad-
dition, a human Brucella sp. isolate from New Zealand
(Brucella sp. 02611), with no zoonotic link, an isolate from
an aborted dolphin (Brucella sp. F5/99), and isolates from a
stranded bottlenose dolphin from the Adriatic Sea (Cvetnic
et al. 2016) define a distinct cluster (Maquart et al. 2009)
herein named cluster H.
To determine if the dispersion and clustering observed by
MLVA-16 could be reproduced by using higher resolution
methods and establish possible explanations for this, we per-
formed WGS of Brucella isolates from marine mammals from
the North Atlantic, Eastern Tropical Pacific and Mediterranean
Sea and analyzed them together with publically-available high
quality Brucella genomes (table 1, supplementary data set S1,
Supplementary Material online). The number of studied
genomes (n¼ 50) was adequate to describe basic genomic
characteristics of the genus, because the pan and core ge-
nome reached a plateau value within the data set (supple-
mentary fig. S2, Supplementary Material online).
The overall genetic structure of Brucella from marine mam-
mals is in tune with the classical pathogenic Brucella from land
mammals. Some conserved traits are: Presence of two chro-
mosomes, absence of plasmids, no major recent recombina-
tion events, similar GIs/anomalous regions, and conservation
of genes encoding virulence factors (fig. 2, supplementary
figs. S3, S4, and supplementary data set S3, Supplementary
Material online). Phylogenetic analysis using O. anthropi
ATCC49188 and O. intermedium LMG3301 as an outgroup
showed that B. ovis shared the most recent common ancestor
within this data set with Ochrobactrum, so it was subse-
quently used to root phylogenies constructed using only
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Brucella isolates. When Ochrobactrum was excluded from the
alignment, a total of 24,340 SNPs were found among the
Brucella genomes. Of these, 19,081 SNPs were located in
coding regions with a dN/dS ratio of 1.61.
The general topology of the SNPs based phylogenetic tree
was consistent with those of similar studies using mainly ter-
restrial isolates, showing a clonal genus (Wattam et al. 2014,
2009) (fig. 2) or when B. suis 1330 was used as reference
genome. It is also similar to a dendogram obtained by con-
catenation of results of matrix-assisted laser desorption/ioni-
zation time-of-flight mass spectrometry (MALDI-TOF MS) with
gas liquid chromatography analysis of the fatty acid methyl
esters (GLC) of Brucella cell extracts (supplementary fig. S5A,
Supplementary Material online). When compared with the
MLVA-16 study (fig. 1 and supplementary fig. S1,
Supplementary Material online), the WGS analysis showed
at least four B. ceti clusters, corresponding to MLVA-16 clus-
ters P1, MR, and A1. The MLVA-16 clusters A2 and B are
grouped in a single cluster that we refer as the A2/B genotype.
The H cluster was represented by Brucella sp. F5/99, had its
most recent common ancestor with B. pinnipedialis C cluster,
and was also closely related to the B. ceti A2/B cluster.
When SNPs positions across each genome are visualized
relative to the tree root, a barcode-like pattern due to differ-
ent SNPs density regions within the genomes was observed.
Some SNPs clusters could be identified, specific for a group of
Brucella genotypes from marine mammals, or a single geno-
type (supplementary fig. S6, Supplementary Material online).
All together, these results expand the panorama observed
in previous genotypic studies (Audic et al. 2011; Garofolo
et al. 2014; Wattam et al. 2014; Maquart et al. 2009) and
indicate a correlation between the evolutionary traits of
Brucella isolated from marine mammals, its geographical or-
igin and preferred host.
In order to benchmark other molecular techniques de-
scribed for identification or typing of Brucella, we compared
results generated using ten different techniques to the WGS
classifications of the marine mammals Brucella isolates. Of
these,multiplexPCRBruce-ladder, adoptedby theOIE for iden-
tification of Brucella species (OIE 2009) was able to classify but
not discriminate all marine isolates (Supplementary data set S2,
Supplementary Material online). Phylogenetic analysis based
on DNA polymorphism at theomp2 locus essentially replicated
the genomic and phenotypic analysis results (supplementary
fig. S5B, Supplementary Material online).
Multiple Sources and Consequences of B. ceti Genome
Variation
To establish if there were genetic traits that could be related
to Brucella host preference and virulence using isolates from
wild animals, a detailed analysis of the genome structure of
B. ceti clusters as compared with other Brucella genomes was
performed.
Analysis of amount of SNPs found in genes encoding viru-
lence traits such as the type IV secretion system virB, some of
its effectors (see below), LPS, membrane lipids, BvrR/BvrS two
component system regulatory network and flagella did not
show significant variations among the isolates
(Supplementary data set S2, Supplementary Material online).
Genome alteration through the active transposon insertion
sequence IS711, usedasaBrucellagenusfingerprint (Ocampo-
Sosa and Garcıa-Lobo 2008), was examined. An increased
number of this element was detected in brucellae from marine
mammals as compared with those from terrestrial strains (fig.
3),consistentwithpreviousreports (Brickeretal.2000;Dawson
et al. 2008; Bourg et al. 2007; Audic et al. 2011). This indicates
that marine isolates show greater genome variability than ter-
restrial ones. Interestingly, several IS711 insertion patterns
along the genome assemblies were observed and related to
phylogenetic position. Some variation among isolates within
phylogeneticclusterswasalsoobserved(e.g.,ClusterP1,fig.3).
To study the en bloc gain or loss of syntenic genes across
the Brucella isolates from marine mammals, further detailed
comparative genomics of representative from each of the four
genome clusters P1, MR, A1, and A2B was performed.
Presence of previously reported 24 GIs, important as evidence
of gene horizontal transfer and gain of virulence traits within
the genus (Mancilla 2012) was investigated (supplementary
fig. S4, Supplementary Material online). Inversion of a GI as
compared with reference sequences was a frequent event
found in all four genomes, particularly those found in
Table 1
Marine Mammal Brucella Isolates Used for WGS Analysis (detailed
information in supplementary data set S1, Supplementary Material online)
Species/Host N. of Isolates Locationa
B. ceti
Balaenoptera acutorostrata (minke
whale)
1 NA
Delphinus delphis (common dolphin) 2 NA
Lagenorhynchus acutus (Atlantic
white-sided dolphin)
1 NA
Phoca vitulina (common seal) 1 NA
Phocoena phocoena (porpoise) 3 NA
Stenella coeruleoalba (striped
dolphin)
27 ETP, MS, NA
Tursiops truncatus (bottle nose
dolphin)
2 MS, France
B. pinnipedialis
Balaenoptera acutorostrata (minke
whale)
1 NA
Lutra lutra (otter) 1 NA
Phoca vitulina (common seal) 2 NA
Brucella sp.
Tursiops truncatus (bottle nose
dolphin)
1 USA
aNA, North Atlantic. ETP, Eastern Tropical Pacific. MS, Mediterranean Sea.
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chromosome II. The 12 kb and the 26.5 kb GIs were absent in
all four genomes. GI-1 was absent in the P1 cluster and as
previously reported, GI-3 was absent in the A2/B cluster rep-
resentative (Wattam et al. 2014). The wbk GI, related to LPS
synthesis, a virulence factor, has a particular rearrangement in
the P1 cluster representative, caused by transposon and IS
derived elements. However, they do not affect codifying
genes as compared with the B. melitensis 16M wbk GI. The
67 kb GI related to B. pinnipedialis and to cluster H (Bourg
et al. 2007; Audic et al. 2011) was found in the B. pinnipe-
dialis isolates included in this study and in B. ceti bmarMR24.
GI IncP was absent in B. pinnipedialis B2/94.
Comparative analysis of draft genome contiguous sequen-
cesorderedagainstB.abortus2308Wrevealedadeletiondueto
repetitive sequences in the P1, MR, and A1 isolates representa-
tives relative to the A2B cluster, including nine genes encoding
mainly sugar transporters (BAW_20470-BAW_20476 and
BAW_20479-BAW_20480) and four adjacent pseudogenes.
Pseudogenization Is a Source of Genetic Variability That
Relates to Host Preference
To study correlations among pseudogene accumulation and
host adaptation, we performed manual pseudogene
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FIG. 1.—MLVA-16 analysis dendogram of Brucella related to geographic location and host. Analysis was performed according to: http://microbe
sgenotyping.i2bc.paris-saclay.fr/ (last accessed July 24, 2017). Increased resolution of marine isolates shown in supplementary fig. S1, Supplementary
Material online.
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annotation in the four B. ceti representative genomes, one
representative B. pinnipedialis, B. abortus, B. ovis, and B. suis
genomes and compared pseudogene traits according to ge-
nome (fig. 4A). In all genomes, the proportion of pseudogenes
was higher in chromosome II than in the larger chromosome I
(supplementary data set S4, Supplementary Material online). A
total of 706 pseudogenes were found among these genomes
and only two were shared among them. The mutation site
within each gene was often conserved, suggesting that they
occurred once in a common ancestor. The main cause of pseu-
dogenization, was frame shift (410/706, 58%), followed by
deletions (90/706, 13%) (fig. 4A and supplementary data set
S4, Supplementary Material online). Their distribution accord-
ing to former gene product, subcellular locationand function is
in Supplementary data set S4, Supplementary Material online.
Putative primary events targeting specific metabolic path-
ways that have become fixed in this population can be
identified by looking at the extent of gene degradation at
nodes of the phylogenetic tree (fig. 2). At the branching point
between the marine mammal isolates and the B. suis/B. canis/
B. microti clade only one shared pseudogene was found.
Likewise, no shared pseudogenes were found at the branch-
ing point between the B. ceti A2B genotype and B. pinnipe-
dialis, and only one pseudogene was shared among the B. ceti
MR and A1 genotypes, suggesting that little gene degrada-
tion occurred when they diverged.
However, extensive pseudogenization was found among
the isolates from marine mammals diverging from the B. suis
clade (fig. 4A). Most of the 35 found pseudogenes, related to
energy metabolism (8/35, 23%), amino acid transport and
metabolism (5/35, 14%), gene regulation/transcription (4/
35, 11%), or unknown function (5/35, 14%) (fig. 4B).
Frame shift (22/35, 63%) was the main cause of pseudoge-
nization followed by insertions (6/35, 17%) (fig. 4C).
Functional analysis of the cognate wild type genes indicated
that several pseudogenes were related to relevant metabolic
pathways (Supplementary data set S4, Supplementary
Material online). Notably, multiple pseudogenizations had oc-
curred in pathways that alter fatty acid metabolism.
Specifically, an acetyl-CoA acyltransferase and an acetyl-
CoA C acetyltransferase very likely lost function in the marine
mammal isolates. Lack of these enzymes is expected to influ-
ence fatty acids synthesis and beta-oxidation. In line with this
finding, AceB, a malate synthase, catalyzing the conversion of
glyoxylate to malate during the TCA, glyoxylate cycle (Zu~niga-
Ripa et al. 2014) has probably lost its function. A functional
glyoxylate shunt provides succinate and malate from acetyl-
CoA and isocitrate for the TCA cycle and it is responsible for
the bacteria ability to grow on fatty acids as carbon source
(Barbier et al. 2011).
Synthesis of betaine glycine an osmoprotectant and source
of carbon and nitrogen, important for B. abortus virulence
(Lee et al. 2014) is probably affected, because two related
genes lost function: Choline dehydrogenase and a glycine
betaine/L-proline ABC transporter. Two more genes related
to Brucella virulence probably lost function in the analyzed
marine mammal isolates: One of the four predicted autotrans-
porters in Brucella encoded by btaE, required for full
virulence and defining a specific adhesive pole in B. suis
(Ruiz-Ranwez et al. 2013) and the predicted sugar porin
encoded by BR0833, required in B. suis for late stages of
macrophage infection (Kohler et al. 2002).
There are 64 genes commonly pseudogenized in B. ceti
genotypes P1, MR, and A1 representatives infecting dolphins,
relative to the remaining marine mammal brucellae clusters
(figs. 2, 4A and supplementary data set S4, Supplementary
Material online), most of them related to amino acid transport
and metabolism (11/64, 17%), carbohydrate transport and
metabolism (10/64, 16%) or unknown function (12/64,
19%; fig. 4B). Although frame shift was still the most impor-
tant mechanism of pseudogenization in this group (25/64,
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FIG. 2.—Whole genome sequence analysis of marine mammal
Brucella shows phylogenetic correlation to host and geographic location.
Phylogenetic tree based on 24,340 SNPs of different Brucella WGS. The
isolates related to marine mammals showed six clusters, corresponding to
those revealed by MLVA-16 analysis: P1, MR, A1, A2/B (which includes
isolates from MLVA-16 A2—marked with asterisk—and B clusters), H and
C. Ochrobactrum sp., used as the original root for the tree, was trimmed
from the figure to increase tree resolution. Each cluster defining branch
showed a 100 bootstrap value. The number of pseudogenes found is
indicated in each defining node. Core genome analysis displayed similar
tree topology.
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39%), deletion and premature stop codons were found in
higher proportions (28 and 27%, respectively) as compared
with the group of all marine isolates (18 and 17%, respec-
tively). Insertions on the other hand were not as common
(2%) as in the second group (17%; fig. 4C).
The P1, MR, and A1 genotypes show a higher proportion of
gene degradation in functions related to carbohydrate trans-
port and metabolism as well as those encoding transporters
and cell envelope biogenesis functions as compared with the
shared pseudogenes in the marine mammal representatives
(fig. 4B). Several pseudogenes were tracked to specific path-
ways. Neither degradation of amino acids such as cysteine,
glutamine, arginine, histidine, alanine, and aspartate nor py-
ruvate fermentation seem essential for survival in their dolphin
host. The highly conserved sigma-54 factor rpoN, related to
control of nitrogen metabolism, shows a frame shift mutation
that very likely impairs its function (Ronneau et al. 2014).
Some genes related to virulence showed mutations.
Degradation of outer membrane protein encoding genes
as well as the flagellum operon, was also observed
in the P1MRA1 B. ceti as in terrestrial Brucella
(Martın-Martın et al. 2009; Moreno and Moriyon 2006).
One of the type IV secretion system VirB effectors encoding
gene, vceC contains an internal in frame deletion, resulting in
loss of 10 amino acid residues as compared with B. abortus
2308 VceC. This mutation was present in all 30 B. ceti
P1MRA1 genomes studied (Supplementary data set S3,
Supplementary Material online) and is different from a previ-
ous reported one in terrestrial isolates (de Jong et al. 2008).
This indicates that either that particular deletion does not af-
fect protein function or that VceC is not needed for survival in
the dolphin host.
Gene galE-1 encoding an UDP-galactose 4-epimerase re-
lated to smooth LPS biosynthesis and attenuation (Rajashekara
FIG. 3.—IS711 insertion signatures for Brucella sp. Each peak represents the location of 50 coverage IS711 insertion. The position in the first and
second chromosomes (shown as a concatenated molecule) is indicated by the scale bar (in Mb) above. The number of IS711 insertions is shown in
parentheses at the end of each genome.
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AB C
FIG. 4.—Classification of Brucella pseudogenes in relevant tree branching points found in representative genomes. (A) The left bar graph indicates
function of each pseudogene according to color code and distributed according to four branches (MRA1, PMRA1, all marine analyzed genomes and all
analyzed genomes). Every other bar represents the pseudogenes in each genome and colors correspond to a specific pseudogene type. “No stop codon”
mutation refers to longer genes as compared with other Brucella reference genes. The number of pseudogenes for each branch is indicated in parenthesis.
Details in Supplementary data set S4, Supplementary Material online, spreadsheet “at branch pseudo” (B, C). Proportional distribution of pseudogenes
classified by their function (B) and by mutation type (C), according to two branching points (marine isolates and P1MRA1) in the phylogenetic tree.
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et al. 2006) has an internal stop codon that probably renders
inactive its product and could be related to the fact that some
B. ceti isolates may appear as a “rough” phenotype (Guzman-
Verri et al. 2012). The premature stop codon was consistently
found in all 30 P1MRA1 analyzed genomes.
It seems then, that when Brucella infects marine mammals,
several important pathways related to energy, transport of
metabolites and regulation/transcription are being degraded
mainly via frame shift mutations. Marine isolates infecting
particularly dolphin hosts showed further degradation of
metabolites transport pathways as well as pathways related
to cell wall/membrane/envelope biogenesis and motility, via
not only frame shift mutations but also by premature stop
codons and even gene absence. Altogether these findings
indicate that degradation of metabolic pathways in Brucella
is related to host preference with pseudogenization being a
source of genetic variability. This is important for the estab-
lishment of host–bacterial interactions among the different
Brucella species and their preferred hosts.
At least three barriers to successful bacterial replication and
transmission exist for an intracellular pathogen in a given host
population. The first is the immune system that will select for
variants capable of withstanding host defenses. The second
one is the intracellular milieu, which imposes conditions such
as requirements for lysosome evasion, intracellular trafficking,
and metabolic requirements. The third one relates to the
mechanisms for transmission to other hosts, which may vary
among different animal species. In the case of Brucella organ-
isms from terrestrial domesticated mammals, at least two ad-
ditional anthropogenic conditions may play a relevant role in
biasing brucellae recovered from these populations:
Domestication of a finite genetic line of the host species
and population management controls such as vaccination
and slaughter strategies (Moreno 2014). It is feasible that se-
lection towards increased virulence, transmissibility, replica-
tion and zoonotic potential observed in B. abortus,
B. melitensis, and B. suis (biotype 1 and 3) from domesticated
animals, has taken place through successive infections in con-
fined domesticated hosts, as proposed for the evolution of
other infectious diseases (Ewald 2004).
Conclusion
Genetic variation is evident in Brucella from marine mammals
and manifests in a variety of ways: 1) specific IS711 insertion
patterns across the genome, 2) higher numbers of IS711 ele-
ments compared with Brucella from terrestrial mammals, 3)
specific SNP signatures across phylogenetic clusters, and 4)
pseudogenization of metabolic pathways. These traits corre-
late with host preference and, in the case of B. ceti, with
oceanic origin.
We conclude that genome decay occurs through insertion
sequence element proliferation and pseudogene formation.
The extensive pseudogenization found suggests that these
Brucella isolates from wildlife are less likely to be zoonotic.
Moreover, the mechanism of pseudogenization varies accord-
ing to host preference. At the same time, this gene loss is a
source of genetic variation within the marine isolates and
results in a signature of host-association. The impact of this
phenomenon in gene content variation has been described as
similar to that exerted by horizontal gene transfer in nonclonal
species (Bolotin and Hershberg 2015).
How humans are intervening with this process by domes-
tication of animals is an interesting question that is not only
relevant in terms of natural history of bacterial diseases but
also in terms of preventive measures such as vaccination.
Supplementary Material
Supplementary data are available at Genome Biology and
Evolution online.
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Abstract 
 
Brucellosis, caused by Brucella abortus, is a major disease of cattle and 
humans, with high prevalence in Costa Rica (CR). The disease was reported in CR 
during the beginning of the 20th century and, despite all efforts, it has not been 
controlled. B. abortus isolated in Costa Rica from bovines, humans and water 
buffalo were analyzed by whole genome sequencing (WGS) and associated to 
geographic origin, date of introduction and phylogenetic associations. Our findings 
are relevant from the epidemiological perspective. Following the brucellosis prevalence 
and the idiosyncratic settings of several middle- and low- income countries, similar 
scenarios could be found in other latitudes. 
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Chapter 4: Proposal for a suitable strategy to control brucellosis in Costa Rica 
In this chapter, we discuss critical factors that should be considered to 
develop a suitable strategy for controlling bovine brucellosis in Costa Rica, and other 
countries in the region.  
The control and eradication of brucellosis is a complex undertaking that 
requires the active involvement of all parties, including government, stakeholders, 
and farmers, among several (Blasco et al., 2016). If the authorities and stakeholders 
propose eradication, then correct political decisions and sustained commitment of 
all relevant parties must be accomplished. The first critical factors for initiating a 
brucellosis control program is the understanding of the epidemiological status of the 
disease in the country, the identification of the circulating Brucella species in the 
livestock and the infection incidence in humans (Lubroth et al., 2007). For this, 
adequate epidemiological data must be collected using serological tests with the 
highest sensitivity and specificity, as well as reliable and efficient isolation and 
characterization of the circulating Brucella strains.  
Once the epidemiological units have been identified and defined, a 
vaccination-test- slaughter strategy has to be designed. Concomitantly, a strict 
individual identification, and control of movements between the epidemiological units 
must be achieved. It is mandatory that the administration provides the funds for the 
intervention costs and promotes the active involvement of all parties, including 
relevant stakeholders and farmers, who must receive educational information 
through the development of the campaign (Blasco et al., 2016). An economic 
incentive for the brucellosis-free status should be promoted between farmers and 
government as well as compensation for culling with the market value of the animals 
to actively involve the producers (Blasco et al., 2016).  The current situation in Costa 
Rica is described in table 1. 
 The definition of the epidemiological unit (restricted area of intervention, 
regardless of administrative or national borders) and the accurate description of 
herd-level should be the base of the selected strategy. For this purpose, three 
strategies are recommended according to the herd seroprevalence of brucellosis 
(Blasco et al., 2016): 
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a) Very low herd seroprevalence (≤1-4%). A test and slaughter eradication 
program and the ban of vaccination could be recommended to eradicate the 
disease in short to medium term.  
b) Low to moderate herd seroprevalence (5-10%). A combined eradication 
program based on the simultaneous application of S19 vaccination in young 
replacements and test and slaughter of seropositive adult animals is 
recommended to eradicate the disease at medium-long term. 
c) High herd seroprevalence (≥ 10%). No matter the level of professional 
organization and economic resources, a mass S19 vaccination program is the 
only strategy to control the disease, a step strictly necessary before undertaking 
any other control or eradication measure. 
Agglutination tests, in particular RBT, should be considered as the baseline 
assay for evaluating infected animals in the epidemiological units in Costa Rica 
(Ducrotoy et al., 2016). In addition, S19 is the vaccine of choice. Up to now, this is 
the only approved vaccine that confers an adequate level of individual and herd 
protection against bovine brucellosis (Moriyón et al., 2004; OIE, 2018). Considering 
this, the herd seroprevalence estimated in the random sampling performed during 
2012-2013 (Chapter 1), only the Brunca Region is classified as low-moderate 
seroprevalence (4.1%), and the rest of Costa Rica possesses a seroprevalence 
between 10.3% and 16% (Hernández-Mora et al., 2017a). Therefore, with the above 
possible described strategies and in accordance with the herd seroprevalence, the 
most feasible strategy is “c” corresponding to mass vaccination of all herds 
regardless the age and physiological condition (Nicoletti, 1976; Alton &Corner, 1981) 
before moving to other strategies.  
The rationale behind mass vaccination with S19 strategy claims that, under 
conditions of high seroprevalence, vaccination followed by test and slaughter 
strategies are not applicable due to substantial economic restrictions and difficulties 
of controlling the circumstances in poor or remote areas. The serological interference 
caused by S19 vaccine could be managed with adequate time between vaccination 
and diagnosis and identification of the vaccinated animals (Blasco et al., 2016). Mass 
vaccination with B. abortus S19 was performed in the early seventies by countries 
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like the United States (see Anexx 1), Australia, and New Zealand, among others that 
have successfully controlled and eradicated brucellosis afterward (Crawford and 
Hidalgo, 1977). This strategy was developed as an alternative to calf vaccination 
with reduce doses of S19 (Nicoletti, 1976; Alton & Corner, 1981). 
To avoid the problems carried out by S19 subcutaneous vaccination, the use 
of a reduced S19 dose by conjunctival route recommended by the OIE and FAO 
(OIE, 2018, Blasco et al., 2016) has been implemented by several authors (Corner 
& Alton, 1981; Corner, 1983; Nicoletti et al., 1978a; Nicoletti et at., 1978b; Lubroth 
et al., 2007. This vaccination strategy has several advantages; i) it diminishes the 
risk of abortion in pregnant animals; ii) it avoids long-term positive reactions that 
hamper the distinction of infected from vaccinated animals; iii) it does not require 
needle for application, diminishing the risk of accidental inoculations; iv) it is the 
cheapest vaccine on the market (table 2), finally; v) it is readily applied and less time-
consuming. To decrease the overall seroprevalence, the coverage of S19 mass 
vaccination should be close to 100% and achieved during the shortest time possible 
(Blasco et al., 2016).  
As expected, the serological background of mass vaccinated animals living in 
a highly infected environment is challenging to interpret (Plommet & Fensterbank, 
1976). Even by the conjunctival route, the serological response induced by S19 
vaccine in adult animals is of greater intensity and duration than that induced in 
young replacements. Although protected, vaccinated animals produce anamnestic 
responses upon contact with field strains in a highly infected environment, precluding 
the straightforward diagnoses (Blasco et al., 2016). For this reason, a serological 
test should be carried out only after 18 months of vaccination, once the antibody 
titers against LPS have lowered in the immunized animals. Test and slaughter 
strategy may be considered after mass vaccination in some epidemiological units 
with lower seroprevalence. For this, the combination of RBT with native hapten gel 
precipitation test has demonstrated to be useful, and therefore recommended by the 
OIE (Greiner et al., 2009; OIE, 2018). Commonly several rounds of mass vaccination 
are required before the overall prevalence is lowered to the necessary prevalence 
levels to move to the following “b” strategy, based on the simultaneous application 
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of S19 vaccination in young replacements and test and slaughter of seropositive 
adult animals, with the economic support of the authorities. Only the calves and 
replacements should be vaccinated every year, following individual tagging of the 
immunized animals. Once the prevalence has lowered, and the disease is under 
control after several years of a successful vaccination, then it is possible to consider 
a strict intervention to move towards the eradication program, step “a”. 
Parallel to the control and eradication strategies, public health and veterinary 
authorities must develop educational policies directed to the general public as well 
as farmers indicating the preventive measures such as pasteurization of dairy 
products, and avoiding consumption of raw milk, as well as biosafety protocols in the 
animal farms, to prevent reinfections (Mattar et al., 2017; WHO, 2014; CDC, 2017; 
NYDH, 2017). Also, health centers and hospitals must include brucellosis specific 
tests as differential diagnosis of common diseases, such as dengue, zika, 
chikungunya, trypanosomiasis, malaria and another fibril illness present in Costa 
Rica (Mattar et al., 2017; WHO, 2014; CDC, 2017). The use of RBT as a screening 
technique (Alton & Jones, 1988) following the current recommendations of the World 
Health Organization and the Center for Disease Control (WHO, 2014; CDC, 2017) 
is a straight forward inexpensive measure (WHO, 2014). 
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Table 1. Factors to include in the strategies of control of brucellosis in Costa Rica 
 No 
available 
 Available 
1. Protective vaccine    X 
2. Affordable diagnostic techniques with high 
sensitivity and specificity 
  X 
3. Identification of all herds X   
4. Capacity of veterinary services to conduct 
the interventions on the whole population 
X   
5. Availability of funds for intervention costs X   
6. Active involvement of the breeders and 
other relevant stakeholders. 
X   
7. Description of the brucellosis status*   X 
8. Occurrence of brucellosis in humans**   X 
9. Circulating Brucella species in the 
livestock* 
  X 
10. Individual identification of the whole animal 
census  
X   
11. Full control of the animal movements X   
12. Funds for compensation for culling X   
13. Sustained commitment of all relevant 
authorities and stakeholders 
X   
*Chapter 1, **Chapter 2     
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Table 2. Prices per dose of commercially vaccines against brucellosis included in 
the OIE (2019), available in Costa Rica  
 
 S19 
Conjunctival 
(CZV) 
S19 
Subcutaneous 
(CDV) 
RB51 
Single dose 
(MSD) 
RB51 
(Double dose)* 
(MSD) 
 
Price 
 
$0.80 
 
$1.6 
 
$1.85 
 
$3.7 
 
CZV: CZ vaccines, Spain CDV: Diagnostic and Vaccines for animal health, 
Argentina, MSD: Merck Sharp and Dohme, United States. 
*Protocol recommended by the fabricant https://www.msd-salud 
animal.com.co/productos/rb51/informacion.aspx. 
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CONCLUDING REMARKS  
Brucellosis is an ancient zoonosis that remains prevalent in the Americas 
(Cardenas et al., 2019) (Annex 1 and 2). As expected, most of the countries have 
limited financial resources for generating reliable epidemiological data and 
implementing a brucellosis control program that involves broad vaccination 
coverage, wide-ranging serological testing and identification and removal of infected 
animals with compensation, and lack of incentives to achieve brucellosis-free 
certification. Instead, the epidemiological data is mostly fragmented and 
inconsistent, so the implemented measures are discontinuous and non-systematic 
(Cárdenas et al., 2019; Aznar et al., 2012; Moreno, 2002).   
Unfortunately, most governments ignore the scientific literature describing the 
reliable diagnostic techniques as well as the efficient vaccines, vaccination 
strategies, and control measures. Instead, they have followed unsuitable control 
measures for the epidemiological conditions of the countries, and are biased by 
propaganda that has led to the selection of fashionable end expensive serological 
tests and unsuitable vaccines. Following this, most American countries have 
implemented brucellosis “control programs” involving voluntary actions, based on 
non-systematic vaccination and revaccination with RB51, S19, or both. These 
approaches have aggravated the problem since it has been established that RB51 
vaccine does not confer adequate protection for bovine brucellosis (Moriyón et al., 
2004; Blasco et al., 2016). Moreover, since its introduction 30 years ago, RB51 has 
failed to control or eradicate brucellosis in the Americas or other latitudes; and 
human infections with this vaccine are not trivial.  Indeed, due to a lack of detectable 
antibodies in routine serological techniques, patients infected with rough RB51 are 
seldom diagnosed (Ashford, 2004). Additionally, this strain is resistant to rifampicin, 
one of the antibiotics used to combat human brucellosis, aggravating the zoonotic 
problem. Unless the RB51 strain is recovered by culture and accurately 
characterized, medical personnel are not aware of the infection, since traditional 
assays to detect antibodies against field Brucella strains do not work with RB51 
cases (Mattar et al., 2017; WHO, 2014; CDC, 2017; NYDH, 2017).   
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 In Costa Rica, the obligatory basis of the control program of brucellosis 
remained from 1958 until 1999, year at which the legislation handed the Brucellosis 
Program over to private hands on a voluntary basis, performed under the supervision 
of the Veterinary Services (MAG-CR, 2000). This modification diminished the control 
measures achieved in previous years, and aggravated the problem as already 
demonstrated (figure 3) (Hernández-Mora et al., 2017a).  
 
Figure 3.  Official reported prevalence of brucellosis estimated by 
agglutination test in Costa Rica 1965 to 2016. The red arrows indicate the 
strategies used by the government and the green arrows indicate the years when 
the disease decrease its prevalence. 
 
Presently, the program lacks: i) specific governmental financial resources, ii) 
field staff, iii) compulsory vaccination with S19, iv) adequate information to the 
producers and, v) actions for the identification of the vaccinated animals. This 
scenario is aggravated by the undisciplined use of RB51 instead of B. abortus S19 
(Piagro, 1996; Hernández-Mora et al., 2017a). Therefore, it is not surprising that in 
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terms of seroprevalence, brucellosis in cattle has increased from 2% in the nineties, 
to almost 11% in current years, as estimated by RBT (Piagro, 1996; Vicente et al., 
1983; Hernández-Mora et al., 2017a) (figure 4).  
 
 
Figure 4.   Herd seroprevalence of brucellosis in bovines of Costa Rica during 
2012-2016.  By RBT, the majority of the territory has a seroprevalence ≥ 10% using 
A) Random sampling during 2012-2013 and B) Non-random sampling during 2014-
2016. 
 
The increased brucellosis prevalence is worsening due to the high 
consumption of unpasteurized dairy products that reach up to 40 % of the consumed 
milk and cheese in Costa Rica (DIPOA, SENASA 2017), and the use the of febrile 
antigens in health centers and hospitals. As already established, this serological 
technique lacks diagnostic sensitivity and specificity to unambiguously identified 
human brucellosis cases (WHO, 2015). In consequence, several cases may course 
without diagnoses. 
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During this thesis, we have described the epidemiological status of bovine 
brucellosis as well as infections in other domestic animals and marine 
mammals.Besides,, we have made efforts to identify the Brucella strains that are 
prevalent in the territory and recommended parameters for the control of brucellosis 
to follow in the next years in Costa Rica. In collaboration with health authorities, we 
have also implemented protocols for the detection of human brucellosis in health 
centers and hospitals, replacing the use of febrile antigens; and instead, using RBT 
as screening assay. We have collaborated with different groups in the diagnosis of 
human brucellosis in stranded cetaceans in Costa Rica and called the attention of 
the risk of zoonosis and described Brucella species (B. neotomae) infecting humans, 
which were not considered zoonotic. Finally, we have collaborated in the 
standardization of the isolation, identification, and molecular diagnostic techniques 
that have served as a framework for reliable epidemiological studies in Costa Rica, 
and as a reference for studies in other countries.  
While much has been accomplished, more work is still needed. Efforts to work 
together with the producers, cattle industry, government, and scientists, under the 
concept of “One Health”, should be carried out in order to finally achieve the control 
and eradication of brucellosis in Costa Rica. Without the long-term engagement of 
all parties, elimination of the disease will not be achieved, even with the best 
strategies and surveillance activities.   
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Annex 1. Brucellosis in the Americas 
Brucellosis is a zoonotic disease that is widespread throughout the world. 
According to the World Health Organization, this bacterial disease is among the 
seven most frequently neglected zoonotic diseases. It has been estimated that in 
low-income countries, there are approximately five and twelve million new human 
brucellosis cases per year (Hull and Schumaker, 2018). Except for B. inopinata, B. 
microti, B. papionis, and B. vulpis, all other accepted Brucella species are present in 
the American continent, primarily associated with their respective preferred mammal 
host (figure 5). According to the Food and Agriculture Organization of the United 
Nations (FAO) the total number of susceptible hosts in the American continent by 
2017 correspond to 516 million bovines, 180 million pigs, 81.3 million sheep, 37 
million goats, 1.3 million buffaloes and close to 150 million dogs in Canada, USA, 
Brazil, Argentina, Colombia, Chile, Bolivia and Costa Rica (FAO, 2017; Statista 
2017; Reid 2011; Bruha 2015; Wall 2018; McMeekin, 2018; WPA 2016).  
Therefore, the economic impact of animal brucellosis and the associated 
zoonotic disease is relevant, thus, the situation requires the application of suitable 
control and eradication programs.  
This section describes the status of animal and human brucellosis in the 
Americas, covering mainly a time span of 85 years, from 1934 to 2019. A significant 
amount of the information collected does not come from scientific journals, but from 
information scattered in national reports issued by Animal and Public Health 
authorities of each country.  During the eighties, Latin American countries had 
military conflicts, critical economic growth, political upheaval against authoritarian 
regimes, and economic recession.  
Therefore, the activities devoted to the control of brucellosis during those years 
diminished, and the access to the information was limited, and in many cases not 
accurate.   
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Figure 5. Reported species of Brucellae in humans, domestic and wildlife animals 
from the Americas during 2006 to 2018 based on the information of CDC (2017); 
Porto (2015); Shury et al., (2015); WAHIS (2018a); WAHIS (2018b). 
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Brucellosis in northern American countries 
Canada 
Several attempts to control and to eradicate bovine brucellosis were carried 
out in Canada since the second half of the XX century. The brucellosis vaccination 
campaign in cattle started in 1950, with the establishment of the Federal-Provincial 
Calfhood Vaccination Program. At that time, the national herd seroprevalence of 
bovine brucellosis was estimated at 9%. The Federal Department of Agriculture 
granted exclusive use of B. abortus S19 vaccine, and they were responsible for the 
management and control of the vaccine. After six years of S19 calfhood vaccination, 
the herd seroprevalence decreased by 4.5%, and then the test and slaughter 
program started in 1957. Individual identification and testing was mandatory, and 
infected herds were quarantined. Diagnosis by serum agglutination test was 
mandatory for all animals. Positive reactors were slaughtered following economic 
compensation. The compensation rates were adjusted according to the animal’s 
age, and affected owners received compensation for the value of the carcasses. A 
total of 687 control areas were established in the country in 1957. These control 
areas were certified for three years when the infection rate was reduced below 1% 
of the cattle population and 5% of the herds. The brucellosis-free areas were certified 
for five years when the infection rate was below 0.2 % of the cattle in the area and 
1% of the herds (Crawford and Hidalgo, 1977).  
The surveillance in farms was carried out by using a combination of the milk 
ring test and testing of cattle at markets, started in 1960. The objective was to locate 
infected herds and to reduce the number of required tests to certify brucellosis-free 
areas. The milk ring testing was done by collecting milk and cream samples three 
times per year from each herd. When positive herds were detected, the origin of 
infection was traced, and all animals were subjected to a blood test (Crawford and 
Hidalgo, 1977). At markets, the female cattle over 24 months of age assigned for 
slaughter were tested by agglutination, and positive animals traced to the herd of 
origin for surveillance. 
Despite all the efforts, an increased brucellosis incidence in a few Canadian 
provinces was detected in 1974.  Most Brucella infections occurred after purchasing 
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cows from untested herds (Crawford and Hidalgo, 1977). All herds adjacent to an 
infected herd were tested and quarantined. In cases in which brucellosis was 
established, the herd was depopulated with economic compensation and replaced 
with brucellosis-free animals.  
In 1976, following S19 vaccination, testing, and slaughter, with compensation, 
the individual brucellosis seroprevalence was below 2%, with a total bovine 
population of 14 million animals. Finally, in 1989, the country was declared free of 
bovine brucellosis, and vaccination was banned (Crawford and Hidalgo, 1977; 
García Carrillo, 1981; FAO, 2017).  
 B. abortus was limited to one or more zones in the territory during 2007, 
suspected but not confirmed and from 2008 onwards absent in domestic animals.  
In wildlife, B. abortus was suspected but not confirmed from 2009 to 2011. In bison 
(Bison bison athabascae) and in elk (Cervus Canadensis), B. abortus was only 
limited to one or few zones from 2012 to 2018 (WAHIS, 2018a, Shury, 2015). B. suis 
biovar 4 was absent in domestic animals during 2006 to 2018, but reported in wildlife 
during 2009 and 2018, mainly in caribou and reindeer (Rangifer tarandus) (WAHIS, 
2018a). In the past B. suis biovar 4 had been reported in moose (Alces alces) 
(Honour and Hickling, 1993). In 2008, B. canis was isolated from kennels in 
Saskatchewan province (Brennan et al., 2008). B. pinnipedialis and B. ceti infecting 
marine mammals were also characterized recently (Whatmore et al., 2017). B. 
melitensis has never been reported in domestic animals or wildlife in Canada 
(WAHIS, 2018a). 
In 1928, human brucellosis was included as a notifiable disease, and since 
then, a total of 6357 cases were reported until 2011. Most of the cases were hunters, 
veterinarians, farmers, abattoir workers, and laboratory personnel (Ontario Agency, 
2016; Berger, 2018). Presently, the rate of Brucella sp. infection in humans 
nationwide in Canada range from 0.2 to 0.5 per 1000000 inhabitants (Ontario 
Agency, 2016). During 2004, in the Nunavk region, less than 1% of seroprevalence 
was detected in indigenous people (Messier et al., 2012). These and other habitants 
of the Arctic regions like Inuits are of concern, since they eat raw caribou meat and 
raw skin and blubber from belugas and other cetaceans, which have been shown to 
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be a source of infection with B. suis biovar 4 and B. ceti, respectively (Chan et al., 
1989; Whatmore et al., 2017). Intermittent human brucellosis cases caused by B. 
suis biovar 4 have been detected in Canada (Turvey et al., 2017). From 2003 to 
2014, the infection rate in Ontario ranged from 0.2 to 0.8 per 1000000 inhabitants 
(Ontario Agency, 2016). Of those cases, 44% were attributable to imported cases of 
B. melitensis, 7% to B. abortus, 10% to other Brucella species, and 39% did not 
specify the Brucella species found. Most of the cases (76.2%) were attributed to 
imported cases from travelers from Mexico, Central America, South America, 
Mediterranean countries, Africa, Middle East, and Asia. In the remainder of the cases 
(23. 8%), the risk exposure was unknown (Ontario Agency, 2018) (figure 6).  Other 
sources reported between 4 and 19 human patients from 2005 to 2016 (figure 7) 
(WAHIS, 2018b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Human infection rate in America between 2005-2018 
(Porto, 2015, WAHIS, 2018b) 
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Figure 7. Brucellosis human cases officially reported in Canada between years 
2005-2016 (WAHIS, 2018b) 
 
United States 
The first attempts to control bovine brucellosis in the United States started in 1934, 
with the Cooperative State-Federal Brucellosis Eradication Program (Crawford and 
Hidalgo, 1977). By 1940, 17 states, including 209 counties, were certified for 
reducing brucellosis herd seroprevalence to less than 5% and less than 1% 
seroprevalence of cattle. In 1941, individual identification, control of animal 
movements, S19 vaccination (3 to 6 months of age), and serological testing were 
introduced for calves in 39 states. In 1942, North Carolina was the first state to 
achieve modified certified status, starting from an individual seroprevalence 
(estimated by agglutination tests) of 11.5% in 1934-1935 to 5% in 1937 and to 2.4% 
in 1941 (Crawford and Hidalgo, 1977; García Carrillo, 1981). The efforts were 
dampened during World War II, and by 1946 the number of reactors among 
individual cattle tested increased to 5%, despite the use of S19 vaccine; mainly 
because there was an increased number of susceptible non-vaccinated cattle 
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introduced into the herds (Crawford and Hidalgo, 1977). In 1947, the United States 
Livestock Sanitary Association adopted an eradication program on a national basis, 
approved by USDA. A frequent screening of dairy herds with milk ring testing was 
initiated in 1952. By 1954, it was estimated that 26% of the national herds were 
positive for brucellosis. During that year, additional funds were available to eradicate 
brucellosis with new efforts involving state by state planning using Rose Bengal Test 
(RBT), elimination of reactors, and broader S19 vaccination. By 1960, greater 
emphasis was given to surveillance activities, and many states achieved the 
brucellosis-free status, following serological testing of beef and dairy cattle, including 
the milk ring testing (Crawford and Hidalgo, 1977; García Carrillo, 1981). In addition, 
two programs were established: firs, market cattle identification (MCI) for animals 
being tagged for slaughter, and tracing of positive animals to the herd of origin; 
second was livestock market cattle testing, for monitoring the total population for 
brucellosis in areas where the number of infected herds was low (Crawford and 
Hidalgo, 1977; García Carrillo, 1981). However, the market cattle testing showed 
some weaknesses. It provided limited information to specific areas but did not 
include the surrounding farms. 
 With a population of nearly 108 million bovines and despite the success 
achieved in previous years for lowering the brucellosis herd seroprevalence, the 
government decided to decrease calf vaccination with S19 in 1964. The main 
argument was the high costs and “low” probability of infection in areas with reduced 
brucellosis individual seroprevalence (Crawford and Hidalgo, 1977; García Carrillo, 
1981; FAO, 2017). Due to this measure, calf vaccination decreased from 7 million to 
3.8 million and reached a minimum in 1975. Brucellosis increased from 12000 
positive herds in 1971 to 16000 positive herds in 1975, revealing that the decrease 
of calf vaccination was premature. Calf vaccination was recommended once more 
in 1979, even though the individual seroprevalence was below 1% in most states. 
From that year on, the vaccination began to increase up to 5 million S19 doses. 
According to Crawford and Hidalgo (1977), the progress of the campaign was 
obtained following these activities: 1) The individual identification of the animals and 
the compulsory control of animal movements, 2) The establishment of the National 
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Commission and committees in the different states, which included representatives 
of the agricultural and livestock sectors, the food-producing industries, scientific and 
educational institutions, industry associations and physicians; 3) the oral and written 
press with active participation; 4) the production of printed matter broadly distributed; 
5) information and literature material for cattle owners; 6) the compulsory action 
followed by most of the owners in the regions; 7) the standard diagnostic techniques 
which included the simplest and less expensive ones, such as card tests and RBT; 
8) slaughter of the reactors with partial compensation to the owners; 9) payment of 
indemnity to the owners after depopulation of reactor problematic herds; 10) the use 
S19 by all states for over forty years with satisfactory results (Crawford and Hidalgo, 
1977; García Carrillo, 1981). National eradication in cattle was mostly achieved by 
the early 2000s with now only an occasional spillover case in cattle in the Greater 
Yellowstone Area, but none elsewhere since 2010 (USDA, 2018). 
According to the World Animal Health Information System (WAHIS, 2018a), B. 
melitensis is currently absent in the USA in domestic animals and wildlife. As a direct 
consequence of important anthropogenic interventions, (winter-feeding of wildlife, 
which increased the animal density and the frequency of contacts) B. abortus has 
been reported in free-ranging elk (Cervus elaphus) and bison (Bison bison) in the 
Yellowstone Park region since the last decade (WAHIS, 2018a). The individual 
seroprevalence in pigs and feral pigs from Texas and Georgia was 13% and 22%, in 
2015 and 2017, respectively (Pedersen et al., 2017). In wildlife B. suis, biovar 4 is 
endemic in wild caribou (Rangifer tarandus) herds in Alaska. B. suis biovar 1 is 
endemic in feral swine in several states, and it is reported as a pathogen limited to 
one or several zones in the country (WAHIS, 2018a). B. ceti and B. pinnipedials 
infecting marine mammals in the Atlantic and Pacific of the United States have also 
been reported (Whatmore et al., 2017).  
From 1993 to 2010, the Center for Disease Control reported 1971 human 
cases in the United States. California, Texas, Arizona, and Florida are the states 
with the higher number of cases, close to 56.5% of all reports. Approximately 70 to 
75% of U.S brucellosis human cases are due to B. melitensis and B. abortus, from 
tourist or migrants that consume unpasteurized dairy products from countries of the 
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Mediterranean Basin (Portugal, Spain, Southern France, Italy, Greece, Turkey and 
North Africa) as well as Mexico, Central and South America, Eastern Europe, Asia, 
Africa, the Caribbean and the Middle East. Feral swine hunters that manage infected 
carcasses or consume raw or undercooked pork are also at risk for food-borne 
exposure to brucellosis (B. suis) as well as owners who buy dogs as pets from 
infected kennels (B. canis) (CDC, 2017; Dentinger et al., 2015). According to WAHIS 
(2018b), an average of 118 human patients were reported yearly between 2005 and 
2018 (figure 8). 
 
Figure 8. Brucellosis human cases officially reported in the United States  
between years 2005-2018 (WAHIS, 2018b) 
 
Mexico  
Even though many National Brucellosis Programs had been proposed in 
Mexico before 1970, it was not until 1971 that a more or less well-established 
national campaign was implemented, with an estimated individual seroprevalence of 
14% in a population of 22.2 million bovines (García Carrillo, 1981; FAO, 2017). Three 
stages were implemented; first, the Department of Animal Health conducted a 
serological survey for the exportation of cattle in 1968 and 1969, and decided to 
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survey selected areas. Second, on a voluntary basis, there were efforts of test, 
slaughter, and quarantine reactor farms. Third, vaccination with S19 vaccine of 
female calves between three and six months of age (Crawford and Hidalgo, 1977; 
García Carrillo, 1981). The campaign included surveillance in 26 Mexican states 
(representing 9.5% of the country) at the slaughterhouses, pasteurization plants, and 
milk collection in dairy farms (Crawford and Hidalgo, 1977). As expected, due to its 
voluntary basis the program failed, mainly due to the absence of compensation for 
the slaughtered animals as well as other coordinated actions, such as following up 
of the cases, identification of the vaccinated animals, and regular testing of the 
herds. In addition, other factors delayed the progress of the control program in some 
areas, including: i) the absence of a professional veterinary service represented by 
a lack of human and material resources needed for the program; ii) lack of economic 
resources to compensate or indemnity the owners for cattle slaughter; iii) the 
absence of vaccines and diagnostic tests when needed; iv) poor identification 
system to control movement of bovines from one region to another, and finally; vi) 
the social, economic, and cultural level of the owners which made it difficult to 
execute the program (Crawford and Hidalgo, 1977). 
Currently, the campaign has been partially supported by the National 
Campaign against Brucellosis in Animals NOM-041-ZOO-1995, and it is of 
nationwide application, on a compulsory basis. However, the coverage is very low. 
The Secretariat coordinated with state governments, producers, and industry and 
sectors linked to livestock farming, the financing mechanisms, and actions to 
compensate the owners of brucellosis reactor cattle slaughtered. Vaccinations are 
based on the use of a full dose of S19 vaccine in calves only from 3 to 6 months of 
age, and a reduced dose S19 vaccine for females older than 6 months and pregnant 
cows, both applied subcutaneously (SENASICA, 2019). Like in other countries, 
RB51 vaccine is also used, in Mexico, however, its efficacy under a high prevalence 
of circulating bacteria is debatable due to a low protective performance (Moriyón et 
al., 2004). 
The state of Sonora claims (with no clear and accessible epidemiological 
data), to be free of brucellosis caused by smooth Brucella species. Also, 31% of the 
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Mexican national territory has been declared in the “eradication phase” (Baja 
California Sur, Campeche, Colima, Guerrero, Nayarit, Quintana Roo and Yucatán, 
as well as some regions of Aguascalientes, Baja California, Chiapas, Guanajuato, 
Huasteca region, Hidalgo, and Puebla), even though several of these states and 
regions have reported high seroprevalence, with cases of bovine and human 
brucellosis. In addition, no solid epidemiological data for cattle brucellosis is 
available in most of these regions (García-Juarez et al., 2014). Moreover, during 
2014, Mexico had the largest number (5514) of reported outbreaks in animals 
worldwide, of which 5174 (93.9%) were due to B. abortus and 340 (6.1%) to B. 
melitensis, with no reported cases for B. suis (Hull and Schumaker, 2018). As 
expected, bovine brucellosis continues to be highly prevalent in Mexico, and failures 
in the control measures are evident.  
B. melitensis is also highly prevalent in both sheep and goats. During 2009-
2012, an individual seroprevalence of 0.52% was reported in Veracruz (Román 
Ramírez, 2017). Higher seroprevalence of 9.8% and 11% was reported in 
Michoacán in 2007 and 2013, respectively (Solorio-Rivera et al., 2007; Oseguera et 
al., 2013). During 2013, a seroprevalence of 38% was described in Jalisco 
(Oseguera et al., 2013), and in 2014, a seroprevalence of 66.8% in Huanantla, 
Tlaxcala (García-Juarez et al., 2014).  
Official data issued by the Animal Health authorities at WAHIS (2018a) report 
that in Mexico, B. melitensis is mainly restricted to goats and sheep, while B. abortus 
is mainly detected in bovines. Likewise, B. suis is present in swine and suspected in 
wildlife animals, but not confirmed. However, the absence of systematic surveillance 
and epidemiological data regarding the isolation and characterization of the Brucella 
strains in the country precludes any significant conclusions. 
Human blood donors from the Northeastern area of Mexico had 
seroprevalence of 0.71% during 2009 (Serrano Machuca et al., 2009). In 2010-2012, 
in Ixtenco, Tlaxcala, the reported seroprevalence of housewives from rural areas, 
was 1.51%. The most relevant risk factors reported were related to traditional socio-
cultural aspects, such as low educational level, goat production units, sanitary 
deficiencies, and unpasteurized dairy products (García-Juarez et al., 2014). During 
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2016, a survey of dairy farmworkers in Hidalgo, described a seroprevalence of 
18.1%, primarily been the calf caretakers (45.4%) (Cervera et al., 2016). According 
to WAHIS (2018b), Mexico is the country with the highest number of reported human 
cases of the Americas, with an average of 2587 human brucellosis cases per year 
from 2005 to 2018 (figure 9). 
Figure 9. Brucellosis human cases officially reported in Mexico between 
years 2005-2018 (WAHIS, 2018b) 
 
Guatemala  
In 1981, the seroprevalence of brucellosis in Guatemala ranged from 1% to 
20%, and it was considered an endemic zoonosis. Different strategies have been 
implemented since then, including test and slaughter and vaccination of calves with 
S19, with unknown coverage (García Carrillo, 1981). In 1997, a low- prevalence of 
B. abortus, B. suis, and B. melitensis was reported (Corbel, 1997). Sporadic 
vaccination with Rev 1 in goats was used (Moreno, 2002).  
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Using RBT in 31038 routine bovine samples, the estimated national bovine 
brucellosis prevalence ranged from 4.8% to 9.8%, from 2008 to 2015, been Peten, 
Izabal, and Escuintla were the most affected provinces (Chajon, 2015; Zelaya et al., 
2017). In 2010 a study of 19733 samples indicated a RBT individual seroprevalence 
of 1.95% (OIRSA, 2014). Moreover, in 2011, a prevalence of infected herds was 
estimated to be 85.4% for a total of 2532 farms from 22 provinces (MAGA, 2011). 
During 2011, the Ministry of Agriculture, livestock and food, described the 
progressive control of farms and reported areas “free” of the disease. There was no 
compensation for the slaughter of positive animals. The basis of control was the 
elimination of the reactors from the herd (MAGA, 2011). However, no systematic 
epidemiological data regarding the status of the disease in Guatemala is available. 
Currently, the progressive control program of brucellosis includes test and 
slaughter in different ruminant species (B. taurus, B. indicus, B. frontalis, B. javanicus 
and B. grunniens, Bison bison, B. bonasus and Bubalus bubalis). Vaccination is 
performed either with S19 or RB51, with no clear criterion regarding the 
immunization strategy. Dairy products, as well as their mobilization, are subject to 
governmental veterinary controls. Bovines in slaughterhouses are tested for Brucella 
infection, as well as bacteriological studies are performed after reports of abortion. 
Movements of positive herds are not allowed, and the only final destination is 
slaughter. Animals that attend exhibitions, fairs, markets, national or international 
livestock auctions, must come from farms free of the disease (MAGA, 2018). 
B. abortus was reported from 2006 to 2017 in bovines and other domestic 
animals like buffaloes and is suspected but not confirmed in wildlife from 2009 to 
2017 (WAHIS, 2018a). No attempts at isolating B. melitensis and B. suis have been 
performed in the country, and therefore was not reported from 2006 to 2018 in 
domestic animals or wildlife.  
According to WAHIS (2018b), a total of 26 human patients with brucellosis 
were reported in Guatemala between 2005 and 2012 (figure 10). 
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Figure 10. Brucellosis human cases officially reported in Guatemala between 
years 2005-2012 (WAHIS, 2018b) 
 
Belize  
In 1980, the reported individual prevalence of brucellosis was 0.1% in 8133 
bovines (García Carrillo, 1981). Since then, the National Bovine Brucellosis Program 
is mandatory (FAO, 2017). Up to now, vaccination against bovine brucellosis is 
prohibited, all animals are individually identified and strict control of animal 
movements is performed (Belize Agricultural Health Authority, 2011). 
Bovines were tested by agglutination assay, and all reactor animals were 
slaughtered with financial compensation by the Ministry of Agriculture and by the 
producer´s association. The Belize animal health authorities declared brucellosis-
free areas when individual serological prevalence was less than 0.1%. Animals 
introduced into these zones came from brucellosis-free herds. The free areas 
established quarantines before the entry of new animals into brucellosis free herds, 
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with two consecutive serological tests separated by 30 days. Milk was verified by 
ring test on a regular basis. Susceptible animal species, such as equines and 
canines, were forbidden to enter the production units (Belize Agricultural Health 
Authority, 2011). 
The current bovine population of Belize is 113122 animals (FAO, 2017). 
During 2012, an individual seroprevalence of brucellosis of 0.2% was reported 
(OIRSA, 2014). In 2016, the government declared the country “free of brucellosis” 
(claiming less than 0.01% of individual prevalence) (Cocom, 2016; FAO, 2017). 
According to the Minister of Agriculture, this condition was finally achieved in 2018. 
No human cases have been reported by FAO from 2005 to 2018 (WAHIS, 2018b), 
and Brucella organisms have not been reported in domestic animals or wildlife 
(WAHIS, 2018a). However, no clear epidemiological data is available certifying the 
brucellosis-free status. Moreover, no attempts to isolate B. melitensis, B. abortus 
and B. suis have been carried out (Ical D, 2018), in spite of the fact that neighboring 
countries such as Mexico and Guatemala have brucellosis. 
 
El Salvador  
National individual seroprevalence of bovine brucellosis in El Salvador during 
1975, 1977, and 1983 was estimated to be 1.08%, 1.95%, and 1%, respectively 
(García Carrillo, 1981; Reyes-Knoke & Rice, 1983). In 1979 an individual 
seroprevalence of 1.2% in adult swine was reported (Rice et al., 1979). The program 
for the control and eradication of bovine brucellosis consisted in the certification of 
free herds based on serological diagnoses. Vaccination with S19 was sporadic, and 
no compensation for the slaughter of positive animals was granted. According to the 
Regional International Agency of Agricultural Health (OIRSA, 2014), the estimated 
herd seroprevalence during 2010-2013 was 7.5% and individual seroprevalence of 
1.17%. However, according to the Ministry of Agriculture and Livestock, the national 
prevalence from 2014 to 2018 among 13340 animals sampled in all the territory was 
1.4% (MAG-El Salvador, 2018). However, no publication or governmental 
epidemiological data is available. 
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Currently, the brucellosis program in El Salvador is voluntary, and the main 
objective is to certify herds free of brucellosis (MAG- El Salvador, 2018). The vaccine 
used is RB51, and the government sells it with an average cost of $1.00 per vaccine 
doses (MAG- El Salvador, 2015). Positive animals are marked for slaughtered with 
no compensation (MAG- El Salvador, 2018). 
B. melitensis and B. suis are not reported in domestic animals or wildlife from 
2006 to 2018 (WAHIS, 2018a). B. abortus was reported from 2006 to 2017 in 
domestic animals, and there is no information available in wildlife. However, no 
information on attempts to isolate and characterize these Brucellae strains is 
available. In 2016, a national survey detected 1% of antibodies on goat and no 
reaction in sheep using RBT (Linderot et al., 2016). Human and animal cases due 
to B. abortus and B. suis have been reported (Rice et al., 1979; Corbel, 1997). From 
2010 to 2016, nine human brucellosis cases were reported in El Salvador (figure 11) 
(WAHIS, 2018b), indicating the presence of this bacteria in the territory. 
Figure 11. Brucellosis human cases officially reported in El Salvador between 
years 2010-2016 (WAHIS, 2018b) 
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Honduras  
In 1972 the herd prevalence of brucellosis in Choluteca (8.72%), Morazán 
(7.7%), Comayague and La Paz (5.9%) and Santa Bárbara (4.1%) was reported, 
with an average of 6.6% (García Carrillo, 1981). The governmental strategy used 
was test and slaughter, with optional vaccination of calves with S19 when the herd 
prevalence was equal or higher than 5%. The country program began in 1977 with 
Area I, which included San Pedro de Sula and Choloma with herd prevalences of 
25% to 48%, respectively (García Carrillo, 1981). During the same year, the infection 
with B. abortus bv1 was confirmed at the Pan American Zoonoses Center (García-
Carrillo et al., 1978).  
During 1997, actions for the control and eradication of the brucellosis were 
established by the Ministry of Agriculture and Livestock of Honduras. The same year 
the presence of B. abortus was detected, and a high brucellosis individual 
prevalence was reported in the swine population (Corbel, 1997). The actions were 
mandatory nationwide, with test and slaughter to be executed progressively, giving 
priority to the areas and herds with the highest risk. Calf vaccination with S19 was 
performed by government veterinarians, and each animal identified by tagging. The 
governmental animal authorities (SENASA) paid for sampling and surveillance, but 
the diagnoses costs were covered by the owners. Diagnosis was only performed in 
cattle older than 12 months, except for males and tagged animals. Mobilization was 
allowed only for animals coming from “brucellosis-free” herds. Positive herds were 
subjected to quarantine. Only serologically negative animals were allowed in 
exhibitions. Compensation was established at the beginning of the program but not 
anymore (Secretaría de Agricultura y Ganadería, 1997). Milk from positive herds 
was pasteurized or boiled. During 2014, an individual seroprevalence of 0.11% was 
reported by the authorities, however, only 0.51% of the national bovine population 
was reported under control of the Brucellosis National Program (OIRSA, 2014). 
B. melitensis and B. suis were officially reported as absent from 2006 to 2018 
(WAHIS, 2018a). However, no published or governmental information on attempts 
to isolate or identify these strains is available. B. abortus was reported in the territory 
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from 2010 to 2014 and limited to certain infected zones from 2014 to 2017. However, 
due to the small size of the country, brucellosis is considered prevalent in all areas. 
There is no information regarding wildlife (WAHIS, 2018a). From 2006 to 2016, a 
total of 39 human patients were reported as infected with brucellosis in Honduras 
(figure 12) (WAHIS, 2018b).  
Figure 12. Brucellosis human cases officially reported in Honduras between years 
2006-2016 (WAHIS, 2018b) 
 
Nicaragua  
In 1976, the Ministry of Agriculture started the Brucellosis Control and 
Eradication Program by test and slaughter in some areas. In herds with a high 
number of animals (>500), sacrifice was precluded, and unrestricted vaccination with 
S19 of calves aged between 3 to 6 months was carried out (García Carrillo, 1981). 
In 1977, B. abortus biovar 1 and 4 were isolated in Nicaragua. In 1979, the estimated 
nationwide brucellosis individual seroprevalence was 2% within a cattle population 
of 2.7 million animals (García Carrillo, 1979; García Carrillo, 1981; FAO, 2017).  
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Currently, some regulations are executed, giving priority to dairy cattle. The 
diagnostic tests include RBT, rivanol, CFT, and milk ring test. The positive animals 
(females and males older than 6 months) are slaughtered after the diagnoses with 
no compensation. Farms adjacent to the positive herds are regularly screened by 
serological tests. The Animal Health authorities declared brucellosis-free farms 
when herds tested negative for 6 months. An area is declared free of brucellosis 
when its herd prevalence is less than 0.2%. Mobilization of the animals is restricted 
to those that tested negative within 60 days. Animals that participate in fairs and 
exhibitions should come from brucellosis-free farms (MAGFOR, 2009). Owners are 
required to cover all diagnostic tests, tags, maintenance, and certifications. Since 
2009, vaccination against brucellosis is not allowed in Nicaragua (MAGFOR, 2009), 
though some unofficial vaccination with RB51 vaccines is carried out. From 2008 to 
2013 the reported individual seroprevalence of brucellosis ranged from 2.55% to 
1.28% (OIRSA, 2014). 
In 2016, a serological survey was performed in 1047 bovines from 170 farms 
in San Pedro de Lovago. The estimated individual seroprevalence via RBT and 
Rivanol test was 0.29% and 0.19%, respectively (Polanco & Riso, 2006).  
B. melitensis was reported in 2006, B. abortus from 2006 to 2018, and B. suis 
was present in 2006 and 2012. However, no clear attempts to isolate or characterize 
the bacteria or epidemiological studies have been carried out. There is no 
information on Brucella species in wildlife (WAHIS, 2018a). Sixteen cases of human 
brucellosis were reported from 2005 to 2017 (figure 13) (WAHIS, 2018b), indicating 
the presence of Brucella organisms in the territory.  
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Figure 13.  Brucellosis human cases officially reported in Nicaragua between 
years 2005-2017 (WAHIS, 2018b) 
 
 
Costa Rica  
In 1950, the Costa Rican National Animal Health Service aimed to control the 
disease through intervention measures in cattle (MAG-CR, 1978). At that time, 
reports of epidemic abortions, S19 vaccination, and agglutination diagnostic tests 
were the only strategies followed. In 1958, the serological diagnosis of brucellosis in 
bovine herds became mandatory and a national campaign for the control and 
eradication of the disease started on a voluntary basis with S19 calf vaccination, and 
elimination of the positive reactor animals with no compensation (Piagro, 1996).  
An official governmental program to control and eradicate brucellosis started 
in 1976 (Vicente, 1983).  The strategy consisted in S19 calf vaccination combined 
with test and slaughter.  By 1980, the coverage of vaccination reached close to 43% 
of the bovines (Vicente, 1983). During 1999, S19 vaccine was replaced by RB51, 
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and the national program was changed from a compulsory to a voluntary basis with 
supervision by the authorities (MAG-CR, 2000). The results of the national survey 
performed during 2012 described a herd prevalence of 10.5 % nationwide, using 
RBT. This estimated herd prevalence was supported by routine testing of close to 
500000 sera of bovines in 2016 and 2017 (Hernández Mora et al., 2017a). In 2018, 
the control program returned to being compulsory (MAG-CR, 2018). By the end of 
2018 and 2019, field trials had been conducted in order to define more suitable 
control strategies for the country and the most affordable options for vaccination, 
including conjunctival vaccination with S19 as described before by different countries 
including The United States (Plommet & Fensterbank, 1976). 
At least five B. abortus clusters, determined by whole-genome sequence 
analysis, have been found to affect humans and bovines (including water buffaloes) 
(Suárez-Esquivel et al., 2019). B. canis in dogs, B. ceti in dolphins and B. neotomae 
in humans are present in the country (Hernández-Mora et al., 2008; Hernández Mora 
et al., 2017b; Suárez et al., 2017a; Suárez-Esquivel, 2017b). In addition, a new 
smooth species named Brucella BCCN 84.3 was isolated from a dog (Guzmán-Verri 
et al., 2019). 
B. melitensis and B. suis have not been currently detected in Costa Rica 
(Hernández Mora et al., 2017b). According to the National Reference Center of 
Bacteriology (CNBR-INCIENSA), a total of 111 human brucellosis cases were 
reported in Costa Rica from 2003 to 2017 (figure 14). B. abortus was the species 
isolated in most human patients (Hernández Mora et al., 2017b; Chanto, 2018). B. 
neotomae was reported in two human brucellosis cases (Suárez-Esquivel, 2017b). 
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Figure 14. Brucellosis human cases officially reported in Costa Rica between 
years 2003-2017 (WAHIS, 2018b) 
Panama  
By 1970, the estimated individual seroprevalence ranged between 2% and 
4.7% in a bovine population of 1.1 million bovines (García Carrillo, 1981; FAO 2017). 
Then, a strategy of test and slaughter with no vaccination was implemented until the 
present day. The Ministry of Agricultural Development of Panama (MIDA) annually 
performs epidemiological surveillance for the control and eradication of bovine 
brucellosis. Diagnosis includes the RBT and iELISA, and the reactors are sent to the 
slaughterhouses with compensation to the owners (MIDA, 2018). Monitoring 
includes serological testing at slaughterhouses, dairy processing plants, and 
selected farms. After testing, farms and areas may be declared free of brucellosis. 
Alternatively, infected farms with brucellosis are declared in quarantined, and the 
mobilization of animals comes under official control (MIDA, 2018).  
During 2008, 2 samples resulted positive in RBT from 151585 animals tested 
nationwide as well as 7 samples out of 119699 bovines tested in 2010. No positive 
samples resulted in RBT during 2011 and 2012 out of 79879 and 92902 animals 
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tested (OIRSA, 2014). Beside sporadic official reports, no published epidemiological 
data are available in this country. After 2008, no isolation of Brucellae have been 
obtained, nor characterization of Brucella species and strains are documented either 
(OIRSA, 2014).  According to the official data submitted to WAHIS (2018a), from 
2006 to 2018, B. melitensis and B. suis are reported absent in domestic animals. B. 
abortus was present nationwide from 2006 to 2012 and was reported causing 59 
outbreaks involving the seven provinces (Berger, 2018). There is no information on 
these Brucellae species in wildlife (WAHIS, 2018a). A total of 14 human brucellosis 
cases were reported from 2005 to 2014 (WAHIS, 2018b), indicating the presence of 
this organism in the territory (figure 15).  
 
Figure 15. Brucellosis human cases officially reported in Panama between years 
2005-2014 (WAHIS, 2018b) 
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Brucellosis in the Andean Area countries (Bolivia, Peru, Ecuador, Colombia 
and Venezuela) 
 
Bolivia  
Bolivia made efforts to control and eradicate brucellosis since the decade of 
1970; however, they were unsuccessful (Agronegocios, 2017; Dirección General de 
Ganadería, Bolivia. 1974). In 1978, the bovine prevalence using the milk ring test in 
dairy herds at the Department of Santa Cruz and in Cochabamba were 30.5% and 
1.06%, respectively (García Carrillo, 1981). In 1997, the estimated herd 
seroprevalence in cattle was 10% (Kerby et al., 1997), and it was reported the 
presence of B. abortus in bovines. B. melitensis has been detected in small 
ruminants and B. suis in swine with low and sporadic incidence (Corbel, 1997). In 
2010, B. melitensis was reported as absent in goats in the region of Mizque 
(Zambriski et al., 2010). 
The current National Program for the control and eradication of bovine and 
bubaline brucellosis was established in 2014 (SENASAG, 2014). The purpose of the 
program is to join efforts between producers, veterinary professionals, health 
authorities, and government, among others (Agronegocios, 2017). Since 2014, 3-8 
months old calves and females older than 8 months are vaccinated with S19 and 
RB51, respectively. Currently, the serological test used is milk ring test, cELISA, and 
Buffered Plate Antigen (BPA) (SENASAG, 2012). Positive reactors must be sent for 
slaughter with no compensation (Agronegocios, 2017). 
Official data provided by the veterinary authorities at WAHIS (2018a), 
reported the presence of B.abortus from 2006 to 2018, B. melitensis was suspected 
but not confirmed during the same period of time and B. suis was reported in 2006 
and 2008 and absent from 2009 to 2018. In wildlife, including alpacas and lamas, 
brucellosis has been reported since 2005 (Suxo Blanco, 2005). However, no clear 
epidemiological data is available. 
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Brucellosis in humans was reported in Cochabamba during 2017. A study of 
276 samples from blood donors resulted in 1.1% seropositive using ELISA IgG 
(Vargas-Chiarella et al., 2017). Health authorities reported one human brucellosis 
case per year since 2018 (WAHIS, 2018b). 
 
Colombia  
Colombia started the brucellosis control campaign in 1970. The estimated 
national individual seroprevalence from 1971-1978 ranged from 0.4% to 11.4%, with 
an average individual seroprevalence of 4.22%. Vaccination was performed with a 
complete dose of S19 in females of all ages. The owners were responsible for 
vaccinating the animals (García Carrillo, 1981). In 1997, the only species reported 
was B. abortus in bovines (Corbel, 1997). Presently the objective of the Program for 
Prevention, Control, and Eradication of Bovine Brucellosis in Colombia is to reduce 
the herd prevalence of the disease in bovine, buffalo, ovine, caprine, and swine 
(IICA/SENACSA, 2017; ICA, 2019).  
Cattle and buffalo calves between 3-8 months of age are vaccinated with S19 
or RB51. Although vaccination is compulsory, revaccination with RB51 is 
recommended in females and buffaloes between 13 and 18 months (ICA, 2019). 
Likewise, revaccination with RB51 is recommended in non-pregnant females 
(bovines and buffaloes) at the age of 5 years and thereafter every five years. Before 
mobilization of bovines from free areas, vaccination with RB51 should be performed. 
In spite of these, there are no reliable epidemiological data reporting the success or 
failure of this idiosyncratic vaccination strategy. The screening tests include RBT, 
FPA, and iELISA. The competitive ELISA is used as a confirmatory test for bovine, 
buffalo, ovine, caprine, and swine. In the case of horses and dogs, the CFT is used 
for diagnoses. Bacteriological and PCR are currently performed by the Colombian 
Animal Health Authorities (ICA, 2019).   
B. abortus, biovar 1, 2, 4 in bovines, and B. suis 1 in swine have been 
identified in Colombia in domestic animals but not in wildlife (Corbel, 1997; Lucero, 
70 
2008). B. melitensis has never been reported, and B. suis has not been detected in 
the last 15 years (WAHIS, 2018a). B. canis was isolated in dogs in Medellin 
Colombia (Giraldo Echeverri, 2009), and an individual seroprevalence of 2.76% was 
reported (Agudelo-Flores et al., 2012). During 2012-2013 an active surveillance of 
humans with undifferentiated tropical febrile illness (fever without a focus of infection) 
reported a seroprevalence of 1% of antibodies against smooth Brucellae (Mattar et 
al., 2017). According to WAHIS (2018b), three clinical brucellosis human cases were 
reported in 2008 and 25 in 2015.  
 
Ecuador  
In 1979, the Ministry of Agriculture started the National Program of Animal 
Health, based on the official S19 vaccination of calves and the voluntary elimination 
of the reactors with no compensation (García Carrillo, 1981; IICA, 1980). Currently, 
the National Program works on a voluntary basis all over Ecuador and it includes 
test and slaughter strategy, as well as epidemiological surveillance, certification of 
brucellosis-free herds, control of the mobilization of animals, and information (SESA, 
2008). The vaccination is compulsory throughout the national territory, and it is 
carried out in female calves (individually tagged) between three and six months of 
age, using the S19 or RB51 vaccines. Vaccination is a requirement for selling and 
trading of dairy products and slaughter, exhibitions, selling cattle, commercialization 
of meat and breeding purposes (SESA, 2008). The diagnostic screening tests 
currently used are milk ring test and RBT, while confirmatory tests are ELISA.  Herds 
vaccinated with RB51 are considered brucellosis-free after two consecutive tests 
with a separation of 6 months each, while herds vaccinated with S19, require three 
negative serological tests with a separation of 6 months each (SESA, 2008). 
Currently, the control program receives financial support from governmental and 
private sectors in a proportion of 23% and 77%, respectively. There is no 
compensation for the owners after the slaughter of positive animals (SESA, 2008). 
According to the official data at WAHIS (2018a), B. abortus has been 
reported in bovines from 2006 to 2017, and B. suis in swine has been suspected 
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but not confirmed from 2011 to 2018.  There is no information of B. melitensis 
infections nor on brucellosis in wildlife. The brucellosis status of 11000 bovines in 
the Galapagos Islands is unknown.  Based on previous studies on the island, during 
1997 and 2014, cattle seemed free of the disease (Gioia et al., 2018). Since 2005, 
an increasing number of human patients with brucellosis has been reported in 
Ecuador (figure 16). 
Figure 16.  Brucellosis human cases officially reported in Ecuador between years 
2005-2018 (WAHIS, 2018b) 
 
Peru  
In Peru, the reported individual seroprevalence of brucellosis from 1972 to 
1975 ranged between 2% and 4% (García Carrillo, 1981). During 1997, it was 
reported that B. abortus was present in bovines and B. ovis in ovines (Corbel, 1997). 
Currently, the National Service of Animal Health (SENASA) is responsible for the 
brucellosis control and eradication program. The program gives priority to areas of 
intensive breeding of dairy cattle or dual-purpose, intending to establishing disease-
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free areas. The diagnostic tests are the RBT as a screening test and the CFT and 
indirect ELISA as the confirmatory tests, while the milk ring test is used for 
surveillance. Vaccination of calves and ear tagging is compulsory in farms with high 
seroprevalence of the disease. Positive animals are sent to slaughterhouses with no 
compensation. Replacements and animals participating in fairs and exhibitions must 
originate from brucellosis-free herds. Every six months, SENASA publishes a list of 
herds free of bovine brucellosis, and it also includes those that have lost their status. 
In both cases, the processing plants are informed. Herds free of bovine brucellosis, 
enjoy a bonus corresponding to 1% of the base price per kilogram of milk. The 
owners enrolled in the program are entitled to the benefits that are granted for trading 
bovine replacements. Trading raw milk is only allowed from brucellosis-free herds. 
According to WAHIS (2018a), B. abortus had been reported from 2008 to 
2018 and was absent in wildlife, while B. melitensis was present in caprine herds 
from 2007 to 2017. B. suis was reported in swine in 2007. Brucellosis has been 
detected in camelids with 20% individual prevalence in some regions of Peru (Murray 
& Fow, 1998). In Lima, in 2016, the individual seroprevalence in dogs using double 
immunodiffusion in agar gel was 21.3% (Zavala et al., 2016). There is no information 
regarding brucellosis in wildlife.  
Despite the efforts mentioned above to control brucellosis, Peru is the second 
country with more human brucellosis cases reported in the Americas, with a total of 
2868 patients since 2005 (figure 17) (WAHIS, 2018b).  Most of the human cases are 
caused by B. melitensis (Lucero et al., 2008). Two humans infected with B. ceti ST 
27 have been reported (Sohn et al., 2003). 
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Figure 17. Brucellosis human cases officially reported in Peru between 
years 2005-2017 (WAHIS, 2018b) 
 
Venezuela   
The first official brucellosis control program in Venezuela started in 1968, with 
S19 vaccination, test and slaughter with no compensation. In 1975, with a cattle 
population of 9 million bovines, the vaccination coverage was close to 35 %, with a 
herd seroprevalence from 16% to 33.4% or individual seroprevalence from 1% to 
3.4% depending on the area (García Carrillo, 1981; FAO, 2017). In 1999, the 
government approved the use of strain RB51 together with S19 for vaccination of 3-
8-month-old female calves and revaccination with RB51 at 10 to 15-month-old as 
well as adult cows in high herd prevalence areas (Vargas, 2000). In 2002, S19 was 
replaced by RB51 in some regions, however, S19 is still used in others (Vargas, 
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2002). Presently, the vaccination strategy has drawbacks such as i) the low 
availability of the vaccine in market ii) the low quality of the vaccine; iii) absence of 
notification after vaccination, and; iv) lack of supervision of the vaccination program 
(González, 1999). Venezuela has established the slaughter of the positive bovines 
with no compensation. 
Since 1999, the Autonomous Service of Animal Health (SASA) established 
RBT as a screening assay every 6 months in female cattle older than 20 months, 
and 2- Mercaptoethanol, CFT, and competitive ELISA as confirmatory assays.  Herd 
surveillance has been carried out by milk ring test and ELISA in milk (Vargas, 2000). 
Herds that give a negative result in two consecutive samplings separated by 6 
months receive a "brucellosis-free" status. Only animals from brucellosis-free herds 
are allowed to move in the territory.  
In 2002, the reported herd seroprevalence in cattle was 10.5%. Even higher 
values were reported in some areas of the country. Official data in WAHIS (2018a), 
reported B. abortus from 2006 to 2018 and it was suspected but not confirmed in 
wildlife from 2009 to 2018. B. suis was suspected in domestic animals from 2009 to 
2017 and in wildlife in 2011, and from 2015 to 2017 (WAHIS, 2018a). The presence 
of B. abortus biovar 1 and 4 in bovines, B. suis in swine, and B. canis in dogs have 
been reported in Venezuela (Corbel 1997; Lucero 2008; Contreras, 2000). 
Serological tests and isolation of B. abortus have been demonstrated in water 
buffaloes, while B. suis was recovered from capibaras (Hydrochaeris hydrochaeris), 
feral pigs and peccaries (Tayassu tajacu) (Lord et al., 1983; Lord et al., 1991). 
 B. melitensis was never reported in domestic animals or wildlife, according 
to the official data submitted to WAHIS (2018a), from 2006 to 2018. However, 
positive serological reactions have been detected in sheep and goats (Vargas, 
2002).  B. abortus, B. melitensis and B. suis have been detected in humans in 
Venezuela, with the former bacteria being the most commonly isolated (figure 18) 
(Vargas, 2002; Lord et al., 1998). 
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Figure 18. Brucellosis human cases officially reported in Venezuela between years 
2005-2018 (WAHIS, 2018b) 
 
Guyana  
The population of bovines, swine, and goats in Guayana is 100249, 12600, 
and 82606, respectively. There is no epidemiological data certifying the absence or 
presence of brucellosis in Guayana. During 2006 to 2018, B. melitensis and B 
abortus were suspected but not confirmed. B. suis was reported as absent. There is 
no information regarding brucellosis in wildlife (WAHIS, 2018a).  In spite of this, 
human cases have been reported with B. abortus, B. melitensis, and B. suis (Berger, 
2018), indicating the presence of Brucella organisms in this region.  
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Suriname  
The population of bovine, swine, and goats in Surinam is 33857, 34465, and 
3852, respectively (FAO, 2017). An individual brucellosis seroprevalence of 6.4% 
was reported in a total population of 40200 bovines in 1970, (Kooy,1970; FAO, 
2017). In subsequent years, the animal health authorities reported no brucellosis 
cases in 25000 bovine heads (WAHIS, 2018a; Berger, 2018). However, no 
epidemiological data regarding the current status of brucellosis is available, and the 
risk with neighboring countries with brucellosis exists. 
French Guiana  
The population of bovine, swine, and goats in French Guiana is 18592, 4772, 
and 1640, respectively (FAO, 2017). In 1981, the national authorities reported no 
brucellosis testing, and in recent years, the human health authorities have not 
reported any cases (García Carrillo, 1981; WAHIS, 2018b). There is no information 
regarding the presence of B. melitensis, B. abortus, and B. suis from 2006 to 2018 
in domestic animals or wildlife (WAHIS, 2018a) nor any epidemiological studies. Still, 
it is a susceptible area, since it borders with countries with reported cases of animal 
and human brucellosis. 
 
Brucellosis in the Southern Area countries (Argentina, Brazil, Chile, 
Paraguay and Uruguay) 
Argentina  
The herd prevalence of brucellosis in cattle during 1980 ranges from 10.75% 
and 13.86% (García Carrillo, 1981; FAO, 2017). Vaccination with S19 produced in 
Argentina since 1980 (García Carrillo, 1981) has been compulsory nationwide in 
calves of 3-8 months of age. In 1982, the Agriculture Department integrated a 
commission for the control of the disease that included governmental institutions, 
federal agriculture offices, private veterinarians, and producers. This program 
included mandatory as well as voluntary strategies, involving vaccination and test 
and slaughter, with no economic compensation. The assays used included plate and 
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tube agglutination test, 2 mercaptoethanol, and complement fixation. In dairy farms, 
the ring milk test was used for surveillance. By 1985, the estimated national herd 
seroprevalence decreased to 10% and individual seroprevalence above 5% 
(Samartino, 2002). 
In 1989, the vaccination coverage with a reduce dose of S19 administrated 
subcutaneously increased from 33.7% calves (in 1980) to 70-74% until the beginning 
of the 1990’s. In 1993, the vaccination increased to more than 90% (Samartino, 
2002). The vaccination program included animals from 3 to 10 months of age and 
adults. In 1998, the milk prices from brucellosis-free herds received better payment, 
promoting the dairy market. During these years, the National Veterinary Services 
(SENASA) performed protection experiments with RB51 vaccine; however, the 
comparative results with S19 revealed that RB51 had low protection and reduced 
herd immunity. Following this, RB51 vaccine was banned from Argentina (SENASA-
Argentina, 2002). In 2004, the national individual seroprevalence of bovine 
brucellosis was estimated to be 2.10% (12.4% in beef cattle farms), while in 2008, 
the herd seroprevalence ranged from 10% and 13% with an individual 
seroprevalence of 4-5% (Aznar et al., 2012; Lucero, 2008). Among the factors that 
promoted the increase in prevalence was the absence of compensation for 
slaughtering the reactors. This contributed to the hiding and selling of positive 
animals and spread of the infection (Aznar et al., 2012). 
The Brucellae species isolated in Argentina included B. abortus biovar 1, B. 
abortus biovar 2, and B. abortus biovar 4, B. melitensis biovar 1, B. suis biovar 1, B. 
suis biovar 1a, B. ovis and  B. canis (Lucero, 2008).  B. melitensis bv.1 has been 
isolated in goats and sheep, and the herd seroprevalence was estimated at 3.6%, 
12%, and 36% in the eastern, central, and western regions of Formosa province 
(border with Paraguay), respectively (Russo et al., 2016). The persistence of B. 
melitensis follows the distribution of goats in the central, western, and northern 
regions of the country, whereas B. suis and B. abortus had a higher prevalence in 
the Humid Pampa region where exploitation of cattle and pigs predominates 
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(Ministerio de Salud Argentina, 2013). B. ovis is present in rams all over the regions 
with herd seroprevalence ranging from 3% to 50% (SENASA, 2015).  
In 2014, B. abortus bv 1 and 2 were reported as the most frequent biovars 
isolated in the cattle of the country (Aznar et al., 2012).  Antibodies in wildlife have 
been found in up to 11.8% of the animals tested in the Pampas in 2009. In 2012, B. 
suis biovar 1 was isolated in armadillos (Chaetophractus villosus) from La Pampa 
and European hare (Lepus auropaeus) from Buenos Aires province (Kin et al., 2014; 
Fort et al., 2012).  From 1994 to 2006, B. suis was described as the agent 
responsible for 41% of the reported human cases, while B. melitensis, B. abortus, 
and B. canis, were responsible for the 38%, 20% and 1% zoonotic cases, 
respectively (Lucero, 2008). According to WAHIS (2018b), there were 2885 human 
brucellosis patients in Argentina from 2005 to 2018 (figure 19).  Cases of B. canis 
infecting humans have been described in the provinces of Neuquen, Corrientes, and 
Tierra del Fuego (Lucero, 2008). 
 
Figure 19. Brucellosis human cases officially reported in Argentina 
between years 2005-2018 (WAHIS, 2018b) 
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Brazil 
During 1972 and 1974, the individual and herd seroprevalences of brucellosis 
in cattle from Sao Paulo and other regions ranged fro 10% and 90%, respectively 
(Correa et al., 1972; Costa et al., 1974). Some states such as Rio Grande do Sul 
started an aggressive vaccination program to achieve 80% coverage of eligible 
heifers. Following this, a significant decrease in brucellosis seroprevalence was 
observed in this region (García Carrillo, 1981).  In 1975, a national survey 
determined a herd seroprevalence of 13.2% with a variation between 0.4% in Santa 
Catarina to 17.7% and 32.0% in Minas Gerais and Goias, respectively (García 
Carrillo, 1981). In 1976, the government proposed a National Program on a voluntary 
basis, with S19 vaccination of heifers from 3-8 months old and test and slaughter, 
with no compensation. This program was never fully implemented, and therefore the 
high prevalence remained active in the country, mainly in those regions with a high 
number of bovines (Poester et al., 2002).  In 1994, Minas Gerais achieved a S19 
vaccination coverage of 75% of the eligible heifers. However, in the rest of the 
country, vaccination was erratic, and the prevalence of B. abortus remained high. In 
the nineties, B. suis was sporadically reported in pigs (Corbel, 1997). 
A new National Control Program was implemented in 2001, that included a 
compulsory S19 vaccination of calves from 3 to 8-month-old. The S19 vaccine was 
not free of charge, and the payment was assumed by the farmers. The vaccinated 
animals were eligible for serological testing just after 24 months of age. The 
diagnoses were based on RBT as a screening test and 2 mercaptoethanol, 
complement fixation (CFT), fluorescence polarization assay (FPA), and competitive 
ELISA as confirmatory assays (Poester et al., 2002). Positive animals were 
slaughtered without compensation. This program included voluntary strategies such 
as accreditation of brucellosis-free herds, voluntary monitoring of beef herds based 
on periodic sampling, regular test for breeding stocks before mobilization or livestock 
exhibitions. In 2002, the Ministry of Agriculture set up a program to access cheap 
loans for replacing the slaughter of positive animals (Poester et al., 2002).   
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 From 2000 to 2010, an individual and herd brucellosis seroprevalence of 
9.88% and 86.3%, respectively, was reported in the Cerrado, Pantanal, and Amazon 
(Furtado et al., 2015). From 2007 to 2009, a herd seroprevalence of 11.4% and 
individual seroprevalence of 2.5% from Maranhao was reported (Borba et al., 2013). 
In 2012, an individual seroprevalence in cattle from northern and southern Brazil was 
described as 10.2% and 0.06% with 41.2% and 0.32% herd seroprevalence, 
respectively (Aznar et al., 2012). An individual prevalence of 31% was reported in 
semen samples from bulls from cattle-breeding farm in Minas Gerais, by PCR 
(Junqueira et al., 2013). In 2013, an individual seroprevalence of 4.8% was found in 
water buffaloes from Para State (da Silva et al., 2014).  During 2017, a new 
brucellosis control regulation was established for bovines and buffaloes with 
compulsory vaccination for both species at 3-8 months old with either S19 or RB51. 
The official diagnostic test included RBT as a screening assay and 2-
Mercaptoetanol, CFT, and FPA as confirmatory tests (Secretaria de Defensa 
Agropecuaria, 2017). 
 In addition to B. abortus infections, other Brucellae such as B. 
melitensis, B. suis, B. ovis, B. canis, and B. ceti have been suspected in Brazil. Still, 
very few epidemiological or bacteriological studies regarding these other Brucella 
species are available (WAHIS, 2018a). A survey in 2011 detected an individual 
seroprevalence of 0.7% and 6.1% in goats and sheep from Río de Janeiro, 
suspecting B. melitensis and B. ovis, respectively (Martins et al., 2012). From 2003 
to 2007, B. canis was isolated in 20.9% of the kennels in Sao Paulo (Keid, 2017). 
Also, from 2007 to 2017, B. canis was described in 50.7% of female dogs with 
reproductive problems, in 2.85% free-roaming dogs and 20.9% in kennel dogs in 
Parana (de Paula Dreer et al., 2013). During 2014, according to the World Animal 
Health, Brazil had 1142 domestic animal outbreaks (Hull and Schumaker, 2018). B. 
ceti was detected in the brain of a stranded dolphin in Brazil littorals (Attademo et 
al., 2018).  
B. abortus, B. melitensis, B. suis, and B. canis human infections have been 
reported (Oliveira et al., 2012; Berger, 2018). In 2006, 0.66% of the slaughterhouse 
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workers in Northern Para were reported to have antibodies against smooth Brucellae 
(Gonçalves et al., 2006). An increasing number of human patients have been 
reported by the health authorities. From 2009 to 2018 a number close to 1000 human 
brucellosis cases was reported (figure 20) (WAHIS, 2018b). 
Figure 20. Brucellosis human cases officially reported in Brazil between years 
2005-2018 (WAHIS, 2018b) 
Chile 
During 1974, the herd seroprevalence of brucellosis was 5%, 15%, and 3% in 
the Northern, Central, and Southern regions of Chile respectively, within a total 
bovine population of 3.4 million animals (García Carrillo,1981; FAO, 2017). In 1976, 
the Chilean Agriculture and Livestock Service, the Interamerican Development 
Bank, and the farmers set up a joint project.  This project included mass vaccination 
with S19 of calves between 3 to 8 months in the Central-Southern region, where 
92% of the herds were located. The project considered eradication of the disease in 
a period of five years using test and slaughter in the rest of the country with no 
compensation (García Carrillo, 1981). 
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In 1982, the estimated national herd seroprevalence of brucellosis was 2.9%, 
and in 1991 lowered to 0.4%. In 1992, the national brucellosis seroprevalence was 
described as steady, with strict test and slaughter strategy. Therefore, in 1997, with 
a population of 4.0 million bovines, the government changed the vaccine from S19 
to RB51, with B. abortus infections still present in the country. In 2012, a national 
survey indicated a herd seroprevalence of brucellosis in cattle of 0.2% within a 
population of 3.7 million animals (Aznar et al., 2012; FAO, 2017).  
According to WAHIS (2018a), during 2006-2018, the only Brucella species 
reported in Chile has been B. abortus. Despite B. melitensis and B. suis claims to be 
absent since its eradication in the eighties in domestic animals, though still present 
in humans. There are no reported cases in wildlife either (WAHIS, 2018a). Other 
species of Brucella, such as B. ovis, were reported as sporadic (FAO, 2017; 
Lopetegui, 1999; Corbel, 1997). B. canis is expected to be present in cities like 
Temuco, where 1% of the free-roaming dogs had positive serology (Tuemmers et 
al., 2013). The Chilean National Reference Laboratory for brucellosis in Chile, 
reported human infections from 2001 to 2010. From this, 1% were due to B. suis, 
4% to B. melitensis, 16% to B. abortus, and in 77% of the patients, the Brucella 
species was not identified. The average incidence rate was 5.5/1000000 inhabitants 
(Martínez, 2013), and according to FAO, a total of 68 human brucellosis patients 
were diagnosed from 2005 to 2018 (figure 21) (WAHIS, 2018b).  
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Figure 21. Brucellosis human cases officially reported in Chile from 
2005-2018 (WAHIS, 2018b) 
 
Paraguay 
A survey performed with rose Bengal test in 6360 bovine serum samples was 
performed in the Eastern area of Paraguay in 1974, describing 25% of the farms 
positive for brucellosis.  In the Western area, the individual seroprevalence ranged 
between 7.5% to 25% (Ibañez et al.,1975; Ibañez et al., 1977; García Carrillo, 1981).  
With a population of 4.8 million bovines, the country initiated a strategy of mass 
vaccination with S19 in calves in 1976. The program coordinated by the Ministry of 
Agriculture and the Pan American Zoonoses Center (PAHO/WHO) (MAG- 
Paraguay, 1976; García Carrillo, 1981; FAO, 2017) was followed for eight years on 
a voluntary basis for slaughter of the reactors with no compensation. By 1978, the 
estimated herd prevalence was 2%; therefore, it was considered to adopt an 
eradication program (García Carrillo, 1981). 
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By 1994, B. abortus, B. melitensis, and B. ovis were described as sporadic 
infections (Corbel, 1997). From 1994 to 2014, a herd seroprevalence of 5.1% to 
8.4% was reported in dairy cattle, and 19.8% to 3.9 % in double purpose and beef 
cattle, respectively (IICA, 2017; Aznar et al., 2012).  B. melitensis and B. abortus 
have been reported since 2006 to the present. B. suis was only reported as present 
in 2008 (WAHIS, 2018a). In 2017, the individual prevalence of B. canis in mixed-
breed dogs was 9.6% in Conception City, estimated by immunochromatography test 
(Colman et al., 2017).  
In 2018, the National Animal Quality and Health Service (SENACSA) 
established the compulsory nationwide vaccination of cattle, under the financial 
responsibility of the farmers. The vaccines included S19 for calf vaccination between 
3-8 months old, and RB51 for adult cows and for revaccination (SENACSA, 2018). 
However, the vaccination coverage was low, achieved in no more than 50% of the 
cattle. The program did not include restrictions in the mobilization of herds, with the 
sole exception of animals in fairs or exhibitions (SENACSA, 2017).  
Presently, there are no studies regarding the prevalence of brucellosis in 
Paraguay. According to the analysis based on routine diagnostic data, the estimated 
seroprevalence of brucellosis in bovines is close to 5% of individuals and 20% of the 
herds. Following this, the estimated seroprevalence in dairy cattle is 2% of the cows 
and 8% of the herds. In beef cattle, the estimated seroprevalence is 6% of bovines 
and 25% of the herds. According to the information of IICA, the herd seroprevalence 
may fluctuate as high as 20% (IICA, 2017).  
From 2010 to 2018, thirty-two human cases were described including, 21 
confirmed humans infected by B. melitensis out of 78 suspected students and 
personnel in a Veterinary School in Asuncion in 2017 (figure 22) (Berger, 2018; 
WAHIS, 2018b). 
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Figure 22. Brucellosis human cases officially reported in Paraguay between years 
2010-2018 (WAHIS, 2018b) 
Uruguay 
In 1964, with a population of 8.7 million bovines, the mass vaccination with 
S19 of heifers was established as a compulsory strategy by the government (García 
Carrillo, 1981; Gil, 2009; FAO, 2017). Identification of the vaccinated animals, culling 
of the brucellosis positive animals, and action for the movement and importation of 
bovines were established (Garín A, 2011). In 1973, nine years after the compulsory 
vaccination of more than 80% of the bovines, the estimated herd seroprevalence 
was 3.3% for beef cattle and 1.4% for dairy cattle (García Carrillo, 1981). During the 
late seventies, the herd seroprevalence diminished to 1.2%-6.8% for beef cattle and 
0.4%-3.2% for dairy cattle (Gil et al, 2009). By 1981, the coverage of vaccination 
with S19 reached 95.5% (García Carrillo, 1981).  
In 1998, the Brucellosis Eradication Program was established to achieve the 
status of country free of brucellosis according to the conditions established by the 
International Zoosanitary Code of the OIE. The Brucellosis Eradication Program 
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began, with emphasis on dairy farms on a voluntary basis. The scheme included 
vaccination with S19, two rounds of serological testing with intervals of 6 to 12 
months, and elimination of the seropositive animals. However, this program had low 
acceptance due to the absence of financial support (Gil et al, 2009). 
In the early nineties, the national individual seroprevalence was 0.13% in non-
random serum sampling and lowered to 0.30% in dairy cattle by random sampling. 
Therefore, due to the low seroprevalence of the disease, the Veterinary Services 
banned S19 vaccination in 1996.  The program continued with the surveillance using 
milk ring test and slaughter of seropositive animals. Notification of abortions from 
farms became compulsory (Gil et al., 2009). 
 Due to a lack of suitable official intervention to the outbreaks in the Brazil 
border and the southeast region of the country, vaccination with B.abortus RB51 
started in the risk zones in 2004. At the same time, economic compensation for the 
slaughter of positive cattle was implemented (Lopetegui, 2004). Still, from 2002 to 
2008, the national herd seroprevalence was estimated between 2.04% to 1.30% in 
beef cattle and less than 0.25% in dairy cattle with an overall herd seroprevalence 
of 1.70% to 1.10% nationwide (Gil et al., 2009). During 2012, the individual 
seroprevalence was estimated at 0.04% on 11.4 million bovines (Garín, 2011; Aznar 
et al., 2012; FAO, 2017). No data are proving that bovine brucellosis has been 
eradicated yet. 
 The presence of B. abortus is reported mainly in bovine. B. suis was 
reported present from 2006 to 2015, and absent in 2018. B. melitensis has never 
been reported in domestic animals (WAHIS, 2018a). The authorities recognize that 
the advances that made it possible to reach eradication in cattle have been due to 
the success of vaccination with S19 back in the decades of sixties to eighties (Gil et 
al., 2009). There is no information regarding brucellosis in wildlife. From 2005 to 
2018, 77 cases of human brucellosis have been reported (figure 23) (WAHIS, 2018b; 
Pisani et al., 2017). The only species reported in humans has been B. abortus 
. 
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Figure 23. Brucellosis human cases officially reported in Uruguay between years 
2005-2018 (WAHIS, 2018b) 
 
Brucellosis in the Caribbean countries 
(Antigua and Barbuda, Aruba, Bahamas, Barbados, Bermuda, British Virgin 
Islands, Cayman Islands, Cuba, Dominica, Dominica Republic, Grenada, 
Guadeloupe, Haiti, Jamaica, Martinique, Montserrat, Netherlands Antilles, 
Puerto Rico, St. Kitts and Nevis, St. Lucia St. Pierre and Miquelon, South 
Georgia and the South Sandwich Islands, Suriname, Trinidad and Tobago, 
Turks and Caicos Islands, US Virgin Islands, United States Minor Outlying 
Islands). 
According to the WAHIS (2018a) from 2006 to 2018, there are no reports of 
brucellosis animal cases in the islands of Martinique, Cayman Islands, Dominica, 
Falkland Islands (Malvinas). However, no epidemiological data or scientific studies 
determining the presence or absence of Brucella organisms in these latitudes are 
available.  In the islands of Anguilla, Aruba, Bermuda, British Virgin Islands, 
Guadeloupe, Montserrat, Netherlands Antilles, St. Kitts and Nevis, St. Lucia St. 
88 
Pierre and Miquelon, South Georgia and the South Sandwich Islands, Turks and 
Caicos Islands, US Virgin Islands, United States Minor Outlying Islands, no WAHIS 
(2018a) information was generated. In the case of wildlife of these locations, there 
is no information available regarding the presentation of brucellosis in these 
animals.  
Antigua and Barbuda 
In the islands of Antigua and Barbuda, brucellosis is not considered endemic; 
however, tests with armed B. suis as a biological weapon was linked to this country 
in 1948 (Willis, 2003). There is no information available on B. melitensis, B. 
abortus or B. suis on these islands during 2006 to 2018 (WAHIS, 2018a). However, 
there are no epidemiological data available nor attempts to isolate the bacteria from 
either domestic animals or wildlife.  
Barbados  
In 1975, the program for the eradication of the disease was established in 
14000 animals. By 1977 the reported individual seroprevalence varied between 
0.1% and 0.9% (García Carrillo, 1981; FAO, 2017). By 1997, neither B. abortus, B. 
melitensis, B. suis, nor B. ovis were reported on the island (Corbel, 1997). Currently, 
the disease is reported as absent in domestic animals, and there is no information 
in wildlife or humans (WAHIS, 2018a; WAHIS, 2018b). However, no epidemiological 
data nor attempts to isolate the bacteria either from domestic or wildlife animals from 
this island are available. 
Bahamas 
In this country, B. suis was tested as a biological weapon during 1953 and 
1954 (Willis, 2003). Currently, there is no official information on B. melitensis, B. 
abortus or B. suis in this island from 2006 to 2018 reported in WAHIS (2018a). 
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Cuba  
Brucellosis was first confirmed by the isolation of B. abortus in 1937 from a 
bovine placenta (Pelaiz, 1950). From 1963 to 1973, with a population of 6 million 
bovines and using tube agglutination test, an individual seroprevalence of brucellosis 
diminished from 4.33% to 0.3%. After this, a brucellosis control campaign based on 
test and slaughter, regulation of movement of bovines, and quarantines of imported 
bovines was established.  During 1973-1976, with a cattle population of 5.3 to 5.6 
million animals, an individual prevalence from 0.3% to 0.4% was achieved (García 
Carrillo, 1981). 
From 2006 to 2018, the presence of B. abortus was reported, while B. suis 
was first reported in 1997 (Corbel, 1997). From 2006 to 2012, B. suis was still 
present, but reported absent in the following years. B. melitensis has never been 
reported in domestic animals or wildlife on the island (WAHIS, 2018a). In humans 
Brucella spp. have been described causing endocarditis (García et al., 2012), and a 
total of 345 cases were reported by the authorities between 2005 to 2018 (figure 24) 
(WAHIS, 2018b). Although Brucella organisms have been reported absent in wildlife, 
there are no published data on serological or bacteriological studies. 
Figure 24. Brucellosis human cases officially reported in Cuba between 
years 2005-2018 (WAHIS, 2018b) 
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Dominican Republic 
Serological studies in about 100000 animals were performed from 1966 to 
1971 from a total population close to 1.3 million heads (García Carrillo, 1981; FAO, 
2017).  The individual seroprevalence ranged between 4.1% and 12.2%, with an 
average of 10% (García Carrillo, 1981). In 1972 with a bovine population of 1.4 
million, a program to control and eradicate brucellosis was established using S19 
vaccination, following, test, and slaughter in farms where it was financially possible 
(García Carrillo, 1981; FAO, 2017). There are no recent studies for the estimation of 
the bovine brucellosis prevalence in the Dominican Republic.  
Both S19 and RB51 vaccines are used. While S19 is given free by the 
government, RB51 vaccine has to be purchased by the farmers. Calf and adult 
vaccination with full dose are allowed. During 2018, an estimated vaccination 
coverage reached 36% on an estimated population of 230695 bovines. RBT and 
FPA, as well as RMT, are used as diagnostic tests. Positive animals are marked and 
slaughtered with no compensation. Quarantine and restriction of mobilization of the 
positive herds are mandatory (Duran, U, 2019, per commun). In 2014 and 2015, 40 
human brucellosis patients were reported in Dominican Republic (WAHIS, 2018b). 
B. melitensis has been suspected but not confirmed in domestic animals 
(WAHIS, 2018a). B. abortus was reported as present from 2006 to 2018. B. suis 
seems to be absent; however, isolation or identification of the strains has not been 
attempted on a regular basis. There is no information regarding Brucella infections 
in wildlife (WAHIS, 2018a). No suitable epidemiological data are available from this 
country. 
Grenada 
The number of bovines, sheep, goats, and pigs in Grenada is estimated to be 
5400, 13000, 7000, and 5400, respectively. Vaccination of bovines for Brucella spp. 
protection is not performed in Grenada. A survey during 2013 reported a bovine herd 
seroprevalence of 20% and individual seroprevalence of 6% (Chikweto et al., 
2013a). Antibodies in dogs against smooth Brucellae had been recorded with an 
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individual seroprevalence ranging from 1 to 20% (Chikweto et al., 2013b). The status 
of brucellosis in other animals is unknown, and there is not information about this 
bacterial disease in wildlife or humans in Grenada.  
Haiti  
During 1964, the individual seroprevalence of brucellosis in cattle ranged 
between 3 to 5% (Grosnier, 1964). In 1966, the individual seroprevalence was found 
to be over 10% (Laroche et al., 1966). The estimated population of bovines and pigs 
on the island during 2017 was approximately 1.5 million and 1.6 million, respectively 
(FAO, 2017). Sporadic human cases due to B. abortus have been recorded, and the 
Dominican Republic, the neighbor country, has reported human brucellosis cases 
imported from Haiti. Currently, there is no information regarding the infection in 
domestic animal nor wildlife Brucella infections (WAHIS, 2018a).  
Jamaica  
From 1971 to 1975, the reported individual seroprevalence of bovine 
brucellosis ranged between 1.5% to 0.5% (García Carrillo, 1981). In 1978 and 1979, 
the individual seroprevalence reported was 0.3% and 1.2%, respectively (García 
Carrillo, 1981). Presently the bovine and swine population in Jamaica is of 265000 
and 80000, respectively, with no reported cases of brucellosis (FAO, 2017). The 
number of sheep and goats in Jamaica is low, with no reported cases of brucellosis. 
From 2006 to 2018, there is no information on B. melitensis, B. abortus, and 
B. suis in this island either in domestic animals, wildlife or humans (WAHIS, 2018a; 
WAHIS, 2018b). No suitable epidemiological data are available from this country. 
Puerto Rico  
Brucellosis did not exist in the island until 1923, after the importation of 
infected cattle from mainland USA (García Carrillo, 1981). In 1947, the national herd 
bovine seroprevalence was 13.6%, while the prevalence in human blood donor was 
4.7% (Morales Otero, 1949). Vaccination with S19 started in 1942, followed by a test 
and slaughter strategy and certification of brucellosis-free areas. In 1949, the herd 
prevalence lowered to 1%. The herd seroprevalence described in 1977, 1978 and 
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1979 was 0.77%, 0.59% and 0.61%, respectively (García Carrillo,1981). During 
2006 to 2018, there are no reports of B. melitensis, B. abortus or B. suis in domestic 
animals, wildlife or in humans (WAHIS, 2018a; WAHIS, 2018b). Presently it seems 
that Puerto Rico, as part of the confederation of the United States, is free of 
brucellosis; however, no published epidemiological studies are available. 
St. Vincent and the Grenadines 
B. melitensis, B. abortus, B. suis have been suspected in domestic ungulates 
but there is no confirmation from 2006 to 2018. There is no information regarding 
brucellosis in wildlife (WAHIS, 2018a). No epidemiological data are available from 
this island. 
Trinidad and Tobago  
B. abortus was present in bovines, including water buffalo from 2006 to 2014, 
and it was reported absent from 2015 to 2017 (WAHIS, 2018a). B. melitensis and B. 
suis have not been detected in domestic animals or wildlife. However, systematic 
attempts to isolate the bacterium have not been carried out; no epidemiological 
studies are available.
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Annex 2. Official data of the presentation of brucellosis in domestic animals or wildlife 2006-2018 of the Americas. 
(WAHIS, 2018a; FAO,2017; García Carrillo, 1981). 
 
Country 
 
Cattle 
Population 
 
Year of first 
report of 
brucellosis
-specie 
 
Domestic animals 
 
Wildlife 
   B. 
melitensis 
B. abortus B. suis B. 
melitensis 
B. abortus B. suis 
Anguilla NI NI NI NI NI NI NI NI 
Antigua and 
Barbuda 
5000 NI NI NI NI NI NI NI 
Argentina 53353787 1922  
human 
P  
2006-2018 
P  
2006-2011 
L  
2012-2018 
P  
2006-2017 
L  
2018 
NI L  
2012 
P  
2014- 2017 
A  
2017-2018 
Aruba NI NI NI NI NI NI NI NI 
Bahamas 740 NI NR NR NR NR NR NR 
Barbados 10743 1948 A A A NI NI A 
Belize 113122 NI A NR NR A NR NR 
Bermuda 649 NI NI NI NI NI NI N 
Brazil   NI NR P  
2006-2018 
 
P 
2006 
A  
2007-2018 
NR NI NI 
British 
Virgin Island 
2400 NI NI NI NI NI NI NI 
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Country 
 
Cattle 
Population 
 
Year of first 
report of 
brucellosis
-specie 
 
Domestic animals 
 
Wildlife 
   B. 
melitensis 
B. abortus B. suis B. 
melitensis 
B. abortus B. suis 
         
Canada 11535000 NI NR L 2007 
SN 2008 
A 
2006,2009
-2018 
A NR SN  2009-
2011 
L 2012-
2018 
P  
2009-2018 
 
Cayman 
islands 
2111 NI A A A NI NI NI 
         
Chile 2890840 NI A P  
2006- 
2018 
A A A A 
 
 
Colombia 22461179 1944  
bovine 
placenta 
NR P  
2006-2018 
A NR A A 
Costa Rica 1420979 1914 
hemoculture 
human 
 
 
 
NI P  
2006-2018 
NI NI SN  
2009- 2012 
NI 
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Country 
 
Cattle 
Population 
Year of first 
report of 
brucellosis
-specie 
 
Domestic animals 
 
Wildlife 
   B. 
melitensis 
B. abortus B. suis B. 
melitensis 
B. abortus B. suis 
Cuba 3865500 1937 
bovine 
placenta 
NR P  
2006-2018 
P  
2006-2012 
A  
2013-2018 
NR A  
2010-2018 
A 
Dominica 14076 NI NR NR NR NI NI NI 
Dominican 
Republic 
3000000 NI SN  
2017 
P  
2006-2018 
 
A NI NI NI 
Ecuador 4190611 
 
1952 
vaginal 
fluids bovine 
NI P  
2006-2018 
SN 2011 
P  
2012-2018 
NI NI NI 
El Salvador 962889 NI A P  
2006-2017 
 
A A NI NI 
Falkland 
Islands 
(Malvinas) 
4201 NI NR NR NR NR NR NR 
French 
Guiana 
18582 1941 
human 
A A NI NI NI NI 
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Country 
 
Cattle 
Population 
Year of first 
report of 
brucellosis
-specie 
 
Domestic animals 
 
 
 
Wildlife 
   B. 
melitensis 
B. abortus B. suis B. 
melitensis 
B. abortus B. suis 
Grenada  4552 NI A A A NI NI NI 
Guadeloupe  76975 NI NR NI A NI NI NI 
Guatemala 3850206 NI NR P  
2006-2017 
NR NR SN  
2009- 2017 
NR 
Guyana 100249 NI SN  
2006 
SN  
2006, 2010 
A NI NI NI 
Haiti 1497228 NI NI NI A NI NI N 
 
Honduras 2869201 
 
1977 
Bovine 
NI L  
2006-
2009, 
2014-2017 
P  
2010-2014 
A NI NI 
 
NI 
Jamaica 130668 NI NR A NR NR NI NR 
Martinique 
(France) 
13594 NI A A A A NI NI 
Mexico 31771736 NI P  
2006-2014 
L  
2014-2017 
P  
2006-2010 
L  
2010-2017 
P 
2013-2014 
SN  
2009-2014 
A  
2016-2017 
SN  
2009-2014 
A  
2015-2017 
SN  
2009-2014 
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Country 
 
Cattle 
Population 
Year of first 
report of 
brucellosis
-specie 
 
Domestic animals 
 
Wildlife 
   B. 
melitensis 
B. abortus B. suis B. 
melitensis 
B. abortus B. suis 
         
Monstserrat 10071 NI NI NI NI NI NI NI 
Netherlands 
Antilles 
644 NI NI NI NI NI NI NI 
Nicaragua 4848341 
 
1977 P  
2006 
P  
2006-2018 
P  
2006, 2012 
NI NI NI 
Panama 1521500 
 
NI A P  
2006-
2012, 
2015-2018 
L  
2013-2016 
A A NI NI 
Paraguay 13821526 
 
1976 
cow milk 
P  
2006-
2008, 
2017,2018 
P  
2006-2008 
L 2008-
2018 
P  
2008 
NI NI NI 
Peru 5535569 
 
NI L  
2007, 
2008,2011
, 
2016,2017 
L  
2008-2018 
P  
2007 
NI A  
2016-2018 
NI 
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Country 
 
Cattle 
Population 
Year of first 
report of 
brucellosis
-specie 
 
Domestic animals 
 
 
Wildlife 
   B. 
melitensis 
B. abortus B. suis B. 
melitensis 
B. abortus B. suis 
         
Puerto Rico 
& US Virgin 
Islands 
372524 NI NI NI NI NI NI NI 
St. Kitts & 
Nevis 
2000 NI NI NI NI NI NI NI 
St. Lucia 10981 NI NI NI NI NI NI NI 
St. Pierre & 
Miquelon 
38 NI NI NI NI NI NI NI 
 
St. Vincent & 
the 
Grenadines 
 
3931 
 
NI 
 
SN 
2006-2010 
 
SN 
2006-2010 
A  
 2017-
2018 
 
NR 
 
NI 
 
NI 
 
A 
South 
Georgia and 
the South 
Sandwich 
Islands 
NI NI A NI NI A NI NI 
Suriname 33857 NI A A A A A A 
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Country 
 
Cattle 
Population 
Year of first 
report of 
brucellosis
-specie 
 
Domestic animals 
 
Wildlife 
   B. 
melitensis 
B. abortus B. suis B. 
melitensis 
B. abortus B. suis 
Trinidad and 
Tobago 
35895 NI NR P 
2006,2009, 
2014 
A 
2007-
2008,2010
-
2013,2015
-2017 
NR NR NI NR 
Turks & 
Caicos 
Islands 
NI NI NI NI NI NI NI NI 
US Virgin 
Islands 
8101 NI NI NI  NI NI NI 
United 
States Minor 
Outlying 
Islands 
NI NI NI NI NI NI NI NI 
 
Uruguay 11739000 
 
NI NR P  
2006-2018 
P  
2006-2012 
L  
2015 
A 
2013,2014, 
2016/2018 
NR NI  
2009-2014 
A 
100 
 
 
Country 
 
Cattle 
Population 
Year of first 
report of 
brucellosis
-specie 
 
Domestic animals 
 
 
 Wildlife  
   B. 
melitensis 
B. abortus B. suis B. 
melitensis 
B. abortus B. suis 
Venezuela 16482742 
 
1930 
Bovine 
NR P  
2006,2018 
 
SN  
2009-2017 
NR SN  
2009-2018 
SN 
2011,2015, 
2017 
*Disease reported as: (P) Present, (L) Limited to one or more zones, (SN) Suspected but Not confirmed, (A)Absent, (NI) No 
Information, (NR) Never Reported 
